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ABSTRACT 
Background 
The increasing incidence of chronic whiplash associated disorders II [CWAD II] has been 
attributed to poor understanding of its predominant mechanisms. Documented impairments 
of sensory hypersensitivity and hypoaesthesia reflect a disordered nervous system acting as 
triggers for symptoms. Some impairments are discriminative of CWAD II, although gender 
bias, non-inclusion of a widely-used sensory test [upper limb neurodynamic test (ULNT)], 
and conflicting findings necessitated further study.  
 
Methods  
Review of the literature identified 11 sensory tests used to discriminate CWAD II from 
healthy individuals. The measurement properties of the tests supported preliminary reliability 
studies of dynamic ultrasound imaging to inform the construct validity of the ULNT, prior to 
its inclusion in a cross-sectional discriminative study comparing CWAD II (n=22) and 
healthy participants (n=36).  
 
Data analysis 
Factor analysis (Eigen value ≥1) and logistic regression   
 
 
 
 
 
 
Results 
The CWAD II participants reported mild pain, disability, psychological stress, and no 
neuropathic pain. Three factors of hyperalgesia, hypoaesthesia and hypersensitivity were 
generated. Logistic regression using the factors did not discriminate between the groups 
(p>0.05).  
 
Conclusion 
Sensory impairments exist in CWAD II, but were unable to discriminate a low severity 
population using 4 sensory tests. The findings support further investigation using additional 
tests as they emerge from the literature. 
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 C H A P T E R  O N E  
INTRODUCTION  
 
1.1 Background to Chronic Whiplash Associated Disorders 
Chronic whiplash associated disorders (CWAD) describes the group of signs and symptoms 
that are present 6 months after a whiplash injury. The incidence of CWAD has progressively 
increased over the last 30 years, despite a fall in road traffic accidents, substantial CWAD 
research and evidence-guided physiotherapy treatment intervention (Cote et al., 2001, 2005; 
Ottoson, 2005). The increased incidence might reflect limitations of present understanding of 
underlying mechanisms for the range of symptoms and impairments reported in CWAD (Jull 
et al., 2007), with the implication that the rationale to inform use of tests to evaluate 
underlying mechanisms in a clinical setting is limited. Further research is therefore merited 
to develop understanding of CWAD impairments to guide clinical assessment decisions, 
particularly, as some impairment are reported to discriminate CWAD from idiopathic neck 
pain (Scott et al., 2005; Elliot et al., 2008; Chien and Sterling, 2010). 
 
Symptoms post whiplash injury has been proposed to involve mechanisms of nociception, 
motor dysfunction, psychological factors, peripheral and central sensory sensitisation 
(Sterling 2009). However, treatment interventions targeting these mechanisms in the acute 
phase have not yielded positive outcomes, particularly in those presenting with sensory 
impairments. This claim is informed by preliminary findings within a CWAD trial (n=71) 
which showed that a subgroup with widespread hyperalgesia (to cold and pressure) reported 
 
 
 2 
 
marginal reduction to their pain and disability post multimodal physiotherapy [16%] (n=9; 
neck pain index (SD) = 7.0 (15.8) / 42.3(14.4)) when compared to self-management (advice 
and exercise) [17%] (n=10; neck pain index (SD) = 7.3 (8.1) / 42.5 (11.7)) over a 10 week 
period (Jull et al., 2007). Though the subgroup sample was small, the findings potentially 
suggest that sensory mechanisms are important to understand symptoms persistence in 
CWAD, particularly, after the time that tissue repair is expected to have concluded. 
Radiological investigation and nerve conduction studies further support this as they appear 
normal in a significant proportion of whiplash patients (Greening et al., 2001). Consequently, 
research focused to impairments in CWAD has been developed to understand sensory 
mechanisms (Sterling, 2009). Current conclusions from research is however limited and 
inconclusive due to methodological issues and discrepancies across findings. In particular, 
the evidence for impairments reported to discriminate CWAD that plausibly interpret 
predominant mechanisms in the condition, merit further investigation. 
 
Evidence indicates that both local and widespread sensory hypersensitivity and 
hypoaesthesia to a range of stimuli exists in CWAD, but is absent in patients who recover or 
report mild to moderate symptoms (Sterling 2010). This suggests that sensory mechanisms 
might trigger and promote impairments as well as symptoms that persist in CWAD. It is 
proposed that the impairments are indicative of underlying dysfunctional pain-processing 
mechanisms, maintained by a hyperexcitable peripheral and central nervous systems 
(Curatolo et al., 2001; Sterling et al., 2003). Interestingly, reports of moderate association 
between sensory impairments [pressure and cold hypersensitivity at some limb sites] and 
psychological factors [post traumatic stress disorders (PTSD), psychological factors and pain 
catastrophisation] in CWAD, suggests psychological factors may also contribute to a 
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hyperexcitable neural system in the condition (Sterling 2010). However, recent findings that 
psychological factors did not significantly affect spinal cord hyperexcitability; a lack of 
supportive evidence showing the association for all sensory stimuli and body sites tested; as 
well as pain and disability mediation of association between PTSD and sensory impairments; 
together suggests that psychological factors are not triggers for the spinal cord 
hyperexcitability demonstrated in CWAD (Sterling et al., 2008, 2010). As a result, sensory 
impairments are therefore increasingly gaining attention in CWAD research as they might 
assist further understanding of the condition. 
 
Emerging research (Scott et al., 2005; Elliot et al., 2008; Chien and Sterling 2010) indicates 
that sensory hypersensitivity to cold and pressure as well as hypoaesthesia to vibration 
describes impairments that discriminate CWAD from non-traumatic neck. These findings 
reflect potential predominant mechanisms in CWAD that future assessment methods should 
target. Such assessment followed by appropriate management strategies promise positive 
outcomes in CWAD that could lead to reduced incidence and impact of CWAD. However, 
discrepancies relating to which sensory impairments and limb sites are discriminative of 
CWAD exists (Williams et al., 2007). Apart from the limitation of the number of sensory 
discrimination studies (n=3), the evidence they provide is incomplete and limited due to 
issues of study bias to the female gender (Elliot et al., 2008), exclusion of important sensory 
outcomes e.g. upper limb neurodynamic test (ULNT), conflicting study findings (Scott et al., 
2005; Elliot et al., 2008; Chien and Sterling, 2010), and unsupported study conclusions 
(Chien and Sterling, 2010). For example, there is evidence to suggest that men and women 
differ in their perception and experience of pain plausibly due to biological and 
psychological factors (Bernades et al., 2008; Hurley and Adams, 2008). Gender differences 
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for sensory characteristics have also been reported (Edwards et al., 2004; Sullivan et al., 
2005; Rolke et al., 2006) although evidence suggesting the contrary also exist (Lin et al., 
2005). The non inclusion of ULNT, a simple and costless sensory test that physiotherapists 
perform during assessment of CWAD to interpret changes to peripheral and central neural 
functioning (Elvey, 1997; Nee and Buttler, 2006) in all 3 discrimination studies, negate 
present emphasis for simple and affordable sensory tools as a result of cost savings in the 
National Health Service [NHS], as well as increasing delivery of patient care within 
community settings (Brocklehurst et al., 2011). As a result, direct translation of previous 
research finding to clinical practice will be limited by cost of the sensory equipments. In 
addition, the measurement properties of reliability and validity required for consistent and 
interpretable measurements have not been established for some of the reported sensory tests 
(e.g. electrical detection thresholds), and the suitability, applicability and safety of some of 
the tests (e.g. electrical detection) for use on patients is in doubt. These limitations of existing 
discriminative studies reflect incomplete, limited and inconclusive evidence for sensory 
impairments that discriminate CWAD, as well as lack of clarity for predominant mechanisms 
in the condition. Further evaluation of sensory impairments that are discriminative of CWAD 
is therefore warranted.  
 
1.2 Incidence and cost associated with WAD 
WAD is characterised by a variety of clinical symptoms occurring as a result of bony or soft 
tissue injury caused by injury to the neck during a motor vehicle collision or sporting 
accident (Spitzer et al., 1995). Research statistics report an annual incidence of 300,000 
WAD cases in the UK, approximately 500 cases per 100,000 of the sample (Mercer 2007). 
The incidence of WAD per 100,000 of sample is 106 in Australia (Harder et al., 1998), 70 in 
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Quebec (Spitzer et al., 1995), 94-188 in the Netherlands (Wismans and Huijkens, 1994) and 
400 in the United States of America. The incidence of WAD is reported to be higher in the 
United Kingdom when compared to other developed countries (Mercer, 2007).  Although 
reasons were not provided to justify the incidence data in Mercer, (2007), the recentness of 
the data as well as existing compensation systems may have contributed to their data. 
Caution should be applied when interpreting the incidence of WAD because a significant 
proportion of the reported data is outdated and potentially underestimate its impact on 
society as well as the distribution of the condition. 
 
WAD is associated with substantial economic costs arising from lost productive hours, 
health care, legal services and other disability-related expenses (Sterling, 2011), with 
reported annual estimates of $3.9 billion in the USA (Eck et al., 2001), €10 billion in Europe 
(Lovell et al., 2002) and £3 billion in the UK (Crouch, 2006). Cost data from other 
developed countries to assist interpretation of the impact of WAD is lacking, particularly 
from countries that have reported incidence of the condition. Overall, the reported incidence 
and costs data warrant further evaluation of predominant mechanisms in WAD, to inform 
assessment and in turn treatment strategies that help to reduce the impact of the condition. 
 
1.3 Classification of WAD 
WAD has been described as a heterogeneous condition presenting with varied symptoms that 
warrant a classification system to guide both research investigation and treatment decisions 
(Sterling, 2004). A sub-classification of the condition is also hypothesised will help identify 
homogenous subgroups, so that clinical assessment can be tailored to subgroup specific 
impairments (So¨derlund et al., 2000; Peolsson and Gerdle, 2004). Considering its 
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usefulness, a classification system was proposed by the Quebec task force (Spitzer et al., 
1995) to address subgroup impairments in WAD, and has recently been adapted by the Neck 
Pain Task Force (Guzman et al., 2008) to cover all mechanical neck pain syndromes, 
irrespective of the cause of pain (e.g. traffic collisions, sports, non trauma). Similar sub-
classifications have been developed for mechanical low back pain (Dankaerts et al., 2009; 
Fairbank et al., 2011). The chartered society of physiotherapy [CSP] published guideline for 
WAD equally advocates consideration of subgroups during assessment and treatment of 
patients presenting with the condition (Mercer et al., 2007). However, findings in a recent 
trial (n = 804) that showed patients with self-reported whiplash (n = 133) were not different 
from other non traumatic neck pain conditions (n = 671) in regards of pain, function or 
prognosis, query the usefulness of a classification system for WAD (Verhagen et al., 2011). 
This study was however focused to treatment outcomes, and as a result, its conclusions 
cannot be generalised to negate usefulness of a sub-classification for WAD patients. Overall, 
arguments in support of a subclassification of WAD necessitated the focus of this research to 
the subgroup that predominantly presents, for example, to physiotherapists in a clinical 
setting. This will enable translation of research findings to clinical practice.  
 
Impairments post whiplash injury has been classified using different criteria (Spitzer et al., 
1995; Radanov et al., 1992; Sterling et al., 2004; Soderlund and Denison 2006). The most 
widely used for research trials and clinical studies was developed by the QTF (Spitzer et al., 
1995). The QTF WAD classification is hypothesised to assist clinicians make key decisions 
about assessment and treatment post whiplash injury (Spitzer et al., 1995). In support, a 
review commissioned by the CSP found high level of supportive evidence for clinical 
usefulness of the QTF classification, and therefore recommended its routine use for clinical 
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and research purposes (Hartling et al., 2001; Mercer et al., 2007). The QTF classification has 
however been criticised because of the limited clinical information it provides and its focus 
to signs and symptoms, that contrasts with recent evidence indicating presence of sensory 
impairments and psychological factors (Tenenbaum et al., 2002; Soderlund and Denison, 
2006; Sterling et al., 2006). However, the QTF still provides a useful, widely accepted, 
WAD specific resource that other classification models can complement. The QTF 
classification was therefore used to identify the WAD subgroup of interest for this study. 
 
1.4 QTF classification of WAD 
WAD has been classified by the QTF into 5 sub-groups based on a combination of signs and 
symptoms at clinical presentation [Table 1.1]. Out of the 5 QTF WAD subgroups, Sterling et 
al., (2004) found that the sub-group II was the most predominant (93.4%). Although this has 
not been validated in WAD samples drawn from other geographical regions, their findings 
may have informed the recent focus on the WAD II subgroup. The limited range of 
impairments [neck complaint and musculoskeletal signs, including decreased range of 
motion and point tenderness] captured in the QTF classification for WAD II informed use of 
additional models to reflect other impairments [sensory hyperalgesia, hypersensitivity, 
hypoaesthesia] (Kasch et al., 2005; Scott et al., 2005; Elliot et al., 2008; Chien and Sterling, 
2010) as well as psychological factors (Tenenbaum et al., 2002; Soderlund and Denison, 
2006; Sterling et al., 2006) that have been reported in this subgroup. 
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Table 1.1: The QTF classification of WAD (Spitzer et al., 1995) 
 
Grade              Clinical presentation 
0 No complaint about the neck 
No physical signs 
 
I Neck complaint of pain, stiffness or tenderness only 
No physical signs 
II Neck complaint and musculoskeletal signs 
Musculoskeletal signs including decreased range of motion and 
point tenderness 
 
III Neck complaint and neurological signs 
Neurological signs include decreased or absent deep tendon 
reflexes, weakness and sensory deficits 
 
IV Neck complaint and fracture or dislocation 
 
1.5 Mechanism based classification of CWAD 
CWAD is a multi-component condition demonstrating association between injury, pain 
experience, impairments, as well as environmental and socio-economic influences 
(Nachemson, 1992; Millard, 1995). These components can be used to identify key 
impairments in a health condition e.g. CWAD (World Health Organisation, 2001; Jull et al., 
2007; Sterling 2009; Bossmann et al., 2011). Different health models (used to reflect the 
different mechanisms that underpin impairments) have been proposed to explain 
mechanisms that underlie health conditions (Engel, 1977; Zimmerman and Tansella, 1996; 
Schultz et al., 2000; Nederhand et al., 2003; Daykin and Richardson., 2004; Anderson 2006). 
A previously accepted model, “biomedical” used to describe a causal link between severity 
of reported symptoms and tissue damage (Schultz et al., 2000; Daykin and Richardson, 
2004) has become outdated by recent findings that suggests that tissue injury is not the only 
mechanism responsible for symptoms reported in CWAD, particularly as radiological 
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investigations in a significant proportion of the patients are normal (Arana et al., 2006; 
Daffner, 2010; Sterling, 2011). The limitation of the biomedical model informed 
consideration of an alternative model “biopsychosocial” [Fig. 1.2]. This model recognises 
that whiplash injury can involve soft tissue damage that may lead to impairments of physical, 
psychological and social functioning [disabilities and participation restriction at work and 
other settings] (Scholten-Peeters et al., 2002). This model recognises and integrates a bio 
[physical], psychological, and social dimensions to CWAD, is widely accepted amongst 
clinicians, and underpins the WHO framework for classification of functioning, disability 
and health [ICF] (Fig 1.3). 
 
 
Fig 1.1: Biopsychosocial model of health and illness 
 
 
          
 
 
 
Physical Psychological 
Social 
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Fig. 1.2: ICF classification of health and functioning (WHO, 2008) 
 
The ICF is used by health care professionals globally to measure the impact of a disease 
(WHO, 2001; Nederhand et al., 2003; Anderson 2006; Holm 2007). It uses domains of 
"body structures and functions" and "activities and participation", and potential outcome 
modifiers of “personal factors” (e.g. behaviour changes, coping, lifestyle) and 
“environmental factors” (e.g. medical care, rehabilitation, physical environment), 
comparable to components of the biopsychosocial model, to reflect impairments in health or 
illness (WHO, 2001). The body structure and function (WHO, 2001) in CWAD reflect 
changes to anatomical and physiological functioning, that is comparable to physical 
components described in the biopsychosocial model (Scholten-Peeters et al., 2002), and 
signs and symptoms described in the QTF classification (Spitzer et al., 1995). However, the 
psychosocial impact of CWAD is not captured in the classification proposed by Spitzer et al., 
(1995), a limitation that necessitated use of the ICF as an addition to the QTF classification.  
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1.6 Sensory impairments in CWAD 
Impairments in CWAD II affect the physical, psychological and social functioning (Sterling 
et al., 2009). The impairments are reflective of mechanisms contributing to symptom profile 
of the condition (Smart and Doody 2007; Petty and Moore 2011). A range of mechanisms 
have been proposed to underpin CWAD and sensory impairments that are indicative of 
dysfunctional peripheral and central pain processing functioning, are proposed to be triggers 
of pain in the condition (Chien et al., 2009; Sterling et al., 2009). Sensory impairments can 
be evaluated by quantitative sensory testing [QST], a method that applies different stimuli 
(thermal, mechanical, electrical, and chemical) over body tissue (skin, muscles, and viscera) 
in order to elicit responses that reflect changes to nervous system pain processing. 
Impairments of local and widespread hypersensitivity, hyperalgesia and hypoesthesia to 
mechanical, thermal and electrical stimuli have been demonstrated in CWAD by the QST 
method (Koelbaek-Koelbaek-Johansen et al., 1999; Curattolo et al., 2002; Moog et al., 2002; 
Sterling et al., 2002b, 2002c, 2003a, 2004, 2005, 2006, 2007, 2008, 2009; Banic et al., 2004; 
Greening et al., 2005; Kasch et al., 2005; Scott et al., 2005; Jull et al., 2007; Chien et al., 
2009). Some of the impairments, including thermal (cold and heat), mechanical (pressure) 
hyperalgesia and hypersensitivity, and vibration and electrical hypoaesthesia are reported to 
discriminate CWAD from other non-traumatic chronic neck pain conditions (Scott et al., 
2005; Elliott et al., 2008; Chien and Sterling, 2010). A key limitation of the existing 
discriminative evidence relates to the cost and safety of QST equipments used to evaluate the 
impairments. Present cost saving initiatives within the NHS, and clinical governance issues 
focused to patient safety warrant use of cheap, safe equipments that provide useful and 
interpretable results during patient assessment (Brocklehurst et al., 2011). Evidence to 
support clinical usefulness and safety of electrical detection threshold for CWAD patients 
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that demonstrate sensory hypersensitivity is lacking in the literature. Also, supportive 
evidence regarding their measurement properties is sparse. The range of nerve fibre 
subsamples [C-, Aδ-, Aβ] assessed using electrical stimulus can be evaluated by cheap, safe 
and routinely used alternatives such as ULNT (Nee and Butler, 2006), pressure algometry 
and tuning fork (Hansson et al., 2007) and therefore questions usefulness of electrical 
thresholds to discriminate CWAD. Equipment used for cold testing is expensive when 
compared to routine tests of ULNT and vibration testing, but the consistent supportive 
evidence demonstrating its clinical usefulness (e.g. to discriminate CWAD) and safety, 
outweigh cost considerations. In contrast, cost implication as well as limited, inconclusive 
evidence for heat discrimination of CWAD negates its further evaluation in this sample. 
Overall, there is a merit for further evaluation of sensory discrimination of CWAD using 
cold, pressure, vibration and ULNT to provide further clarity of impairments and 
mechanisms in CWAD, and to guide future clinical assessment and treatment strategies.  
This will in turn contribute to improve clinical outcomes in the short term, as well as reduce 
incidence and impact of CWAD in the long term. These benefits as well as limitations of 
previous sensory discrimination studies informed design of the present study. 
 
1.7 Aim of study 
The aim was to evaluate the ability of ULNT and QST to discriminate CWAD II from 
healthy individuals 
 
1.8 Importance of study 
The findings of the study will: 
a) Provide evidence of sensory impairments that discriminate CWAD II 
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b) Provide clarity of important sensory impairments in CWAD II 
c) Provide evidence to support physiotherapists’ use of ULNT and QST during assessment of 
CWAD II 
d) Guide design of future trials in CWAD II 
e) Stimulate further research in CWAD II 
 
1.9 Structure of the thesis 
The aim and design of the thesis informed a literature review to identify high quality 
consistent evidence to justify selection of sensory impairments and tests that were included 
into the discrimination study. Responsiveness to findings of the literature review informed 
preliminary studies of inter- and intra- rater reliability and construct validity for some of the 
identified tests in order to provide supportive evidence for their use in the discrimination 
study. Overall, the thesis is reported in ten Chapters that are detailed below: 
 
Chapters 
1: Introduction 
2: Literature review to identify high quality evidence to justify sensory impairments and tests 
included into the discrimination study 
3: Inter-rater reliability of dynamic ultrasound imaging [DUI] estimates of median and ulnar 
nerve movement   
4: Further analysis of nerve images focused to measurement error within DUI image capture 
and image analysis components 
5: Further analysis of nerve images focused to measurement error within DUI image analysis  
6: Intra-rater reliability of DUI estimates of median nerve movement  
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7: Construct validity of upper limb neurodynamic test 
8: ULNT and QST discrimination of CWAD II from healthy individuals  
9: Discussion 
10. Conclusion 
 
1.10 Chapter conclusions 
The aim of the study was to evaluate the ability of ULNT and QST to discriminate CWAD II 
participants from healthy individuals. A review of the CWAD literature was conducted to 
guide selection of sensory impairments as well as identify clinically applicable tests with 
established measurement properties to evaluate them. High quality consistent evidence 
informed the selected impairments. The measurement properties and clinical applicability of 
sensory tests for evaluating selected impairments were explored to support translation of 
study findings to a clinical setting. The literature review is reported as Chapter 2 of the thesis 
and its conclusions informed the design of other studies reported within the thesis.      
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 Introduction  
Research data indicates that a significant proportion of people (50-60%) continue to 
experience persistent localised and widespread pain and sensory impairments 6 months post 
whiplash injury [Chronic Whiplash Associated Disorders (CWAD)] (Barnsley et al., 1994; 
Stovner, 1996; Freeman et al., 1998; Carroll et al., 2008; Kamper et al., 2008). The economic 
burden of CWAD with regards to cost of treatment, insurance claims and lost productive 
hours at work or school is enormous (Elliott et al., 2009). The impact in relation to restriction 
of an individual’s activities as well as their social participation is also significant (Carroll et 
al., 2008). Over the years, research and clinical efforts have been focused towards addressing 
impairments in CWAD in order to reduce the incidence, burden and impact of CWAD. 
Despite efforts, CWAD remains an unresolved health challenge, due to a lack of clarity on 
predominant mechanisms that clinical assessment and treatment strategies should address 
(Jull et al., 2007; Schmitt et al., 2008; Sterling, 2009). Also, the rationale underpinning a 
range of tests used to evaluate CWAD is weak. As a result, further evaluation to identify 
impairments and mechanisms that explain symptom-persistence in CWAD is warranted, 
particularly, those that discriminate the condition from other neck pain disorders.  
 
CWAD studies have consistently demonstrated the presence of a range of local and 
widespread sensory impairments in people who fail to recover after a whiplash injury 
(Curatolo et al., 2001; Moog et al., 2001; Sterling et al., 2003a, 2004, 2006, 2008; Chien et 
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al., 2009). The findings have contributed to wide acceptance that sensory mechanisms play a 
significantly role in the onset and sustenance of symptoms in CWAD (Sterling et al., 2008, 
2010; Chien et al., 2009). In particular, hyperalgesia, hypersensitivity, and hypoaesthesia to a 
range of sensory stimuli were found to be features that discriminated CWAD II from 
idiopathic neck pain [INP] (Scott et al., 2005; Elliot et al., 2008; Chien and Sterling, 2010). 
In addition, Sterling et al., (2008) have suggested that pain in a significant proportion of 
CWAD patients was predominantly of a neuropathic nature. Although the CWAD 
discriminative studies present important preliminary data, further evaluation and replication 
of their findings is warranted due to methodological limitations, conflicting results, and some 
unsupported conclusions. For example, supportive evidence for sensory discriminators of 
CWAD is weakened by the focus to the female gender in Elliot et al., (2010). This is 
important as the effect of gender on QST is well reported [lower for women than men] 
(Edwards et al., 2004; Sullivan et al., 2005; Rolke et al., 2006). Findings by Scott et al., 
(2005) indicating increased cold and decreased heat pain thresholds discriminated their study 
groups [(n=29 CWAD) vs. (20 INP)] (p<0.03), conflicts with reports in Elliot et al., (2008) 
and Chien and Sterling, (2010) that support decreased cold pain thresholds [(n=79 CWAD) 
vs. (n=23 INP)] (p<0.001) and [(n=50 CWAD) vs. (n=28 INP)] (p<0.03) respectively. As a 
result, supportive evidence for thermal pain discrimination of CWAD is inconclusive. 
Further, Scott et al., (2005) found that local and remote pressure pain discriminated between 
CWAD and INP (P < 0.05), contrasting with findings from Chien and Sterling, (2010) who 
reported that only remote pressure pain discriminated both groups (p = 0.02). As a 
consequence, supportive evidence for pressure pain discrimination of CWAD is 
inconclusive. Again, Chien and Sterling, (2010) concluded that elevated vibration (p < 0.04), 
heat (p < 0.02) and electrical detection thresholds (p < 0.04) over local and remote sites 
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discriminated between CWAD and INP. However, this conclusion is unsupported because 
their INP group did not demonstrate features of sensory hypoaesthesia (p > 0.12). The 
implication is that evidence for thermal and pressure pain discrimination of CWAD is 
inconclusive. Current sensory discriminative evidence is also incomplete because ULNT, a 
sensory test physiotherapists routinely use during assessment of CWAD (Elvey, 1997; Nee 
and Buttler, 2006) has not been investigated. The advantage of the ULNT is that it is cost 
less and simple, and can interpret changes to both peripheral and central nervous system 
functioning (Nee and Buttler, 2006). There is potential benefit for ULNT to complement 
QST assessment of CWAD in a clinical setting.  A further limitation of existing sensory 
discrimination studies is that clinical applicability, safety, as well the measurement properties 
(e.g. reliability and validity) of some sensory tests e.g. electrical detection, has not been 
established. As a result, only a limited number of discriminating sensory tests are applicable 
to clinical practice. Overall, existing supportive evidence for sensory discrimination of 
CWAD is limited, inconclusive and incomplete. Further evaluation of sensory tests that are 
simple, cheap, reliable, valid and applicable in a clinical setting, to discriminate CWAD is 
required. 
 
2.2 Background to CWAD  
2.2.1 Definition of CWAD  
WAD describes the clinical manifestations that results from a whiplash injury, defined as 
bony and soft tissue injuries of the neck due to acceleration immediately followed by 
deceleration of the neck and head (Spitzer et al., 1995). The persistence of the clinical 
manifestation beyond the timeline proposed for tissue recovery to occur has been described 
as CWAD (Spitzer et al., 1995).  
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2.2.2 Prevalence and economic costs of WAD   
Whiplash is the most common injury associated with motor vehicle accidents, affecting up to 
83% of people involved in collisions, and is a common cause of chronic disability (Cote et 
al., 2001, 2005). Statistics indicate that a whiplash injury occurs in every second car accident 
plausibly due to growing global sample and increasing volume of traffic (Ottoson, 2005). 
Holm et al., (2008) corroborated prevalence data when they found an increase in visits to 
emergency rooms 20 to whiplash injury in the western world over a 30 year period. However, 
existing prevalence data is skewed to developed countries. It is estimated that 13 - 50% of 
individuals presenting with WAD are absent from work or unable to perform usual activities 
6 months after the initial accident (Gargan and Bannister, 1994; Harder et al., 1998). The 
data indicate that WAD results in significant lost productive hours and is equally costly to 
manage (Elliott et al., 2009). The costs associated with WAD cover medical care, disability 
and sick leave and are estimated to be $3.9 billion annually in the US (Eck et al., 2001). In 
Europe, costs associated with WAD are estimated to be 10 billion Euros per annum with 
chronic cases accounting for a substantial proportion of the cost (Kamper et al., 2008). In the 
United Kingdom, 0.4 million people made a claim for WAD in 2007, representing 75% of 
the UK's motor insurance claims and 14% of every driver's premium (BBC news, 2008). 
These data have not been updated in recent years and therefore underestimates present 
proportion and impact of WAD. 
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Figure 2.1: Descriptive statistics of bar chart depicting UK motor insurance claims in 2007 
(Source: Data extracted from BBC news, 2008) 
 
 
2.2.3 Classification of WAD 
A. Classification based on severity of symptoms and signs 
WAD has been classified into 5 sub-groups based on a combination of symptoms and signs 
at clinical presentation [Table 1.1] in order to assist clinicians’ decisions post whiplash injury 
(Spitzer et al., 1995). The classification supports existence of sub-groups within WAD that 
assessment and treatment intervention should target (Klapow et al., 1993; Turk and Rudy, 
1990). It also facilitates comparison of findings across WAD studies (Spitzer et al., 1995). 
Despite its simplicity and ease of application, there are conflicting arguments regarding 
usefulness of the QTF classification of WAD. Some authors have argued against using the 
QTF classification because of its narrowness and focus to somatic disturbances in spite of 
evidence demonstrating a variety of non-musculoskeletal signs and symptoms post whiplash 
injury (Tenenbaum et al., 2002; Soderlund and Denison, 2006). Freeman et al., (1998) 
further queried the validity of the classification because selected criteria involving 
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combinations of signs and symptoms for each subgroup were arbitrary. The criticism lends 
support for a modification of the QTF classification that led to a further sub-classification of 
WAD II (Sterling et al., 2004); as well as development of additional classification tables 
(Radanov et al., 1992; Soderlund and Denison, 2006). However, reliability and validity of 
the new proposed classifications have not been established and they are sparsely used in 
clinical or research settings. There is in contrast, advocacy for use of the QTF classification 
because it was found to be predictive of CWAD (n= 380) when compared with diagnosis 
made by physicians (Hartling et al., 2001). A recent systematic review commissioned by the 
Chartered Society of Physiotherapy [CSP] found a high level of evidence supporting its 
clinical value in WAD and therefore recommended continued use of QTF classification for 
both clinical and research purposes (Mercer et al., 2007). 
 
B.  Classification based on duration of WAD  
WAD has been classified based on the duration of the injury. Acute WAD is defined as 
presence of pain, restriction of motion or other symptom that is sufficient to hinder return to 
normal activities at ≤ 3 months post whiplash injury (Spitzer et al., 1995). Different 
timescales have however been used to describe CWAD. The QTF defined CWAD as the 
presence of pain, restriction of motion or other symptoms at ≥ 6 months after whiplash injury 
(Spitzer et al., 1995). There is no scientific justification for ≥ 6 months over ≥ 3 months 
duration. There is equally no evidence against use of this timescale to define CWAD. 
However, a significant proportion of research have continued to use 6 months to define their 
CWAD population, plausibly because the QTF classification is specific to WAD, and there is 
presently, no clinically useful alternative to it. Interestingly, WAD research groups that 
previously used ≥ 3 months to define their CWAD participants have recently adopted the 
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QTF’s 6 month timescale (Sterling 2004, 2009). The change could have happened to allow 
comparison of their findings to other WAD studies. In contrast, CSP guidelines for managing 
WAD has recommended a classification of WAD into acute (0 - 2 weeks); sub-acute (>2 - < 
4 weeks) and chronic (>12 weeks) (Hartling et al., 2001; Mercer et al., 2007). The CSP 
classification agrees with timescale used for other chronic musculoskeletal conditions. Both 
QTF and CSP classifications highlight a gap in timescales used to describe acute and chronic 
WAD [Fig 2.2].  
 
        
Week      0                       ≤ 2                     ≤ 4                         ≥12                   ≥ 24 
QTF                Acute                                                                                                 Chronic 
CSP                  Acute             Sub-acute                                                     Chronic 
Figure 2.2: Timescale used to classify WAD [Developed from Spitzer et al., 1995; Hartling 
et al., 2001; Mercer et al., 2007] 
 
Overall, the QTF provides a useful and widely accepted classification and timescale to define 
CWAD, despite the limited criteria adopted. The presence of other manifestations in CWAD 
that the QTF classification did not account for, necessitated the development of additional 
classification models that reflects current understanding regarding the multi-dimensions of 
health and illness.  
 
C.  Classification based on mechanisms in C WAD 
A mechanism based approach is underpinned by the hypothesis that different clinical signs 
and symptoms reflect a variety of underlying patho-physiological mechanisms (Greenspan, 
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2001; Hansson, 2002; Jensen and Baron, 2003). Extensive animal studies suggest that a 
variety of mechanisms can operate alone or together to determine a flora of signs and 
symptoms that are specific to a health condition (Woolf and Salter, 2000). Therefore CWAD 
will be better understood by using a mechanism based approach (Petty and Moore, 2011).  
 
Different models of health and illness have been advanced to describe mechanisms 
underpinning CWAD (Engel, 1977; Zimmerman and Tansella, 1996; Schultz et al., 2000; 
Nederhand et al., 2003; Daykin and Richardson., 2004; Anderson, 2006). However, the 
biopsychosocial model is widely accepted and used because it addresses limitations of 
previous health models (Bossman et al., 2010). The model recognises that injury such as 
following a whiplash can cause minor tissue damage that can lead to impairments of physical 
and psychological functioning as well as disabilities and participation problems in work and 
other activities (Scholten-Peeters et al., 2002). The biopsychosocial model have been 
proposed to assist further understanding of the development of CWAD (Malt and Sundet, 
2002; Richter et al., 2004).  
 
The biopsychosocial model underpins the World Health Organisation [WHO] framework for 
classification of functioning, disability and health (ICF) [Fig 2.5]. CWAD reflects a 
complex, multifaceted health problem that involves different mechanisms (Sterling, 2009). 
The ICF provides a suitable model to capture all plausible impairments and mechanisms 
associated with the condition (Schmitt et al., 2008; Sterling, 2009), and this support using the 
ICF to complement the QTF WAD classification. In CWAD, the ICF recognises a physical 
dysfunction [motor and sensory] that results in limitations of an individual’s function 
[activity and social participation], mediated by contextual factors [personal (psychological) 
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and environmental]. Existing evidence suggest that not all of the dimensions contribute to 
persistence of symptoms in CWAD (Sheather and Cohen, 1998; Koelbaek-Koelbaek-
Johansen et al., 1999; Stucky et al., 2001; Curatolo et al., 2001; Ide et al., 2001; Sterner et al., 
2001; Sterling et al., 2002b, 2002c, 2003a, 2004, 2005, 2006, 2007, 2008; Banic et al., 2004; 
Greening et al., 2005; Kasch et al., 2005; Scott et al., 2005; Jull et al., 2007; Chien et al., 
2008). There is supportive evidence to suggest that physical impairments in CWAD, involve 
both motor and sensory systems (Sterling et al., 2006). There is however no substantive 
supportive evidence to suggest that mechanisms that underlie motor impairments contribute 
to CWAD symptoms (Jull et al., 2007). Also, motor impairments are not distinctive features 
that individuals who fail to recover after a whiplash injury demonstrate (Jull et al., 2004; 
Sterling et al., 2006; Field et al., 2008). Furthermore, motor impairments do not discriminate 
CWAD from idiopathic neck pain (Sterling et al., 2008). In contrast, there is emerging 
consistent evidence that sensory impairments are distinctive features that persist in CWAD 
(Scott et al., 2005; Elliot et al., 2008; Chien and Sterling 2010). As a result, sensory 
impairments are proposed to be important triggers and mediators for pain in CWAD 
(Sterling, 2010). This informed the focus of this study to sensory impairments.  
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Figure 2.3: ICF classification of health and functioning (adapted from Bossman et al., 2011) 
 
2.2.4 Sensory impairments in CWAD 
Emerging research has found the presence of impairments in the sensory and motor systems, 
including psychological factors post whiplash injury. However, in CWAD, patients present 
with a more complex clinical picture characterised by the presence of local and widespread 
sensory hyperalgesia, hypersensitivity and hypoesthesia to a range of stimuli [thermal, 
mechanical and electrical] (Scholten-Peeters et al., 2003; Banic et al., 2004; Greening et al., 
2005; Kasch et al., 2005; Scott et al., 2005; Sterling et al., 2003, 2004, 2005, 2008; Chien et 
al., 2008; Sterling, 2009; Elliot et al., 2010). The main features of hypersensitivity are 
hyperalgesia (increased pain response to noxious stimuli) and allodynia (pain produced by 
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non-painful stimuli) while hypoaesthesia describes a reduced sense of touch or sensation, or 
a partial loss of sensitivity to sensory stimuli (Chien and Sterling, 2010). 
 
A. Hypersensitivity in CWAD 
Features of hypersensitivity found soon after a whiplash injury have been attributed to 
peripheral nociceptive input arising from injured tissue. However, it is unclear why 
hypersensitivity persists in CWAD, particularly as tissue damage is not evident in this phase 
of the illness (Sterling, 2010). Based on emerging animal and human research, 
hypersensitivity of the central nervous system has been proposed as the mechanism 
maintaining this feature in CWAD. It is proposed that the hypersensitivity is maintained by a 
disordered central pain processing mechanism as a result of neural changes occurring from 
repeated barrage of peripheral nociceptive input. Sterling (2010) supported this proposed 
mechanism when they reported decreased nociceptive flexion reflex threshold (p=0.04), that 
is reflective of spinal cord hyperexcitability, in CWAD patients (n=20) presenting with 
generalized sensory hypersensitivity (p<0.05). The decreased thresholds was found over 
areas remote to the injury site indicating widespread spinal cord hyperexcitability, 
implicating a disordered descending pain modulation mechanism (Sterling, 2010). It has 
been suggested that central hyperexcitability following tissue injury and ensuing peripheral 
nociceptive input normalise after elimination of the peripheral input (Gracely et al., 1992). In 
support, Sterling (2010) found decreased central hyperexcitability (p=0.04) in CWAD 
participants who recovered [n=25] or reported mild to moderate pain and disability levels 
[n=17; Mean NDI (SD) = 16.5 (9.9)] when compared to those who continued to report 
persistent moderate to severe symptoms [n=20; Mean NDI (SD) = 39.3(17.5)]. In the 
participants that recovered or reported mild to moderate symptoms, sensory hypersensitivity 
 
 
 26 
 
were comparable to those of healthy individuals. Findings of hypersensitivity in CWAD 
participants who failed to recover are interpretive of important underlying mechanisms 
contributing to symptoms persistence that clinical assessment should target. Overall, Sterling 
(2010) provides preliminary supportive evidence to indicate the presence, importance and 
plausible predominance of hypersensitivity in CWAD. However, the evidence merits further 
consideration in future studies in order to replicate its findings and enable generalisabilty of 
its conclusions. Hypersensitivity to cold stimuli has also been shown to provide prognostic 
data for acute WAD patients at risk of progressing to the chronic phase of the illness 
(Scholten-Peeters et al., 2003; Williams et al., 2007), a finding that suggest the importance of 
hypersensitivity for improving clarity of CWAD.  
 
There is some evidence to indicate that hypersensitivity to pressure and cold stimuli can 
discriminate CWAD from INP (Scott et al., 2005; Elliot et al., 2008; Chien and Sterling, 
2010). However, the discrimination of CWAD using mechanical stretch [ULNT] has not 
been investigated. This is important because both pressure and tension are routinely used 
during physiotherapy neurological examination of CWAD. The implication is that existing 
evidence for hypersensitivity discrimination of CWAD is incomplete (see Chapter 1, Section 
1.6 of the thesis) and merit further investigation.  
 
B. Hypoaesthesia in CWAD 
Features of sensory hypoesthesia that are interpretive of central inhibitory processes related 
to nociceptive input have been reported in CWAD (Chien et al., 2008b). Whereas 
hypersensitivity has been suggested to occur from sensitisation of central neurons by 
prolonged nociceptive inputs, hypoaesthesia is suggested to be caused by nociceptive inputs 
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producing inhibitory effects that dampen the central nervous system perception and 
interpretation of sensory inputs (Apkarian et al., 1994). These suggestions support the 
presence of different mechanisms in CWAD and consequently highlight their importance for 
gaining an improved understanding of the condition, as well as guiding the key features 
clinicians should look out for when assessing patients. Chien and Sterling (2010) reported 
that CWAD participants (n=50) demonstrated elevated vibration (p < 0.04), heat (p < 0.02) 
and electrical (p < 0.04) detection thresholds over areas of the upper limb when compared to 
a healthy group (n= 31). The findings were attributed to underlying mechanisms of central 
inhibition of nociceptive input (Apkarian et al., 1994; Chien et al., 2009), central 
sensitisation (Voerman et al., 2000) and cortical reorganisation (Pleger et al., 2006) as 
described previously.  
 
Chien and Sterling (2010) demonstrated that hypoaesthesia discriminated patients with 
CWAD from INP (n=28) (p<0.04). Their conclusions are however weak due to absence of 
features of hypoaesthesia in their INP group, findings that limit comparison of the two neck 
pain conditions. The authors therefore recommended further investigation. Findings from 
Chien and Sterling (2010) provide preliminary evidence to suggest presence and importance 
of sensory hypoaesthesia that is indicative of other key mechanisms in CWAD. Further 
evaluation of hypoaesthesia discrimination of CWAD is required.    
 
2.2.5 Physiological changes that underlie sensory impairments in CWAD 
There is discrepancy within the recent CWAD literature suggesting the presence of sensory 
impairments in CWAD that are indicative of a sensitised nervous system (Bove et al., 2003; 
Scholten-Peeters et al., 2003; Sterling et al., 2003, 2004, 2005, 2008, 2009, 2010; Banic et 
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al., 2004; Greening et al., 2005; Kasch et al., 2005; Scott et al., 2005; Chien et al., 2008a,b; 
Chien and Sterling, 2010). The proposed physiological explanation is that the nervous 
system becomes sensitised from continuous activation of nociceptors [pain receptors] by 
released inflammatory mediators and neuropeptides after the injury (Eriksen and Ursin, 
2004; Carpenter and Dickenson, 2002). The peripheral neural system becomes sensitised 
when events around pain receptors combine to lower the threshold or intensity a stimulus 
requires to evoke a response [action potential] in the nerve (Holdcroft and Jaggar, 2005). The 
anomaly is proposed as being responsible for ongoing localised pain over the site of injury 
beyond the time that the tissue inflammatory response is expected to subside. The central 
nervous system can equally become sensitised and generate pain over areas that are remote 
to the site of injury (Coderre et al., 1993; Li et al., 1999; Kidd and Urban., 2001; Graven-
Nielsen and Arendt-Nielsen, 2002; Staud and Smitherman, 2002; Carpenter and Dickenson, 
2002). The phenomenon occurs because action potentials generated by pain receptors that 
are transmitted through primary afferents [unmyelinated C and thinly myelinated Aδ] into 
dorsal horn neurons of the spinal cord become inhibited or further amplified [augmented] 
before reaching the higher brain centres (Holdcroft and Jaggar, 2005). Further stimulation of 
pain receptors will then result in an increased response of dorsal horn neurons (Baranauskas 
and Nistri 1998). The proposed physiological mechanisms that promote central sensitisation 
include (a) wind-up or temporal summation caused by repetitive noxious stimuli producing 
increased electrical discharges in the dorsal horn, (b) dysregulated descending inhibitory 
pathways as a result of abnormalities within the CNS and (c) upregulated facilitatory 
modulation due to certain behavioural and cognitive factors (Coderre et al., 1993; Li et al., 
1999; Kidd and Urban, 2001; Graven-Nielsen and Arendt-Nielsen, 2002; Staud and 
Smitherman, 2002).  
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2.2.6 Methods for evaluating sensory impairments in CWAD 
Abnormal sensory responses over areas local or remote to an injury can be evaluated through 
a neurological examination that involves quantitative sensory testing (QST), reflex and 
manual muscle testing (Ropper and Brown, 2005). An advantage of QST is its ability to 
detect changes to small nerve fibre unlike the latter two methods (Rolke et al., 2006). QST 
utilises a range of stimuli such as temperature [cold and hot], mechanical [pressure, 
vibration] and electrical to interpret afferent or efferent nerve dysfunction (Lee et al., 2004; 
Rolke et al., 2006). The dysfunction may be present without evidence of nerve tissue damage 
such as small fiber neuropathy and neural inflammation (Lacomis 2002; Hoitsma et al., 
2004). This is important for CWAD because in a significant proportion of patients, the 
profile of sensory impairments does not correlate with radiological investigations and nerve 
conduction studies [gold standard] (Greening et al., 2001), supporting the benefit of QST for 
this patient sample. In addition to QST, physiotherapists utilise a simple, costless, easy to 
administer sensory test, the ULNT, to interpret changes to the mechanical properties of the 
peripheral and central nervous system (Elvey 1997; Butler 2000; Greening et al., 1998, 2001, 
2005; Coppieters et al., 2006, 2009; Shacklock et al., 2006). The test enjoys wide use within 
physiotherapy practice in a clinical setting. An abnormal response to both QST and ULNT 
interprets a dysfunction of the sensory nervous system (Banic et al., 2004). The use of both 
methods in clinical practice is complementary because together, they provide a broad range 
of stimuli to cover different nerve fibre sub-samples as well as various manifestations of 
neural dysfunction. Both methods therefore show a potential to benefit existing methods of 
evaluating CWAD in clinical practice.  To date, sensory discriminative studies have not 
included the ULNT amongst the range of tests investigated. This informed consideration of 
both QST and ULNT for the present study.  
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Figure 2.4: Schematic representation of impairments in CWAD II using ICF domains 
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Figure 2.5: Schematic description of pathway for peripheral and central sensitisation 
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2.3 Review of the CWAD literature to identify sensory impairments 
2.3.1  Purpose of the literature review 
This review searched and appraised the literature for high quality evidence to justify range of 
sensory impairments included into the CWAD II discrimination study. Measurement 
properties and clinical applicability of tests for evaluating the sensory impairments were also 
considered, to ensure that findings from the study are interpretable and can be translated to a 
clinical setting.  
 
2.3.2  Search strategy   
The search strategy was informed by published guidelines for conducting systematic reviews 
such as preferred reporting items for systematic reviews and meta-analyses [PRISMA 2009] 
(Liberati et al., 2009); the Cochrane handbook for systematic reviews of interventions 
version 5.0.0 (Higgins and Altman, 2009) and the Centre for Reviews and Dissemination 
guidance for undertaking reviews in health care (CRD systematic reviews 2009). The search 
strategy was used to eliminate issues relating to selection bias, so that all potential studies 
were considered (Easterbrook et al., 1991).  
 
2.3.3  Search sources  
Potentials articles were identified by searching electronic databases and hand searching key 
journals and reference lists of identified papers, bibliographies and citations to obtain 
additional articles (Liberati et al., 2009; Higgins and Altman, 2009). Electronic databases of 
PubMed, Medline [Ovid], Cinahl [Ebsco], Cochrane Database of Systematic reviews library 
[Wiley], PEDro [Physiotherapy evidence-base database], Science citation index [ISI], 
EMBASE classic [Ovid], and PsycINFO [Ovid] were searched from their inception to 2011, 
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similar to CWAD systematic reviews (Williams et al., 2007; Kamper et al., 2008; Rushton et 
al., 2011). Databases were searched using search terms generated from Medline Medical 
subject headings [MeSH] and previous CWAD articles. Inclusion and exclusion criteria were 
established to focus the search terms to sensory impairments of interest. Duplicates of 
articles were removed. Hand searching of references of articles returned in the literature 
search was undertaken to identify additional articles that are relevant to the focus of the 
review.  
 
2.3.4  Search terms  
Search terms were grouped under PICOS [participants, interventions, comparators, 
outcomes, study design] as reported in previous CWAD systematic reviews (Williams et al., 
2007; Kamper et al., 2008; Rushton et al., 2011). A modification of PICOS to POS 
[participants, outcomes, study design] was adopted because the sensory discrimination study 
was focused to assessment, rather than treatment, and therefore informed exclusion of 
components of “intervention”, and “comparator”. Search terms were combined using “OR” 
within each POS component, and “AND” across the components to generate a list of 
published and unpublished abstracts, reports, articles, conference presentations and 
proceedings [Table 2.1]. This method is supported by previous CWAD reviews (Williams et 
al., 2007; Kamper et al., 2008; Rushton et al., 2011).  
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Table 2.1: Search terms used within each POS components 
Study Characteristics Search terms 
Participant 
Whiplash or whiplash injur$ or whiplash associated 
disorder$ or WAD or whiplash syndrome or neck pain 
or cervical spine or neck or cervical pain or neck sprain 
or cervical sprain or neck strain or cervical strain or neck 
injur$ or CWAD or CWAD symptoms or chronic neck 
pain or chronic cervical pain or late whiplash syndrome 
Outcome 
(Sensory) 
 
Sensory testing or sensory profile or sensory 
hypersensitivity or hypersensitivity or central 
hyperexcitability or generali$ hypersensitivity or 
impairment$ or dysfunction$ or hypoaesthesia or 
hypoesthesia or hyperaesthesia or hyperesthesia or 
hyperalgesia or hypoalgesia or allodynia or quantitative 
sensory testing or QST or neurogenic pain or 
neuropathic pain or neuropathy or peripheral 
neuropathic pain or pressure or pressure threshold$ or 
pain threshold$ or algometry or temperature or 
temperature rating$ or thermal or thermal pain or 
thermal pain threshold$ or cold or cold pain threshold$ 
or cold sensation or heat or heat sensation or heat pain 
threshold$ or vibratometry or vibration or vibration 
sensation or vibration threshold$ or vibration detection 
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threshold$ or vibration sensory testing or electrical or 
electrical sensation or electrical detection threshold$  
 
neurodynamics or neurodynamic testing or neural 
tension test$ or neurodynamic tension test or neural 
tissue provocation test or upper limb neurodynamic test 
or upper limb tension test or brachial plexus or brachial 
plexus tension test or brachial plexus provocation test or 
mechanosensitivity or mechanical stress or peripheral 
nerve or nerve movement or nerve mobility or neural 
mobilisation or biomechanic$ or nerve biomechanic$ or 
neurobiomechanics or nerve sliding or nerve excursion 
or longitudinal sliding or transverse sliding or LM or 
TM or median nerve or median neuropathy or ulnar 
nerve or radial nerve or ultrasound or ultrasound 
imaging or diagnostic ultrasound or ultrasonography or 
speckle tracking or cross-correlation or frame by frame 
cross-correlation  
Outcome 
(Psychological / Pain 
and Disability) 
 
 
Psychological factors or psychological factors or anxiety 
or depression or post traumatic stress reaction or post 
traumatic stress disorder or PTSD or fear avoidance or 
self efficacy or impact of event scale or IES or general 
health questionnaire or GHQ or tampa scale of 
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kinesiophobia or TSK or short form 36 or SF-36 or short 
form 12 or SF-12 or catastrophi$ or pain catastrophising 
scale or hospital and anxiety depression scale or pain or 
pain rating$ or visual analogue scale or disability or 
disability rating$ or neck disability or neck disability 
index or whiplash disability or whiplash disability 
questionnaire  
Study design 
 
Systematic review$ or randomi$ control$ trial or 
randomi$ clinical trial or RCT or experimental or 
prospective or retrospective or longitudinal or time 
series or follow-up or cross-section$ or observation$ or 
cohort  
 
2.3.5  Eligibility criteria 
Articles identified from the literature search were subjected to the following criteria in 
other to be to be included in the review. 
 
Criteria of study characteristics: (Liberati et al., 2009)  
A. CWAD participants ≥ 6 months post injury (Spitzer et al., 1995)  
B.  WAD II (Cote et al.,, 2001; Kamper et al.,, 2008) 
C.  Aged above 18 years (Soderlund and Denison, 2006; Williams et al., 2007) 
D. Study reported at least one impairment using an outcome measure (Williams et al., 
2007) 
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E.  Systematic review, randomised controlled trial [RCT], or cohort study as they provide 
the highest level of evidence (Sackett et al., 1996, 1997; NICE 2001) 
 
Criteria of report characteristics: (Liberati et al., 2009) 
A. Abstracts, full reported articles, reports, conference proceedings (Liberati et al.,, 2009) 
B.  Any language (Higgins and Altman 2009; Liberati et al., 2009). Potential articles 
published in other languages will be translated into English.  
C.  Publications and unpublished materials (CRD systematic reviews 2009; Higgins and 
Altman 2009; Liberati et al., 2009).  
 
2.3.6  Articles generated from the literature search strategy 
The search generated 985 potential articles. Following review of the title, abstract, or full 
text, 868 articles were found to be irrelevant; 54 articles were duplicates; and 32 articles 
failed to fulfil all inclusion criteria. 30 articles representing 23 studies fulfilled all review 
criteria and were therefore included. The search result is presented as Figure 2.10.  
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Figure 2.6: Articles generated from the search strategy  
 
2.3.7  Evaluation of the quality of eligible articles using the GRADE appraisal tool 
The quality of evidence component of the Grading of Recommendations Assessment, 
Development and Evaluation [GRADE] appraisal tool was used to evaluate the quality of all 
30 eligible articles (Atkins et al., 2004; Guyatt et al., 2008; Brozek et al., 2009). GRADE 
utilises two components (a) rating the quality of evidence and (b) grading the strength of 
recommendations in systematic reviews, health technology assessments, and clinical practice 
guidelines in other to inform alternative management options (Brozek et al., 2009; Guyatt et 
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al., 2011). The tool enjoys a benefit over other widely used appraisal tools including: 
PRISMA, Cochrane, CRD, Scottish Intercollegiate Guidelines Network (SIGN), and 
National Service Framework for long-term neurological conditions critical appraisal tool 
(NSF)] in that it allows appraisal of quality of evidence across different study designs using 
explicit and comprehensive criteria to downgrade and upgrade the quality of the source of 
the evidence (Guyatt et al., 2008; Brozek et al., 2009). For example, within the hierarchy of 
research designs, randomised controlled trials, considered as the highest level of evidence, 
are placed at the top. Controlled observational studies are placed in the middle, while 
uncontrolled studies and opinion are placed at the bottom of the hierarchy (Sackett et al., 
1996).  
 
GRADE recognises that quality can be compromised by imprecision, inconsistency, 
indirectness of study results and publication bias, irrespective of the study design (Guyatt et 
al., 2011). The presence or absence of a limitation warrants a downgrade or upgrade 
(depending on design) of the quality of evidence to reflect the level of confidence in study 
conclusions (Guyatt et al., 2011). GRADE therefore provides a useful, unbiased approach to 
evaluate quality of evidence in CWAD, because different study designs have been used to 
report the presence of sensory impairments in the condition, and methodological limitations 
may exist (Guyatt et al., 2008). Despite the benefits of GRADE, its primary focus to 
treatment interventions limits its use for this review (Guyatt et al., 2011). However, because 
characteristics within one (level of evidence) out of the two components of the tool are 
generic to intervention and non-intervention studies, the use of this component for the 
evaluation of quality is supported. The GRADE tool was therefore adapted so that only the 
level of evidence component ([A] in figure 2.11) was utilised for appraising the quality of the 
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30 eligible articles in the review. Another component that was focused to the level of clinical 
importance (critical, important, low importance) of the sensory impairments in CWAD was 
used as a part of the appraisal process [Figure 2.11 (A)] (Guyatt et al., 2011). The level of 
clinical importance was informed by previous research conclusions on their role in CWAD 
(Guyatt et al., 2011). Both components of quality of evidence and clinical importance were 
used to inform the level of evidence provided for the sensory impairments [Figure 2.11 (A)] 
(Guyatt et al., 2011).  
 
GRADE provides a transparent stepwise process that helps to link level of evidence to 
recommendations for the consumption of patients, clinicians and policy makers (Guyatt et 
al., 2008, 2011; Brozek et al., 2009). Baker et al (2011) compared grading and appraisal 
tools of GRADE, SIGN, and NSF in relation to important factors (methodological strengths 
and weaknesses, applicability and ease of use) that specialist groups considered to be 
important when selecting an evidence grading system. The study used n=12 assessors to 
grade papers (n=20) over a 3 month time frame. The results, independently assessed for 
emerging themes, showed that all 3 systems had strengths and weaknesses depending on the 
type of evidence being evaluated. GRADE was reported as the most complex but rigorous 
system. SIGN and NSF were reported to be more user-friendly, but less methodologically 
rigorous. In grading the evidence, 10% of assessors used GRADE incorrectly, 33% used 
SIGN incorrectly and 75% used NSF incorrectly. Despite this findings, Kavanagh (2009) 
criticised GRADE for its poor inter-rater reliability [kappa value, k=0.27] and lack of data to 
support its validity. In contrast, Ansari et al (2009) argued that GRADE should be recognised 
and utilised as a framework rather than a health tool that would require measurement 
properties of reliability and validity. They further argued that GRADE should be used 
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primarily to uncover implicit subjectivity and provide a systematic, transparent and explicit 
approach to capturing evidence. GRADE has been reported as the best available approach to 
deal with inherent subjectivity when assessing or rating evidence (Ansari et al., 2009). These 
arguments outweigh the limitations of GRADE, and support its use to appraise the level of 
evidence for the 30 eligible CWAD II studies.  
 
 
Figure 2.7: Schematic representation of GRADE appraisal tool, developed from Guyatt et 
al., (2008). 
 
2.4 Level of evidence for impairments in CWAD II 
Thirty articles were included, representing 23 cohorts. Using GRADE, 17 articles (44%) [10 
cohorts] were rated high quality; 7 articles (30%) [7 cohorts] were rated moderate quality; 4 
articles (17%) [4 cohorts] were rated low quality; 2 articles (9%) [1 cohort; 1 systematic 
review] were rated very low quality. Table 2.2 presents the GRADE summary of findings 
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table. A range of impairments [motor, sensory, psychological and limitations of function] 
were identified from the articles. Although evidence for all the impairments were appraised, 
the focus of the discrimination study informed the consideration of only impariments of 
sensory function. The other impairments were used to describe participants in the sensory 
discrimination study and is described in Chapter 8 of the thesis. 
 
2.4.1  Sensory impairments in CWAD II  
Thirteen of the 30 eligible articles [10 cohorts] reported on sensory impairments in CWAD 
(Koelbaek-Johansen et al., 1999; Sterling et al., 2002, 2003, 2006; Banic et al., 2004; 
Greening et al., 2005; Kasch et al., 2005; Raak and Wallin, 2006; Elliot et al., 2008, 2009; 
Gerdle et al., 2008; Wallin and Raak, 2008; Chien et al., 2009).  8 articles [6 cohorts] were 
rated high quality (Sterling et al., 2003, 2006; Kasch et al., 2005; Gerdle et al., 2008; Wallin 
and Raak, 2008; Chien et al., 2009; Elliot et al., 2009); and 5 articles [4 cohorts] were rated 
moderate quality (Koelbaek-Johansen et al., 1999; Sterling et al., 2002; Banic et al., 2004; 
Greening et al., 2005; Raak and Wallin, 2006) [Table 2.2]. In terms of clinical importance, 
sensory impairments were rated as critical [underpins a very important and relevant outcome 
variable] based on evidence within the whiplash literature (Kasch et al., 2005; Sterling et al., 
2003, 2006; Wallin and Raak 2008) [Table 2.2]. The level of evidence for sensory 
impairments in CWAD is considered to be high owing to the moderate to high quality 
studies and the critical clinical importance of sensory impairments. 
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Table 2.2: Study characteristics of 30 articles from 23 cohorts indicating presence of sensory impairments in CWAD II population 
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Sterling et al 
(2006) 
observational 
study 
1 65 0 N N N N N P<0.01 – 
0.0521 
HIGH Sensory 
 
CRITICAL High 
Kasch et al 
(2005) 
observational 
study 
1 141 40 N N N N N P<0.00123 HIGH Sensory CRITICAL High 
Greening et al 
(2005) 
Randomised 
Trial 
1 9 8 Y26 N N N N P<0.0527 MODERATE Sensory CRITICAL High 
Banic et al 
(2004) 
observational 
study 
1 27 29 Y2 N N N N P<0.03528 MODERATE Sensory CRITICAL High 
Sterling et al 
(2003b) 
observational 
study 
1 76 0 N N N N N P<0.0119,30 HIGH Sensory CRITICAL High 
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Sterling et al 
(2002) 
observational 
study 
1 156 95 Y2 N N N N P<0.0131 MODERATE Sensory CRITICAL High 
          
  
  
 
 
             
 
Elliot et al., 
2010 
observational 
study 
1 78 31 N N N N N p<0.00011 HIGH Motor IMPORTANT High 
Woodhouse et 
al (2010) 
observational 
study 
1 35 48 Y3 N N N N p<0.00011 VERY LOW Motor IMPORTANT Low 
Elliot et al 
(2009) 
observational 
study 
1 79 0 N N N N N P<0.015 HIGH Motor 
 
IMPORTANT High 
Elliot et al 
(2008a) 
observational 
study 
1 79 34 N N N N N P<0.00011 HIGH Motor IMPORTANT High 
Elliot et al 
(2008b) 
observational 
study 
1 79 23 N N N N N P<0.0019 HIGH Motor IMPORTANT High 
Gerdle et al 
(2008) 
observational 
study 
1 21 20 N N N N N P<0.00110 HIGH  Motor IMPORTANT  High 
Woodhouse and 
Vasseljen (2008) 
observational 
study 
1 59 57 Y3 N N N N P<0.0113 LOW  Motor IMPORTANT  Low 
Descarreaux et 
al (2007) 
observational 
study 
1 17 14 Y N N N N P<0.0515 LOW  Motor IMPORTANT  Low 
Elliot et al 
(2006) 
observational 
study 
1 73 34 N N N N N P<0.00011 HIGH Motor IMPORTANT High 
Armstrong et al 
(2005) 
Randomised 
trial 
1 23 23 N N N N N P<0.0522 HIGH Motor IMPORTANT High 
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Koelbaek-
Johansen et al 
(1999) 
observational 
study 
1 11 11 Y2 N N N N P<0.0133 MODERATE Motor IMPORTANT High 
Sterling et al 
(2003c) 
observational 
study 
1 66 20 N N N N N P<0.0130 HIGH Motor IMPORTANT High 
 
             
 
Buitenhuis et al 
(2006) 
observational 
study 
1 240 0 N N N N N P<0.0318,19 HIGH Psychological CRITICAL High 
Carroll et al 
(2006) 
observational 
study 
1 5211 0 N N N N N 17.8% -  
42.3%20 
HIGH Psychological CRITICAL High 
Williamson et al 
(2008) 
Systematic 
Review 
17 0 0 Y12 N N N N - VERY LOW Psychological CRITICAL Low 
Sterling et al 
(2006) 
observational 
study 
1 65 0 N N N N N P<0.01 – 
0.0521 
HIGH Psychological CRITICAL High 
 
         
 
   
 
Sterling et al 
(2003a) 
observational 
study 
1 76 0 N N N N N P<0.0129 HIGH Psychological CRITICAL High 
Wenzel et al 
(2002) 
observational 
study 
1 61110 0 N N N N N 15.0% - 
24.2%32 
HIGH Psychological CRITICAL High 
 
             
 
Wenzel et al 
(2009) 
observational 
study 
1 1095 52208 N N N N N OR=6.87-
9.586 
OR=2.3-
2.136 
MODERATE Functioning IMPORTANT High 
Holm et al 
(2007) 
observational 
study 
1 266 0 Y N N N N OR16 LOW Functioning IMPORTANT High 
Bunketorp et al 
(2005) 
observational 
study 
1 108 931 Y24 N N N N P<0.00125 LOW Functioning IMPORTANT High 
KEY: Level of significance achieved for impairments evaluated 
 
 
 
 46 
 
1
 p<0.0001 for measures evaluated 
2
 demographic, medico-legal, social and treatment issues 
3
 Examiner was not blinded to participants grouping but claimed commands were standardized. 
4
 P<0.01 for pain catastrophising; P<0.001 for chronic pain self efficacy  
5
 P<0.01 presence of association between fatty infiltrate in cervical muscle and sensory, physical and 
psychological measures  
6
 Odds ratio [OR] of 6.87 - 9.58 for reported widespread pain and stiffness; 2.3 -2.13 for depression 
and anxiety 
7
 [P<0.05 for lowered pressure pain at all test sites]; [P<0.05 for vibration detection at all sites]; 
[P<0.01 for cold pain at all sites]; [P>0.1 for heat pain at all sites]; [P<0.01 for heat detection at all 
sites]; [P<0.05 for cold detection at 5th metacarpal]; [P<0.01, 0.01, 0.05 for electrical detection - 
2000Hz, 250 Hz and 5Hz respectively at upper limb sites; P>0.83 at tibialis anterior]; [P=0.05 for 
SVR and QI]; [P=0.05 for pain and brachial plexus provocation test]; [P<0.05 for psychological 
factors] 
8
 P<0.05 for cold and mechanical pain 
9
 P<0.001 for altered cold pain thresholds and fatty infiltrate distinguish whiplash from insidious-
onset neck pain 
10
 P<0.001 for pressure pain over trapezius and tibialis anterior muscle; P=0.008 for elevated levels of 
interleukin-6; P<0.05 for elevated levels of interstitial pyruvate; P=0.05 for elevated levels of 
serotonin 
11
 methodological issues include: participants recruitment; different methods used at baseline and end 
point for measuring smooth pursuit eye movements; data collecting and analysis; confounding 
variables such as medication / treatment prior to testing was uncontrolled for;  
12
 systematic reviews inclusion criteria for language of publication [English] 
13
 P<0.01 for decreased conjoint motion in whiplash group 
14
 P<0.007 for cold pain and P<0.009 for heat pain between WAD and control; lowered score on the 
HRQoL questionnaire [SF-36] 
15
 P<0.05 for lowered maximal voluntary contractions in flexion and extension in WAD; P=0.038 for 
lowered time to peak force in WAD; No significant difference in EMG recordings 
16
 21% developed widespread pain; odds for developing WP was> in those with depressive symptom 
(OR 3.2); VAS pain 55-100 (OR 3.2); pain>3 months (OR 1.9); localised pain (OR 2.6) 
17
 P<0.01 for warmth threshold; P=0.038 for heat apin; P=0.03 for cold pain when comparing thenar 
emminence and trapezius muscle sites within the whiplash group. P=0.048 for warmth threshold over 
the thenar eminence; P=0.09 for heat pain; P=0.07 for cold pain over the trapezius muscle; P=0.03 for 
pain catastrophising between whiplash and control 
18
 P<0.03 for presence of PTSD at 6 and 12 months and this was related to severe con-current post-
whiplash complaints 
19
 Age, gender, back pain intensity, use of medication and diagnosis of PTSD 
20
 42.3% [95% CI 40.9-43.6] of cohort developed depressive symptoms within 6 weeks post injury; 
subsequent onset in 17.8% [95% CI 16.5-19.2]; recurrent or persistent in 37.6% of those presenting 
early post injury onset. 
21
 P<0.01 for neck ROM and EMG for neck muscle activity; P<0.01 for sensory measures of 
pressure, heat and cold pain, brachia plexus provocation test response; P<0.01 for psychological 
measures of general health, PTSD and fear avoidance at 6 months and 2-3 years post injury 
22
 P<0.05 for active cervical ROM; P>0.05 for neck position sense 
23
 whiplash group showed higher pain scores at 6 months follow-up and non recovery compared to 
the ankle pain controls; P<0.001 for increase in pain area at 12 months post whiplash injury 
24
 methodological flaws in control participants sampling 
25
 P<0.001 for higher NDI and neck pain intensity 
26
 sample size and inadequate power 
27
 P<0.05 for median nerve longitudinal and TM in whiplash compared to control 
28
 P<0.035 for reflex thresholds after repeated and P<0.024 after single stimulation in whiplash 
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compared to controls 
29
 P<0.01 for GHQ and IES psychological measures at 6 months 
30
 Significant difference P<0.01 between entry and exit data for outcome measures studied in this 
whiplash cohort 
31
 P<0.001 for reduced elbow ROM and pain response during the brachial plexus provocation test in 
CWAD compared to controls 
32
 24.2% and 15.0% showed elevated levels of anxiety and depression in the whiplash cohort studied 
33
 P<0.01 for measures of pressure pain and generalised pain distribution
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The identified sensory impairments included local and widespread hypersensitivity, 
hyperalgesia and hypoesthesia to stimuli [thermal, mechanical and electrical stimuli], 
allodynia, and sympathetic nervous system dysfunction [See Table 2.2]. There was a high 
level of evidence for local and widespread lowered pressure pain threshold [PPT] (Koelbaek-
Johansen et al., 1999; Sterling et., 2003, 2006; Greening et al., 2005; Gerdle et al., 2008; 
Chien et al., 2009; Elliot et al., 2009); elevated vibration detection threshold [VDT] (Chien et 
al., 2009); and lowered cold pain threshold [CPT] (Sterling et al., 2003, 2006; Kasch et al., 
2005; Raak and Wallin, 2006; Elliot et al., 2008, 2009; Wallin and Raak, 2008; Chien et al., 
2009). In addition, there was a moderate to high level of evidence for increased response to a 
neurodyanmic test [brachial plexus tension test – BPPT, now referred to as ULNT in the 
literature] (Sterling et al., 2002, 2003; Greening et al., 2005; Chien et al., 2009). In contrast, 
there was a moderate to high evidence for lowered heat pain threshold [HPT] (Sterling et al., 
2003, 2006; Raak and Wallin, 2006, 2008; Chien et al., 2009); and local and widespread 
elevated electrical detection threshold [EDT] (Banic et al., 2004; Chien et al., 2009). The 
sensory impairments that demonstrated moderate to high level of evidence were taken 
forwards to the discrimination study, but the measurement properties of tests to evaluate 
them were explored prior to their use in the study. However, EDT and HPT were dropped 
due to limitations already discussed in Chapter 1, Section 1.6. Overall, there was moderate to 
high level of evidence for presence of altered pressure, cold, and vibration thresholds, and 
altered response to mechanical stretch in CWAD II. Measurement properties of sensory tests 
to evaluate the impairments relating to pressure, cold, vibration and mechanical stretch were 
however not critiqued in detail as this was beyond the focus and scope of this thesis. 
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A. Widespread lowered PPT 
Seven studies (Koelbaek-Johansen et al., 1999; Sterling et., 2003, 2006; Greening et al., 
2005; Gerdle et al., 2008; Chien et al., 2009; Elliot et al., 2009) demonstrated high level of 
evidence for local and widespread lowered PPT. 
 
Koelbaek-Johansen et al (1999) examined sensibility in CWAD II participants using pressure 
stimulation, pin-prick stimulation, and cotton swap. They found pressure pain thresholds to 
be lowered in the WAD group (p<0.01) compared to a gender and age matched healthy 
group. Although Johansen et al (1999) provides evidence for lowered PPT in CWAD II, their 
low sample size and restricted age range [28 – 69 years] warrant caution when interpreting or 
implementing their findings.  
 
Sterling et al (2003, 2006) showed evidence of lowered PPT over the C2/3, C5/6 articular 
pillars, median, radial and ulnar nerve trunk at the elbow, and at a remote site [tibialis 
anterior] in 76 CWAD II-III in comparison to 20 healthy individuals (p<0.01). They 
concluded that their findings demonstrated that presence of central hypersensitivity to 
pressure contributed to CWAD pain. However, it is not clear whether one or both WAD 
subgroups [II or III] contributed to the reported lowered PPT.  
 
Greening et al (2005) reported signs of local mechanical allodynia [pain response to non-
innocuous stimuli] following moderate digital pressure over the trunk of the median nerve 
and chords of the brachial plexus in 9 CWAD II participants. They concluded that local 
mechanosensitivity may contribute to pain in CWAD, although the study was underpowered 
and the digital pressure utilised was not calibrated. This is in contrast to the pressure 
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algometry that was used in other CWAD studies (Koelbaek-Johansen et al., 1999; Sterling et 
al., 2003, 2006; Elliot et al., 2009; Gerdle et al., 2008; Chien et al., 2009). However, the 
results from Greening et al (2005) agree with findings reported within other pressure 
algometry studies (Koelbaek-Johansen et al., 1999; Sterling et al., 2003, 2006; Elliot et al., 
2008, 2009; Gerdle et al., 2008; Chien et al., 2009).  
 
Gerdle et al (2008) reported signs of generalised hypersensitivity to pressure over the 
trapezius and tibialis anterior muscles in 22 female CWAD II participants compared to 20 
healthy females (p<0.001). They concluded that CWAD II is characterised by local and 
widespread sensory hypersensitivity that reflects an underlying disordered peripheral and 
central nervous system. Their conclusions are not generalisable due to the study focus to the 
female gender.  
 
Elliot et al (2009) reproduced findings from Gerdle et al (2008) when they reported local and 
remote lowered PPT over C2/3, C5/6 articular pillars and tibialis anterior muscle in 79 
CWAD II females in comparison to 23 healthy female individuals with INP (p<0.001). Their 
cohort was restricted to female participants owing to a higher incidence of persistent pain 
post whiplash documented in women (Larsen and Holm, 2000).  Although data for the 2 
study groups were collected at different time points, their findings agree with other CWAD 
PPT studies (Koelbaek-Johansen et al., 1999; Sterling et al., 2003, 2006; Gerdle et al., 2008; 
Chien et al., 2009).  
 
Chien et al (2009) found lowered PPT over the articular pillars of C5/6, trunk of median 
nerve at the elbow and belly of tibialis anterior in 31 CWAD II participants, compared to 31 
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healthy individuals (p<0.05). Their findings are in agreement with previous CWAD II 
studies (Koelbaek-Johansen et al., 1999; Sterling et al., 2003, 2006; Elliot et al., 2008; 
Gerdle et al., 2008).   
 
Overall, there is consistent evidence for lowered pressure pain threshold over the C2, C5/6 
articular pillars, median nerve trunk and tibialis anterior muscles in CWAD II. Measurement 
properties of tools used to evaluate PPT were explored as discussed in Section 2.3.1 of this 
Chapter. Measurement properties were however focused to reliability and validity as both 
properties are reported in the scientific literature to be important requirements that tests used 
for research and clinical purposes must fulfil (Sherman et al., 2011). This is important 
because decisions regarding the appropriateness of a test for a particular purpose, sample, 
and setting are informed by evidence of a test’s reliability and validity (Sherman et al., 
2011).  
 
(i) Measurement properties of tools to evaluate PPT 
PPT occurs at the transition point when applied pressure is sensed as pain (Fischer, 1988). 
PPT can be used to demonstrate sensory hypersensitivity (Kosek et al., 1993). Pain response 
to an unusually low pressure is suggested to reflect an underlying sensory mechanism (Rolke 
et al., 2006). Algometry describes the method, while the algometer is the instrument used to 
evaluate PPT (Rolke et al., 2006). The algometer evaluates the maximum amount of pressure 
an individual can cope with before the pressure sensation becomes sensed as pain (Fischer, 
1987). Pressure pain sensory testing target both C and Aδ fibres peripherally and the 
spinothalamic tract centrally (Hanson et al., 2007). PPT has been previously evaluated in 
WAD using the algometer [Somedic AB, Farsta, Sweden] (Scott et al., 2005; Sterling et al., 
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2002b, 2008; Chien et al., 2008). The intra-rater reliability (Fischer, 1987; Nussbaum and 
Downes, 1998; Rolke et al., 2006; Ylinen et al., 2007) and criterion validity (Kinser et al., 
2009) of pressure algometry has been established within the literature. 
 
B. Widespread lowered CPT 
Eight studies (Sterling et al., 2003, 2006; Kasch et al., 2005; Raak and Wallin, 2006; Elliot et 
al., 2008, 2009; Wallin and Raak, 2008; Chien et al., 2009) demonstrated high level of 
evidence for local and widespread lowered CPT.  
 
Sterling et al (2003, 2006) showed evidence of lowered CPT over the C2/3, C5/6 articular 
pillars, median, radial and ulnar nerve trunk at the elbow, and at a remote site [tibialis 
anterior] in 76 CWAD II-III when compared to 20 healthy individuals (p<0.01). Their 
finding provides evidence for the presence of central hypersensitivity to cold in CWAD II. 
They also found CPT to be a significant predictor of poor outcome at long term follow up 
(OR = 1.1 – 1.13). However, the contribution of one or both WAD subgroups [II or III] to 
the lowered CPT remains unknown. The implication is that their conclusions cannot be 
generalised to a CWAD subgroup. Also, comparison of their findings to studies that are 
focused to a CWAD subgroup is difficult.    
 
Kasch et al (2005) evaluated CPT over the hand in 141 CWAD participants [subgroups I-III] 
and 40 chronic ankle-injured. They found lowered CPT in the CWAD group when compared 
to the ankle-injury group (p<0.01). In addition, they reported larger areas of pain in their 
non-recovered CWAD group (p<0.001). However, the contribution of one WAD subgroup 
[I, II or III] to the lowered CPT remains unknown. Also, their conclusions cannot be 
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generalised to a CWAD subgroup as features and characteristics are reported to differ across 
the subgroups (Spitzer et al., 1995). Also, comparison of their findings to studies that are 
focused to a CWAD subgroup is difficult. 
 
Raak and Wallin (2006) found significant differences in CPT over the trapezius muscle 
(p<0.007) and thenar eminence of the hand (p<0.048) in 17 CWAD participants when 
compared with 18 healthy individuals. They concluded that treatment strategies directed at 
cold sensory impairment were important when considering management of patients 
presenting with CWAD. However, their sample’s CWAD subgroup was not declared, so the 
contribution of one of the subgroups [0-IV] to the lowered CPT remains unknown. This is 
important because CWAD subgroups have been described as heterogeneous (Spitzer et al., 
1995), and when investigated as a homogenous group, can lead to misleading conclusions 
and in addition, limit generalisability to a subgroup.  
 
Wallin and Raak (2008) found significant difference in CPT over the trapezius muscle in 26 
CWAD participants when compared to 18 healthy individuals (p<0.007). However, their 
CWAD subgroup was not declared, so the contribution of individual subgroups [0-IV] to the 
reported lowered CPT was not clear. Same implication for authors’ previous study is 
applicable.  
 
Elliot el al (2008, 2009) reported local and remote lowered CPT over C2/3, C5/6 articular 
pillars and tibialis anterior muscle in 79 females presenting with CWAD II when compared 
with 23 females presenting with INP (p<0.001). Although data from the groups were 
collected at different time points, a contrast with methods used in other CWAD research, 
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they report findings that are in agreement with the CWAD studies (Sterling et al., 2003, 
2006; Kasch et al., 2005; Raak and Wallin, 2006; Wallin and Raak, 2008; Chien et al., 
2009). However, their findings are not comparable to previous CWAD research, due to its 
focus to the female gender.  
 
Chien et al (2009) found lowered CPT over the articular pillars of C5/6, trunk of median 
nerve at the elbow and belly of tibialis anterior in 31 CWAD II participants when compared 
to 31 healthy individuals (p<0.01). Their findings are in agreement with previous CWAD 
studies (Sterling et al., 2003, 2006; Kasch et al., 2005; Raak and Wallin, 2006; Wallin and 
Raak, 2008). It however addressed issues of subgroups that was a key limitation of previous 
CWAD studies. Their findings therefore provide evidence to suggest the presence of lowered 
CPT in CWAD II patients.  
 
Overall, there is consistent evidence for lowered CPT over the C2, C5/6 articular pillars, 
median nerve trunk and tibialis anterior muscles in CWAD II. Measurement properties of 
tools to evaluate CPT were explored, and the rationale for this doing has already been 
discussed.  
 
(i) Measurement properties of tools to evaluate CPT 
CPT occurs at a transition point when cold becomes sensed as pain (Hansson et al., 2007), 
and is used to demonstrate sensory hypersensitivity (Kosek et al., 1993). CPT can be 
evaluated through a thermotest equipment [Somedic AB, Sweden], that measures the amount 
of cold that an individual can cope with before the stimulus becomes sensed as pain (Rolke 
et al., 2006). CPT is used to assess the integrity of small fibre and spinothalamic tract 
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function (Hanson et al., 2007). Evidence regarding measurement properties (reliability and 
validity) of CPT is sparse despite the increasing use of the test for research and clinical trials. 
However, the intra-rater (Krassioukov et al., 1999; Park et al., 2001) and inter-rater 
reliability (Felix and Widerström-Noga, 2009) of CPT have been established in the literature. 
The validity of CPT measurements has been established in the literature (Hansson et al., 
2007) although the type of validity that was investigated is unclear.  
 
C. Widespread elevated VDT 
There was high level of evidence for elevated vibration threshold (Chien et al., 2009). The 
authors found elevated VDT over the dorsal surface of the 2nd and 5th metacarpal and palmar 
surface of the 1st and 2nd metacarpal in 31 CWAD II participants when compared to 31 
healthy individuals (p<0.05). This is the first study within the literature that has evaluated 
VDT in CWAD II participants. However, there was no VDT investigation over areas (sites) 
of the neck and Tibialis anterior muscle, when compared to other CWAD II sensory studies 
(Koelbaek-Johansen et al., 1999; Sterling et al., 2002, 2003, 2006; Banic et al., 2004; 
Greening et al., 2005; Kasch et al., 2005; Raak and Wallin, 2006; Elliot et al., 2008, 2009; 
Gerdle et al., 2008; Wallin and Raak, 2008; Chien et al., 2009) that have used those sites to 
investigate local and remote sensory changes (Greening et al., 2005; Sterling et al., 2006). As 
a consequence, their conclusions are limited and further studies are required to replicate their 
findings over sites that were not investigated, to assist interpretation and comparison of 
findings to previous CWAD studies. Measurement properties of reliability and validity for 
tools used to evaluate VDT were explored, and the rationale underpinning this decision has 
already been discussed.  
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(i) Measurement properties of tools to evaluate VDT 
VDT evaluates Aβ fibres peripherally and the lemniscal tract centrally (Hanson et al., 2007) 
through a tuning fork [64, 128, 256Hz], Vibrametre [Somedic AB, Sweden with a tissue 
displacement range of 0.1+
-
400 mm and a constant frequency of 120 Hz]; or a Vibratimer 
(O’Conaire et al., 2011). VDT is agreed to be useful for early detection of peripheral 
pathologies (Goldberg and Lindblom, 1979). The intra- and inter-rater reliability for the 
Vibrameter (Peters et al., 2003); inter-rater reliability for the Vibratimer and the tuning fork 
as well as the concurrent validity for the Vibratimer (O’Conaire et al., 2011) have been 
established in the scientific literature.   
 
D.  Increased sensory response to passive mechanical stretch   
There was moderate to high level of evidence for increased response to a neurodyanmic test 
[brachial plexus tension test – BPPT, now referred to as ULNT in the sensory literature] 
(Sterling et al., 2002, 2003; Greening et al., 2005; Chien et al., 2009). The ULNT is used to 
move and exert mechanical longitudinal stress on peripheral nerve trunks, their proximal 
nerve roots and the cervico-brachial plexus (Jaberzadeh et al., 2005). The test increases 
tension on peripheral nerves as they stretch or slide in response to multi-joint (combinations 
of joint) motion, and results in sensory and motor responses that are interpreted and used to 
inform clinical decisions (Jaberzadeh et al., 2005). Restrictions along the course of the nerve 
and or inflammation around the nerve surrounding are proposed as responsible for a positive 
response during the test (Hall et al., 1993; Balster & Jull, 1997; Elvey, 1997; Butler, 2000; 
Greening et al., 1998, 2001, 2005; Shacklock et al., 2005). However, this claim is largely 
informed by animal and cadaver studies, but has not been verified in humans’ in-vivo.  
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Sterling et al (2002) reported a decrease in elbow extension range of movement and higher 
pain scores using a visual analogue scale [VAS] following the ULNT 1 in 156 CWAD II-III 
participants in comparison to 95 healthy individuals (p<0.001). However, it is not clear 
whether one or both WAD subgroups [II or III] accounted for their results. As a 
consequence, comparison of their findings to other ULNT studies is limited, and 
generalisation of their conclusions to one of the subgroups is difficult. 
 
Sterling et al (2003) showed evidence of reduced elbow extension range of movement and 
higher pain scores [using a visual analogue scale] when performing the ULNT 1 in 76 
CWAD II participants in comparison to 20 healthy individuals (p<0.01). The size of their 
healthy group was disproportional to their WAD group and could have skewed their 
statistical analysis. Their findings however identified and support test components that are 
used in a clinical setting to demonstrate a positive ULNT 1 (Nee and Butler, 2006).  
 
Greening et al (2005) reported signs of local hypersensitivity to mechanical stretch when 
performing the ULNT 1 in 9 CWAD II participants, concluding that mechanisms promoting 
local hypersensitivity to mechanical stretch may contribute to symptoms in CWAD. They 
also found that nerve movement in a longitudinal plane was reduced in the CWAD II 
participants when compared to 8 healthy individuals (p<0.05). A key limitation of their study 
is the small sample size. However, its findings provide preliminary data to suggest that 
altered movement of peripheral nerves is an important construct of the ULNT that underpin 
responses observed during the test. Further studies are required to replicate their findings in a 
larger sample.  
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Chien et al (2009) reported decreased elbow extension range of movement [ROM] and 
higher pain VAS scores when performing ULNT 1 in 31 CWAD II participants when 
compared to 31 healthy individuals (p=0.05). Their findings agree and support one of the 
proposed criteria used to interpret a positive ULNT 1 response, i.e. increased pain response 
linked to decreased elbow extension ROM (Nee and Butler 2006). However, their evidence 
does not capture other criteria e.g. nerve movement, flexor muscle resistance that are used to 
interpret a positive ULNT 1. Further evaluation of the four constructs is required in CWAD 
to support the hypothesis that is currently relied upon when interpreting the test.   
 
Overall, there was moderate to high level of evidence for increased response to ULNT. It is 
important to explore the measurement properties of ULNT prior to including the test in the 
sensory discrimination study. The rationale underlying this decision has been discussed 
already.  
 
(i) Measurement properties of ULNT 
The intra-rater reliability of ULNT has been reported within the scientific literature 
(Selvaratnam et al., 1994; Coppieters et al., 2002; Oliver et al., 2010). However, the 
construct validity of the test has been informed by cadaver [in-vitro] studies (Kleinrensink et 
al., 1994, 1995, 2000; Shaclock 1996; Wright et al., 1996; Lewis et al., 1998; Coppieters et 
al., 2001; Coppieters and Butler 2008). Available cadaver-based ULNT studies provide 
preliminary validity evidence, but have been criticised as being limited in their conclusions 
and applicability to humans because (a) nerves and surrounding tissues in cadavers do not 
demonstrate same physiologic characteristics as those of living humans (b) procedures used 
to embalm cadavers further adds to alter tissue characteristics and (c) pain response, an 
 
 
 59 
 
important outcome of ULNT cannot be evaluated in cadavers (Coppieters et al., 2009).  
There is no clarity about the type of validity investigated in the cadaver studies. Also, there is 
a lack of supportive evidence for the four constructs or criteria used to interpret a positive 
ULNT test. This is important because of ongoing debate challenging the usefulness and 
rationale underlying the test. Firstly, there is discrepancy about the usefulness of ULNT for 
patients e.g. CWAD who demonstrate signs of mechanical hypersensitivity (Dilley et al., 
2008; Nee and Butler 2006). Those in favour argued that the test is useful as it is able to 
demonstrate sensory changes in neural structures (Nee and Butler 2006), while those against 
it believe the test will further provoke and worsen patients’ sensitised nerves (Dilley et al., 
2008). Secondly, opinions are divided whether restriction of nerve movement, is actually 
responsible for the increased pain, decreased elbow ROM and muscle resistance 
demonstrated during the test [Figure 2.12]. The debate illustrates limitation in present 
understanding of mechanism and effect of ULNT in-vivo. However, advancement in 
biomedical technology is providing tools that are increasingly overcoming limitations of 
previous research, thereby enabling further evaluation of components underpinning tests 
such as ULNT in-vivo. Dynamic ultrasound imaging [DUI] is one such tool.  
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Figure 2.8: Theorised components underlying ULNT 
 
 
Dynamic Ultrasound Imaging 
With the emergence of DUI, it is now possible to evaluate nerve movement (Walker 2004) in 
order to validate the ULNT in-vivo (Greening et al., 2005). Coppieters et al (2009) used DUI 
in 10 healthy individuals to validate the theorised assumptions that neurodynamic positions 
that promote nerve sliding were associated with more nerve movement than those that 
promote tensioning. They found that more nerve movement occurred during neurodynamic 
sliding (p<0.0001) when compared to the tensioning positions. However, a limitation of their 
study is that the reported neurodynamic positions involved modifications to the ULNT limb 
positions, and as a consequence, their evidence cannot be used to inform validity of the test. 
Their findings are however important as it provided preliminary data that show potential of 
DUI to be used to investigate nerve movement in-vivo, amongst the constructs used, to 
interpret the ULNT. This construct have not been investigated in existing validity studies for 
ULNT, and is therefore required to complete the evidence, particularly in a patient 
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population e.g. CWAD. However, prior to conducting the ULNT validity study, it was 
important to first consider the measurement properties of DUI. This is important because 
conflicting nerve movement estimates within same or similar pain conditions exists within 
the DUI literature.  
 
DUI evaluation of nerve movement is well reported within the literature (Heinemeyer and 
Reimers 1998; Hough et al., 2000; Dilley et al., 2001; Greening et at 2001; Dilley et al., 
2003; Erel et al., 2003; Greening et al., 2005; Dilley et al., 2007; Ellis et al., 2008; 
Coppieters et al., 2009; 2007). However, previous DUI studies have reported conflicting 
nerve movement estimates that have raised concerns about the reliability of the method, 
especially in a patient sample.  
 
Greening et al (2001) compared median nerve movement in the transverse plane (referred to 
hereafter as transverse movement [TM]) in non specific arm pain [NSAP] (n=12) against a 
healthy group (n=16) and reported a 75% reduction in median nerve TM between the two 
groups [Table 2.3]. However, in CWAD II participants (n=9), a pain condition suggested to 
be similar to NSAP (Greening et al., 2005), same authors found increased median nerve TM 
when compared to healthy individuals (Greening et al., 2005) [Table 2.3]. These findings 
were unexpected, difficult for the authors to explain, and contrast with their previous reports, 
considering that both groups are comparable. Their findings raise questions regarding 
consistency of TM measurements and in turn, reliability of DUI technique for TM. The small 
sample size of both studies could equally have affected their results and conclusions. 
However, further investigation of TM, particularly, its reliability is warranted. 
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Greening et al., (2005) compared median nerve movement in the longitudinal plane (referred 
to hereafter as longitudinal nerve movement [LM]) in NSAP (n=8) and healthy individuals 
(n=8). They reported a 68% reduction in median nerve LM when compared to the healthy 
group [Table 2.4]. However, same authors in a later study found no difference in median 
nerve LM between NSAP (n=18) and healthy individuals (n=39) [Table 2.4]. These findings 
are inconsistent, considering that both cohorts were sampled from the same pain sample. The 
findings therefore raise questions regarding consistency of TM measurements and in turn, 
reliability of DUI technique for LM. Further investigation of LM, particularly its reliability is 
warranted. 
 
Table 2.3: Conflicting estimates of median nerve TM  
Study Sample Findings (mm) 
Greening et 
al (2005) 
 
Greening et 
al (2001) 
9 CWAD 
 
 
12 NSAP 
8 Healthy 
 
 
16 Healthy 
7 times more median nerve TM in 
CWAD (2.57 ±  
0.80) Vs Healthy (0.39 ± 0.52) 
75% reduction in median nerve TM in 
NSAP (1.2) Vs  healthy (4.8)  
 
 
 
 
 
 
 
 
 
 
 63 
 
Table 2.4: Conflicting estimates of median nerve LM  
Study Sample Findings (mm) 
Greening et 
al (2005) 
 
Dilley et al 
(2008)  
8 NSAP 
 
 
18 NSAP 
8 Healthy 
 
 
39 Healthy 
68% reduction in median nerve long. 
movement in NSAP (0.49±0.19) Vs 
healthy (1.55±0.19)  
No difference in median nerve   
Long. movement in NSAP (1.26 - 4.73) 
Vs Healthy (1.43 - 5.57)  
 
Overall, there was a merit to consider reliability of DUI technique for computing nerve TM 
and LM. This informed an appraisal of DUI literature to identify supportive evidence for its 
reliability. There is however a dearth of literature for reliability of DUI technique, 
particularly for a patient population (e.g. neck pain patients). Three studies (Dilley et al., 
2001; Erel et al., 2003; Coppieters et al., 2009) have reported reliability of DUI 
measurements for median nerve LM, but only one study (Greening et al., 2001) have 
reported DUI reliability for median nerve TM. However, methodological issues identified 
within the reliability studies weaken and limit their conclusions.  
 
Out of three studies reporting DUI reliability of median nerve LM, only one (Erel et al., 
2003) was reported in a patient sample (Carpal Tunnel Syndrome [CTS]). The bias of 
majority of the reliability to healthy individuals could be due to problems (e.g. stability of 
symptoms) associated with testing a patient population (Coppieters et al., 2009). However, 
no reliability study to date has been conducted in WAD. This is important because reliability 
of a measure will be different between patients and healthy individuals (Haas et al., 1991). 
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Also, the DUI reliability studies were focused to median nerve, and investigated intra-rater 
reliability that can be associated with measurement error arising from inherent, innate bias 
(Haas et al., 1991). These findings warranted further studies to provide a higher level of 
evidence for reliability (inter-rater reliability) of DUI for radial and ulnar LM, as the nerves 
are part of the brachial plexus implicated in sensory impairments in CWAD (Chien et al., 
2008). 
 
The methodological quality of the three reliability studies (Dilley et al., 2001; Erel et al., 
2003; Coppieters et al., 2009) are queried [Table 2.5]. Dilley et al (2001) evaluated intra-
rater reliability of DUI estimate of median nerve LM during 3-4 repeated wrist [n=3] and 
index finger [n=7] extension movement. Also, test-retest data was obtained for wrist [n=1] 
and index finger [n=2] extension, at 5 and 14 days intervals respectively. They concluded 
that DUI was reliable, interpreting statistics of within-participant and between-trial variation, 
rather than the ICC that is widely recognised as the gold standard for interpreting reliability 
(Haas et al., 1991; Bland and Altman, 1996). In addition, test-retest data for wrist and finger 
extension varied by 0.5-0.7mm, which translates to >10-50% of the initial measurements. 
Their study sample was also small. These limitations weaken their conclusions of good 
reliability for DUI, and warrant further investigation of reliability of the technique.  
 
Erel et al (2003) evaluated DUI reliability for median nerve LM in CTS (n=4). The authors 
concluded that DUI was a reliable method, interpreting a within-participant standard 
deviation of 0.31mm for repeated measurements on a single occasion and tests-retest (1-6 
months) standard deviation of 0.41mm. The study was underpowered (Walter et al., 1998) 
and their conclusions were not based on the ICC statistic (Haas et al., 19991). In addition, the 
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nerve movement [TM or LM] evaluated was not clear. Conclusion from the study is limited, 
and generalisation to a nerve movement is difficult. Further evaluation of DUI reliability in a 
patient sample is warranted.  
 
Coppieters et al (2009) evaluated inter-rater reliability of the image analysis component of 
DUI, using 3 raters and 10 median nerve LM images. The study reported excellent inter-rater 
reliability [ICC2,1 = 0.96; 95% CI: 0.88 to 0.99; standard error of measurement [SEM] = 
0.66mm; minimum detectable change [MDC] = 1.84mm]. They concluded that DUI was a 
reliable technique. However, their study was underpowered, as Walter et al (1998) defined a 
sample size of n ≥ 12, using n=3 raters, at 80% power and 5% level of significance. Also, 
their study investigated one of the two components of DUI, and therefore provided 
incomplete evidence for DUI reliability for LM. The limitations warranted further 
investigation of DUI reliability that takes into account, both components of the technique.  
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Table 2.5: DUI reliability studies of median nerve LM  
Study Participants  Nerve (Level of 
Reliability) 
DUI component Reported 
Statistics 
Reported 
Reliability 
 
Dilley et al 
(2001)  
7 Healthy Median (Intra-rater)  
 
Nerve Image Capture 
and Image Analysis 
 
*WS SD= 0.2-0.4mm  
*WT  SD = 10%  
Good 
Erel et al (2003)  
 
4 Carpal Tunnel 
Syndrome 
Median (Intra-rater) 
 
Nerve Image Capture 
and Image Analysis 
 
*WS SD = 0.31mm  
*WT  SD = 0.41mm  
Good 
 
Coppieters et al 
(2009)  
 
10 Healthy 
 
 
Median (Inter-rater) 
3 Raters 
Nerve Image Analysis ICC2,1 = 0.96  Excellent  
*WS – Within Participant; WT – *Within Trial; SD – Standard Deviation
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There is only one study (Greening et al., 2001) that has evaluated reliability of DUI estimates 
for median nerve TM. Greening et al (2001) evaluated test-retest reliability of DUI 
measurement of median nerve TM using a Matlab® developed TpsDig nerve image analysis 
program. The study measured median nerve TM in (a) healthy individuals and NSAP 
participants (n=4), on two occasions [interval of 1-6 hours] and (b) healthy individuals (n=5) 
at 1-2 days interval. The authors concluded that DUI was a reliable method, using the 1-2 
days re-tests standard deviation -0.03 [SD=1.88; Range = -2.0±2.0] mm, rather than the ICC 
statistic. Their heterogeneous sample limits the applicability of their findings and weakens 
their study conclusions (Walter et al., 1998; Haas et al., 1991). Further, there is no report in 
the literature regarding reliability of DUI estimates of radial and ulnar nerve TM. 
 
Overall, existing evidence regarding reliability of DUI for LM and TM are focused to 
median nerve, healthy individuals, intra-rater reliability, and use of re-test standard deviation. 
These methodological issues can mislead interpretation of findings and also limit 
generalisability of conclusions that emerge from the studies. Further evaluation of DUI 
reliability for median, ulnar and radial nerves, in CWAD, using inter-rater reliability design, 
and the ICC statistic was warranted. This study was required before DUI can be used, with 
other measures to provide evidence of construct validity for the ULNT in CWAD II. 
Findings from these preliminary studies provided evidence to complete the measurement 
properties of ULNT, a criterion that all selected sensory impairments fulfilled. 
 
2.5 Conclusions from the literature review  
The aim of the literature review was to identify sensory impairments from high quality 
evidence, to justify sensory tests that were used to discriminate CWAD II from healthy 
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individuals. Measurement properties and clinical applicability of the sensory tests were 
considered, to ensure that findings from the study are interpretable and can be translated to a 
clinical setting. Moderate to high level consistent evidence was identified for altered sensory 
response to pressure, cold, vibration and mechanical stretch in CWAD (Koelbaek-Johansen 
et al., 1999; Sterling et al., 2003, 2006; Kasch et al., 2005; Greening et al., 2005; Raak and 
Wallin 2006; Wallin and Raak 2008; Chien et al., 2009; Elliot et al., 2008, 2009; Gerdle et 
al., 2008; Elliot et al., 2009). This supports inclusion of these impairments in a sensory 
discrimination study. Tools for evaluating these impairments were appraised to establish 
their measurement properties of reliability and validity. The evidence in regards of validity 
of ULNT is incomplete due to a lack of in-vivo nerve movement data in previous reports. 
Validity of ULNT therefore merits further consideration, particularly, with the emergence of 
DUI technique for computing in-vivo nerve movements.  
 
This informed the design of a construct validity study for the ULNT. However, reliability of 
DUI was questioned due to conflicting estimates, and potential for measurement error, of 
median nerve TM and LM within similar and same patient sample. Existing DUI studies are 
limited by their focus to median nerve; healthy individuals; intra-rater reliability; and use of 
re-test standard deviation. These limitations informed further evaluation of DUI reliability 
for median, ulnar and radial nerves, in CWAD, using inter-rater reliability design, and the 
recommended ICC statistic to interpret findings. The studies undertaken and reported in the 
thesis and the underpinning rationale for them is graphically illustrated in figure 2.13. 
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2.6 Chapter summary 
The literature review identified clinically important sensory impairments from high quality 
CWAD II studies to justify their inclusion in the discrimination study. Consideration of 
measurement properties of tools for evaluating the impairments highlighted the importance 
of investigating construct validity of ULNT, prior to the discrimination study. A key 
construct required to validate the ULNT is nerve movement, but existing evidence for its 
reliability is weak and inconclusive, therefore warranting further evaluation of DUI 
reliability, prior to the validity study.
 
 
 70 
 
 
 
Figure 2.9: Schematic representation of studies in the thesis 
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CHAPTER 3 
 
Inter-rater reliability of the measurement of nerve movement in CWAD II using 
dynamic ultrasound imaging (DUI) 
 
3.1 Background  
There are conflicting estimates for nerve movement obtained within CWAD and NSAP 
sample (Table 2.3). Greening et al (2005), the only nerve study conducted in WAD,  
compared DUI estimate of median nerve LM and TM in CWAD (n=9) and healthy 
individuals (n=8), during inspiration and wrist extension motion. They found the TM was 
approximately 7 times greater in CWAD [mean=2.57mm, SD=0.80mm] in a radial direction 
in comparison to the healthy group [mean=0.39mm, SD=0.52mm], whose nerve moved in an 
ulnar direction. This finding contrasts with the same author previous report demonstrating a 
75% reduction in median nerve TM in n=12 NSAP [mean=1.2mm] compared to n=16 
healthy individuals [mean=4.8mm], in a radial direction during wrist motion (Greening et al., 
2001). It has been suggested that CWAD and NSAP exhibit similar clinical features 
(Greening et al., 2005) and comparable TM of the median nerve were expected across the 
two studies. Although differences of joint motion were advanced to explain the conflicting 
directions of nerve movement, the authors were not convincing. Other examples of 
conflicting estimates of movement of the median nerve were discussed in the Chapter 2 and 
summarised in Tables 2.3 - 2.4. The conflicting results raise questions regarding consistency 
of measurements and potential measurement error that in turn implicate reliability and 
validity of nerve movement measurement obtained by the DUI technique. Reliability is 
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important because it ensures reproducibility of measurements, a precondition for 
measurement validity (Batterham and George, 2003; Tuijn et al., 2011). Sound measurement 
properties increase clinicians’ confidence in test findings and assist meaningful interpretation 
of clinical change to inform clinical decisions (Chen and Barnhart, 2008).  Consequently, 
establishing reliability of DUI would provide preliminary evidence for its applicability in a 
clinical setting.  
 
Reliability of DUI measurements 
High reliability has been reported for estimates of median nerve LM (Dilley et al., 2001; Erel 
et al., 2003; Coppieters et al., 2009) and TM (Greening et al., 2001) using DUI. Existing 
DUI reliability studies have been focused to longitudinal nerve movement measurements and 
were limited by methodological issues such as inadequate sample sizes, bias to healthy 
individuals and median nerve, and inappropriate design and data analysis [Table 2.5]. For 
example, only one (Erel et al., 2003) out of three (Dilley et al., 2001; Coppieters et al., 2009) 
DUI reliability studies were conducted in a patient sample CTS.  The data are however, 
limited by their small sample sizes and inappropriate statistical analysis (Table 2.5). There is 
no DUI reliability data for CWAD, which is important because reliability estimates could 
vary within subsets of samples (Haas et al., 1991), and there is no DUI reliability data for 
ulnar and radial nerves. There is no DUI inter-rater reliability study that involves both 
components of the technique [Table 2.5]. Generally, estimates of reliability from intra-rater 
studies are larger than those from inter-rater studies and over-estimate reliability of methods 
or tools used in a clinical setting (Haas et al., 1991).  
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Overall, conflicting median nerve TM and LM estimates, as well as, inconclusive evidence 
of DUI reliability for both nerve movements necessitated its further consideration, 
particularly in CWAD II.   
 
3.2  Aims and objectives 
 
3.2.1 Aim of study 
To evaluate inter-rater reliability of DUI estimates of median and ulnar nerve movements, 
during passive contra-lateral neck side-flexion [CNSF], a key component of ULNT, in 
CWAD II 
 
3.2.2 Objectives of study 
1. To estimate inter-rater reliability of estimates (mm) of LM for: 
1. median nerve at the wrist  
2. median nerve at mid forearm 
3. ulnar nerve at the upper arm proximal to the elbow and  
2. To estimate inter-rater reliability of estimates (mm) of TM for: 
4. median nerve at the wrist; 
5. median nerve at mid forearm; 
6. ulnar nerve at the upper arm proximal to the elbow during CNSF in CWAD II.  
 
The obtained reliability coefficient encompassed measurement error from nerve image 
capture through to computation of nerve movement using offline image analysis programs. 
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3.3 Method 
3.3.1 Design 
A cross-sectional design was used to evaluate inter-rater reliability of movement of median 
and ulnar nerves, during passive CNSF in a CWAD II sample using three raters 
[Physiotherapists].  
 
Radial nerve was excluded due to poor DUI image quality and delineation of its borders 
during a pilot phase. CNSF was chosen to reflect the sensitizing component of ULNT that is 
used commonly in the clinical setting (Shacklock 2005; Nee and Butler 2006). WAD II is the 
most predominant of the five established WAD subgroups that present to Physiotherapists in 
a clinical setting (Sterling et al., 2004), and individuals presenting with WAD ≥ 6 months 
post injury [chronic] were targeted because reported symptoms during this phase of the 
condition were expected to be stable, ensuring that repeat measurements were collected 
under the same conditions (Sterling et al., 2006). Randomisation using a random-number 
table was conducted to decide the sequence of examiners measuring each participant during 
data collection and to balance any potential order effect.  Raters were blinded to each other 
scanned DUI images to eliminate visual bias as well as to replicate testing conditions for a 
clinical setting (Ellis et al., 2008). 
 
3.3.2 Participants 
A convenience sample of eighteen (14 females, 4 males) CWAD II, mean age (SD) = 35 
years (12) who were not presenting for treatment at the time of data collection, participated 
in the study. A Sample size of n≥12 was calculated a priori so that the study had 80% power 
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with an alpha level of 0.05 for ICC estimates of reliability of 0.9 and 0.7, using 3 raters 
(Walter et al., 1998).  A sample of 18 participants allowed for potential data loss or 
corruption during data transfer between the ultrasound scanner and the computer system 
used for offline data analyses.  
 
3.3.3 Eligibility criteria   
 Eligibility criteria were established to focus to the sample and nerve characteristics of 
interest and also to eliminate potential confounding factors that can compromise nerve 
mobility or mislead interpretation of reliability results.   
 
Inclusion criteria were defined as: 
 Currently enrolled students or employed staff of a UK University. The sampling method 
provided access to CWAD II that were not presenting for treatment, to minimise 
participants variability during testing.  
 WAD II according to QTF whiplash classification (Spitzer et al., 1995) 
 Six months post whiplash injury (Sterling et al., 2004)  
 Aged between 18 and 55 years, as a significant proportion of WAD fall within this age 
range (Hendriks et al., 2005).  
 Understand and communicate in English language, as this is the language of 
communication in the University 
 
Exclusion criteria were: 
 CWAD II patients receiving treatment 
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 Cervical hernia, past cervical pathologies not associated with whiplash injury (Hendriks 
et al., 2005) 
 Concussions, loss of consciousness and head injury as a result of the accident (Sterling et 
al., 2004) 
 Diabetes Miletus, renal failure, rheumatoid arthritis, epilepsy, HIV, tuberculosis, cancer, 
uncontrolled hypertension and pregnancy (Sterling et al., 2004). 
 
3.3.4 Ethical Considerations 
Ethical clearance was obtained from the Medical Research Ethics Committee of the School 
of Sports and Exercise Sciences and Health and Population Sciences. A Participant 
Information Sheet (PIS), Consent Form and Risk assessment were produced and submitted 
as part of the ethical approval process [Appendix A]. 
 
3.3.5 Raters 
Three musculoskeletal [MSK] physiotherapists were involved as raters in nerve image 
capture and analysis, while a fourth MSK physiotherapist performed all passive contra-
lateral neck side flexion to limit of pain [P2] (Maitland, 2001) or movement [R2] (Petty and 
Moore 2011). Prior to the study, all three raters were trained and certified competent in 
regard to nerve image capture by a qualified Sonographer. Two raters received training and 
undertook practice sessions over an 8 week period, while the third rater practised over a five 
month period. The MSK physiotherapists had a minimum of two years post-qualification 
clinical experience and were studying at a postgraduate level at the time of data collection.  
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3.3.6 Recruitment strategy 
Recruitment of participants was done through posters, e-mail and word of mouth within the 
University. 
  
3.3.7 Data collection 
A. Health questionnaire and neurological examination  
Participants were asked to complete a health questionnaire. A point tenderness and 
restriction of neck ROM as described by Spitzer et al., (1995) was used as criteria to define 
CWAD II participants. A neurological examination was carried out to evaluate eligibility 
criteria and to rule out CWAD III.  
 
B. Nerve image capture equipment 
Ultrasound imaging of median and ulnar nerve movement in both transverse and longitudinal 
plane were captured using a Diasus ultrasound system (Dynamic Imaging, Livingston, 
Scotland, UK) with an 8-16 MHz 26mm linear array transducer. Sequences of nerve images 
were acquired at 10 frames per second, converted to digital format and analysed offline using 
software developed in Matlab®. Image resolution was 0.044 mm/pixel with an image size of 
590 X 790 pixels. To ensure study findings are comparable to previous DUI reliability 
studies, images were analysed using a conversion algorithm in a cross-correlation program to 
achieve the equivalent equipment and image setup used in the DUI literature (Erel et al., 
2003; Dilley et al., 2001, 2003, 2007; Greening et al., 2001, 2005; Ellis et al., 2008; 
Coppieters et al., 2009).  
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C.  DUI transducer position 
 The DUI transducer was first positioned in the transverse plane to identify the relevant 
nerve. Median and ulnar nerve TM were imaged during CNSF, in this transducer position. 
The transducer was then turned 900 to align with the longitudinal plane of the nerve and 
median and ulnar nerve LM imaged during CNSF in this US transducer position. The 
transducer positions are established within the DUI literature (Dilley et al., 2001, 2003, 
2007a, 2007b; Greening et at 2001, 2005;  Erel et al., 2003; Ellis et al., 2008; Coppieters et 
al., 2009).  
 
D.  Participant position   
For median nerve movement measurements, the participant’s starting position was supine 
lying, 30 degrees shoulder abduction, elbow extension and wrist in neutral (Greening et al., 
2005).  During median nerve imaging, the participant’s neck was moved in an opposite 
direction to the side of the arm being imaged (Nee and Butler, 2006). Median nerve images 
were acquired at the wrist and mid-forearm (Greening et al., 2005). For ulnar nerve 
movement measurements, the participant’s starting position was supine lying, shoulder 
abduction, elbow flexion and wrist extension to their maximal range without causing any 
discomfort or pain. The sequence of joint motion replicates the ulnar nerve ULNT position 
(Nee and Butler, 2006). During ulnar nerve imaging, the participant’s neck was moved in an 
opposite direction to the side of the arm being imaged (Nee and Butler, 2006). Ulnar nerve 
images were acquired at the upper arm proximal to the elbow (Dilley et al., 2003, 2007, 
2007). CNSF was used to lengthen the nerve bed to produce nerve movement (Szabo et al., 
1994; Shacklock 1995; Byl et al., 2002; Dilley et al., 2003; Coppieters et al., 2006). Five 
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passive CNSF warm-ups were carried out prior to imaging, to eliminate serial effects as was 
reported by Shuba (2009) (Unpublished Dissertation). The sixth CNSF range of movement 
value was recorded and maintained during nerve movement imaging for each participant. A 
pictorial view of the testing protocol is illustrated in Figure 3.1A-B. 
 
 
 
Figure 3.1A: Arm starting positions for median [left] and ulnar nerve [right] 
 
 
Figure 3.1B: Nerve movement image capture during contralateral passive neck side 
flexion  
 
 
 
  80 
E. Image capture by raters 
Each rater imaged each participant once, for each test position. There was no rest period 
between measurements because no evidence exists to support adverse reaction following 
repeated CNSF. The testing protocol is presented as appendix B. 
 
F. Image Analysis by Raters 
Offline analysis programs developed in Matlab were used to analyse the acquired nerve 
images. These programs were developed by A. Dilley and J. Rohlf, who gave permission for 
their use. Each rater analysed their own acquired images of median and ulnar nerve 
movement for all n=18 CWAD participants, reflecting practice in a clinical setting. Each 
image was analysed three times and the mean (mm) calculated as a measure of nerve 
movement (Dilley et al., 2001). The image analysis methodology is established within the 
ultrasound literature (Dilley et al., 2001, 2003, 2007; Greening et at., 2001; Erel et al., 2003; 
Greening et al., 2005; Ellis et al., 2008; Coppieters et al., 2009).  
 
(i) Analysis of LM images  
A cross-correlation algorithm program was used to estimate movement of speckle features in 
selected regions of nerve between consecutive frames of nerve images (Dilley et al., 2001). 
The pixel shift that produced the highest correlation coefficient between consecutive frames 
corresponded to the relative nerve movement in the region of interest (Dilley et al., 2001). To 
control for any probe or arm movement, speckle features in deep static structures (bone) 
were tracked using the same method. Movement of the bone was subtracted from nerve 
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movement values to compute overall estimates of nerve movement (Dilley et al., 2001, 2003, 
2007). The detailed protocol of the longitudinal image analysis is presented in appendix C. 
 
 
Figure 3.2A and B: (A) Four boxes are placed within the nerve and (B) Two boxes are 
placed over bone (fixed tissue) used as reference to compare the nerve movement against 
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Nerve image analysis template used for LM 
The protocol described in appendix C for the analysis of LM images utilised three boxes of 
varying sizes placed within the nerve (Ellis et al., 2008), to enable the oflline program to 
track movement of fine speckles within the boxes [regions of interest]. Korstanje et al (2010) 
reported that the number, size and position of boxes affected DUI estimates. To enhance 
consistency across raters’ placement of boxes during longitudinal nerve image analysis and 
to improve upon the previously established protocol (Dilley et al., 2001), a template was 
developed [Figure 3.3]. The template divided the nerve into four equal quarters, and a box 
was positioned within each quarter across the nerve length. Boxes were placed 0.1cm below 
the upper and lower margins of the nerve and separated by 0.5cm [Figure 3.3]. Using the 
template, analysis of median nerve images by 3 researchers in a pilot phase produced 
excellent inter-rater reliability of image analysis (ICC = 0.93) [Table 3.1].  
 
 
Figure 3.3: The image analysis template developed to improve consistency of box sizes and 
position used during  offline analysis of LM 
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Table 3.1 : Reliability between each rater 3 repeated analysis of n=18 CWAD II median and 
ulnar nerve LM images using the image analysis template 
 
 
 
 
Researcher A Researcher B Researcher C 
Nerve 
Mean 
movement 
(mm) 
SEM 
(mm) 
 
ICC 
 
 
Mean 
movement 
(mm) 
SEM 
(mm) 
 
ICC 
 
 
Mean 
movement 
(mm) 
SEM 
(mm) 
 
ICC 
 
 
Median 0.36 0.08 0.97 0.15 0.12 0.93 0.63 0.11 0.98 
Ulnar 0.32 0.09 0.93 0.15 0.04 0.98 0.35 0.10 0.96 
 
(ii) Analysis of TM images  
Nerve TM was calculated offline from bitmap images of nerve TM using the “TpsDig” 
software program (Department of Ecology and Evolution, State University of New York). 
Points representing coordinates were selected within nerve images taken pre and post CNSF. 
The points were placed at the upper and lower extreme borders, as well as at the left and 
right borders of the nerve. Two additional points were placed on two skin markers used as 
reference points [Figure 3.4A]. The coordinates for all six selected points were loaded into 
Excel “WhipTrans” program and the change in nerve position was computed from the 
coordinates [Figure 3.4B].  
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Figure 3.4 A: Positions of markers used to generate movement coordinates for TM during 
image analysis 
 
 
Figure 3.4 B: Excel “WhipTrans” program used to compare changes in the coordinates of 
markers between  pre and post CNSF TM images 
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3.4 Statistical Analysis 
The ICC2,1 (Haas, 1991; Bland and Altman, 1996) was used to assess reliability of nerve 
measurements by three raters using the DUI technique. However, the ICC can be affected by 
between participant variations (Haas 1991). Small differences between participants can 
produce a false negative [type II error] i.e. an overestimation of standard error of regression 
coefficients and a false low reliability estimates (Haas, 1991). In addition, the ICC does not 
give an indication of the magnitude of inter-rater discrepancy (Sim and Wright 2000). 
Hence, 95% Confidence Interval [95% CI] of the ICC, coefficient of variation [CV], 
standard error of measurement [SEM], and minimum detectable change [MDC] were 
reported to assist interpretation of reliability results. All statistics were computed using SPSS 
[version 15.0]. 
 
3.4.1 Intra-class correlation coefficient [ICC] 
The ICCs are used to evaluate level of reliability on measurements taken by two or more 
raters (Shrout and Fleiss 1979; Haas 1991; Bland and Altman 1996).  ICC is a dimensionless 
index, with values between 0 [indicating no reliability] and 1 [indicating perfect reliability] 
(Sim and Wright 2000). In this study, ICC was used to estimate reliability in nerve 
movements obtained by three different raters, where each movement was a mean value from 
3 repeated analyses of nerve images. An ICC2,1 model (selecting the “absolute reliability” 
option in SPSS) was used because each rater assessed each participant and the three raters 
were considered to be representative of potential raters, enabling the results to be generalised 
to a similar sample of clinicians (Shrout and Fleiss 1979; Eliasziw et al., 1994). 
Interpretation of the ICC has usually been based on pre-specified cut-off values or 
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boundaries, although these might be considered arbitrary (Jordan, 2000). Several boundaries 
have been suggested in the literature. Landis and Koch (2000) proposed the following –  
ICC values between:  0.1 and 0.2 indicate slight reliability, 0.21 to 0.40 fair reliability, 0.41 
to 0.60 moderate reliability, 0.61 to 0.80 substantial reliability, and 0.81 to 1 almost perfect 
reliability. Eliasziw et al (1994) proposed acceptable cut-offs to be ICC=0.6 for inter-rater 
and ICC=0.8 for intra-rater reliability, permitting only a dichotomous labelling of reliability. 
Previous DUI reliability studies of median (Coppieters et al., 2009) and sciatic (Ellis et al., 
2008) nerve movement used the following boundaries and descriptors:  
• “Excellent” = ICC ≥ 0.90 
• “Good” = 0.70 ≤ ICC < 0.90 
• “Fair” = 0.40 ≤ ICC < 0.70 
• “Poor” = ICC < 0.40 
It was decided to adopt these boundaries to assist comparison of findings from the current 
study with those from previous studies. In addition, the descriptors were simple, clinically 
meaningful and applicable to the current study.  
 
3.4.2 The 95% Confidence interval of the ICC 
The 95% confidence interval is a useful statistic when interpreting an ICC (Bland and 
Altman 2000; Sim and Wright 2000; Peat et al., 2002).  It defines a band of values that has a 
95% chance of containing the value of the sample ICC.  A narrow confidence interval is 
indicative of a more precise estimate of the true ICC, that in turn increase confidence in the 
measurement reliability for the DUI technique (Bland and Altman 2000; Sim and Wright 
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2000). The 95% CI has been used in previous DUI reliability studies (Ellis et al., 2008; 
Coppieters et al., 2009). 
 
3.4.3 Standard error of measurement (SEM) 
Keating and Matyas (1998) and Bruton et al (2000) argued that limitations of the ICC negate 
its use as a sole indicator of reliability because it can be affected by between-participant 
variability. In a heterogeneous sample of participant,  ICC values are likely to be larger than 
when estimated in a homogeneous sample, other conditions being the same, and vice versa 
(Weir 2005). In addition, the ICC value does not provide an estimate of the expected 
variation between measurements of the same situation, which would be important to 
clinicians for patient assessment (Weir 2005). To address these issues, the standard error of 
measurement [SEM] was calculated to interpret reliability in the current study (Domholdt 
2005; de Vet et al., 2006).  The SEM computes variation between measurements of the same 
quantity, on the same individual, and is expressed in the unit of the measurement (de Vet et 
al., 2006).  A small SEM is associated with a higher reliability coefficient and vice versa.  
SEM was also used, in the current study, to establish degree of systematic and random error 
associated with the DUI technique.  
 
3.4.4 Minimum detectable change [MDC] 
The MDC is defined as the minimal change that falls outside the measurement error in the 
score of an instrument used to measure a symptom or construct (Kovacs et al., 2008). This 
implies that measurements above the MDC can be interpreted, with 95% certainty, not to be 
due to measurement error (Van der Roer et al., 2006). The MDC was calculated from the 
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SEM, which is the measurement error inherent to a measurement tool, through 1.96 x √2 x 
SEM (Bago´ et al., 2009). The MDC interprets clinical relevance of measurements, and was 
used in this study to assist interpretation of reliability estimates.  
 
4 Coefficient of Variation  
The coefficient of variation [CV] is a measure of variability relative to the mean and is 
calculated as the standard deviation [SD] divided by the mean, expressed as a percentage 
(Sim & Wright 2000).  Higher values of CV would indicate lower precision of the 
measurement technique, and lower values a higher precision. In general, the CV does not 
change in proportion to the magnitude of the mean or the measurement units (Reed et al., 
2002). The CV allows comparison of variability across different raters (Hopkins 2000) and 
can be used as a measure of precision of a measurement technique (Reed et al., 2002). Since 
no cut-off value has been reported for CV relating to nerve movement measurements, CV ≤ 
20% was adopted for the current study. This value has been reported and accepted within the 
science literature (Reed et al., 2002).  CV values were used to compare inter-rater precision 
of computed DUI nerve movement estimates, for median and ulnar nerves. 
 
3.5 Results  
This study sought to evaluate inter-rater reliability of DUI measurements of median and 
ulnar nerve TM and LM in a CWAD II sample. 
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3.5.1 Median and ulnar nerve TM 
The ICC2,1 estimate of inter-rater reliability on analyses of images of nerve TM for n=18 
CWAD II participants during CNSF are presented in Table 3.3. Inter-rater reliability 
estimates were poor for median and ulnar TM estimates (Coppieters et al., 2009).The 95% 
CI of the ICC was narrow. A large SEM and high MDC in comparison to the nerve 
movement were demonstrated. The CV between raters’ computed median and ulnar nerve 
TM was high. The variation between the 3 raters’ measurements is graphically illustrated in 
Figure 3.3A, B, C. 
 
Table 3.2: Inter-rater reliability across three raters mean of three repeat computation of 
median and ulnar TM of n=18 CWAD II participants 
Nerve ICC2,1 95% CI Movement [mm] 
SEM 
(mm) 
MDC 
(mm) 
CV  
[%] 
Median [at the wrist] 0.00 0 to 0.22 1.1 1.90 5.27 35 
Median[at the 
forearm] 
0.00 0 to 0.31 0.46 0.50 1.39 30 
Ulnar [above elbow] 0.00 0 to 0.26 0.89 1.56 4.32 24 
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(A) Median nerve (Wrist) 
 
 
(B) Median nerve (forearm) 
 
(C) Ulnar nerve
 [Above elbow] 
 
Figure 3.5 A, B, C: Descriptive illustration of reliability across three raters mean of three 
repeat computations of median and ulnar TM of n=18 CWAD II participants 
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3.5.2 Median and ulnar nerve LM  
The ICC2,1 estimate across 3 physiotherapists’ analyses of images of nerve LM for n=18 
CWAD II participants during CNSF are presented in table 3.3.  
 
Inter-rater reliability estimates was fair for median LM (Coppieters et al., 2009).The 95% CI 
of the ICC for median nerve was wide. The SEM in comparison to the nerve movement was 
small and the MDC was greater than the nerve movement. The CV between raters computed 
median nerve LM estimates was low. The variation between the 3 raters’ measurements is 
graphically illustrated in Figure 3.4A. 
 
Inter-rater reliability estimates was poor for ulnar nerve LM (Coppieters et al., 2009). The 
95% CI of the ICC for the ulnar nerve was wide. The SEM was large and the MDC was 
greater, both in comparison to the nerve movement. The CV between the 3 raters computed 
ulnar nerve LM estimates was low. The variation between the 3 raters’ measurements is 
graphically illustrated in Figure 3.4B. 
 
Table 3.3: Inter-rater reliability across three raters mean of three repeat computation of 
median and ulnar nerve LM of n=18 CWAD II participants 
Nerve ICC2,1 95% CI Movement [mm] 
SEM 
(mm) 
MDC 
(mm) CV [%] 
Median 0.4 0.1  to  0.66 0.69 0.38 1.05 16 
Ulnar 0.20 0 to 0.55 0.45 0.31 0.86 24 
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(A) Median [Forearm] 
  
(B) Ulnar [above elbow] 
 
Figure 3.6A and B: Descriptive illustration of reliability across three raters mean of three 
repeat computation of median and ulnar nerve LM of n=18 CWAD II participants 
 
3.6 Discussion 
This study provided the first DUI reliability data for measurements of median and ulnar 
nerve movement in CWAD II participants. It was also the first inter-rater reliability study 
involving both DUI components of image capture and image analyses, using the CNSF 
movement component of ULNT, and physiotherapists as raters. Although previous DUI 
reliability studies have used experienced DUI operators, the involvement of physiotherapists 
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as raters reflects the focus of the current study to clinical setting where physiotherapists are 
increasingly using DUI as a part of their professional practice.  
 
3.6.1 Median and ulnar nerve TM  
Inter-rater reliability estimates were poor for median (ICC2,1 = 0.00) and ulnar (ICC2,1 = 0.00) 
nerve TM. The high SEM data corroborated the low ICC and were suggestive of the 
presence of measurement error within the DUI technique. Also, high CV ≥ 20% (Reed et al., 
2002) demonstrated significant variance between raters’ measurements that contributed to 
the low reliability coefficients, affecting computation and interpretation of nerve 
measurements obtained by different raters from the same participants. The low ICC 
estimates obtained in the present study were unexpected and contrast with previous reports 
of high reliability for DUI (Greening et al., 2001; Ellis et al., 2008). Differences of study 
sample, starting positions, joint motion used to induce nerve movement, amount of nerve 
movement produced data analysis method and experience of image capture and image 
analysis could individually or collectively have contributed to the low reliability coefficients. 
The findings explain the conflicting TM estimates reported within the DUI literature 
[Chapter 2, Table 2.3 - 2.4] and questions continued use of DUI in research to compute TM. 
The literature relating to DUI reliability of TM for upper limb peripheral nerves is sparse 
(Greening et al., 2001) and as a result limit comparisons between previous studies and the 
current reliability study. 
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A. Issues associated with DUI image capture 
Greening et al (2001) reported high reliability for DUI measurement of median nerve TM 
using statistics of within-participant standard deviation [WSD]. However, their use of WSD 
alone to interpret high reliability can be misleading considering that the SD can be affected 
by magnitude of the mean (Weir, 2005). Complimenting statistics of ICC, 95% CI, SEM and 
CV have been suggested when interpreting reliability (Bland and Altman 1996, 2000; 
Keating and Matyas, 1998; Bruton et al., 2000; Sim and Wright, 2000; Peat et al., 2002; 
Domholdt, 2005; Weir, 2005; de Vet et al., 2006). Further, Greening et al (2001) found that 
median nerve TM obtained between 1-2 days (n=5) versus 1-6 days (n=4) interval varied 
more as the days between testing increased. In reliability with their findings, variability in 
TM was observed in this reliability study and could have arisen from intervals between the 
three raters’ testing. This could have resulted in subtle variance in computed TM estimates 
and contributed to the poor reliability coefficients found.  
 
Differences across raters’ experience of nerve image capture could have contributed to low 
reliability estimates. Evidence within the literature has indicated that assessments can be 
influenced by inter-rater variation (de Vet et al., 2006) and DUI has been described as an 
operator dependent technique (Martinoli et al., 2000; Peer et al., 2002; Chiou et al., 2003; 
Beekman and Visser 2003, 2004). Ellis et al (2008) suggested that potential sources of error 
exist within the image capture component of the technique. Systematic error can be 
introduced during nerve image capture as a result of angulation of the DUI transducer, 
applying excessive pressure on the transducer as well as movement of the transducer over 
skin (Kristjansson 2004; Ellis et al., 2008). These can individually or collectively affect 
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image quality, lead to an under or over estimation of nerve movement and consequently 
compromise reliability (Ellis et al., 2008). However, sources of measurement error in DUI 
have not been verified in any known DUI nerve movement study. To control for raters’ 
experience of image capture, all raters were trained and certified competent with regards to 
the DUI transducer handling and orientation, identification of the nerve in the transverse 
plane, as well as, image acquisition prior to data collection. However, differences of length 
of DUI practice (between 8 and 20 weeks) might have impacted on raters’ experience of TM 
image capture. This merits further investigation in order to inform the best methods for nerve 
image capture in future DUI studies, as well as clinical practice. 
 
It has been observed that nerves can move in multiple planes (Ellis et al., 2008). This is an 
anatomical, biomechanical and neurodynamic characteristic demonstrated by peripheral 
nerves. Such a movement is practically impossible to capture and account for when 
computing transverse nerve movement analysis using the present DUI technique that relied 
on a 2D ultrasound scanner. Nerve rotation movements can compromise consistent 
positioning of markers utilised by the image analysis program to compute movement 
between pre and post CNSF images. This could have led to an under or over estimation of 
nerve movement estimates and consequently compromised reliability coefficients (Ellis et 
al., 2008). This could have contributed to the poor inter-rater reliability estimates.  
 
B.  Issues associated with DUI image analysis 
 Ellis et al (2008) have suggested that measurement error could be introduced during nerve 
image analysis from incorrect and inconsistent positioning of markers used to identify areas 
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of interest within the nerve. The image analysis program used four markers over the nerve, 
and two fixed skin surface markers to account for DUI transducer movement during nerve 
image capture. To enhance consistency in raters’ identification and placement of markers, a 
transparent graph sheet was used during the nerve image analysis. The nerve borders (top, 
right, left and bottom) were identified relative to the centre of the nerve using visual 
assessment of gridlines of the graph. However, individual differences could have affected 
consistency of raters’ visual identification and placement of image markers. These could 
have contributed to the poor reliability estimates.   
 
3.6.2 Median and ulnar LM   
Inter-rater reliability estimates were fair (ICC2,1 = 0.4) for median and poor for ulnar (ICC2,1 
= 0.2) LM. A larger SEM was associated with ulnar (SEM = 0.31) than median (SEM = 
0.38) nerve LM when compared to their mean nerve movement values. Also, a high CV ≥ 
20% (Reed et al., 2002) indicated differences between raters’ measurements that could have 
affected reliability coefficients. The low ICC estimates were unexpected and contrast 
previous reports of high reliability for DUI (Dilley et al., 2001; Erel et al., 2003; Coppieters 
et al., 2009). Differences of study sample, starting positions, joint motion used to induce 
nerve movement, amount of nerve movement produced, data analysis method, and DUI 
components investigated could individually or collectively have accounted for differences 
between the present study and previous reliability reports. These differences exist, and could 
limit comparison of previous studies to the present reliability study (Haas et al., 1991).  
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A. Issues associated with DUI image capture  
Greening et al (2001) observed that computed estimates of median nerve LM varied as 
intervals between measurements increased, although no reason was advanced for the 
observation. Similarly, Erel et al (2003) found that median nerve LM increased by 33.3% 
[0.31mm] against [0.41mm] between 1 - 6 months of testing, with no reason provided for 
their result. Also, Dilley et al (2001) found a variation of 0.5 - 0.7mm for median nerve LM 
during index finger extension obtained at 1-2 weeks interval and the difference was an 11 - 
51% increase to the initial median nerve LM estimate. The variability across these studies 
suggests that DUI might provide inconsistent nerve movement estimates as intervals between 
testing increases. The intervals between raters testing in the present study could therefore 
have resulted in subtle variation in nerve movement data obtained by the 3 raters, and could 
have contributed to the low reliability estimates.  
 
Differences of method used in the present study in comparison to previous studies could 
have contributed to the low inter-rater reliability estimates. Coppieters et al (2009) evaluated 
inter-rater reliability across 3 raters’ analysis of the same set of 10 median nerve LM images. 
Their study focused on the nerve image analysis component of DUI, eliminating potential 
error that is associated with nerve image capture. Only one study (Ellis et al., 2008) has 
evaluated both DUI components. Their study however, contrasted with the present inter-rater 
reliability study with regards to the nerve (sciatic), sample (healthy) and level of reliability 
(intra-rater design). The inter-rater reliability design used in the present reliability study was 
likely to be associated with higher rater variance and measurement error (Haas, 1991), as all 
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the 3 raters acquired and analysed their own-acquired images, a method that potentially 
increased inter-rater variance and potential systematic error, and contributed to affect 
reliability. However, the inter-rater reliability design provided a higher level of evidence for 
considering reliability (Haas, 1991; Bland and Altman, 1996). In addition, the present study 
evaluated both DUI components, so that reliability estimates were more representative of the 
DUI technique than Coppieters et al (2009). Moreover, the present inter-rater design 
replicated practice in a clinical setting better than the intra-rater design used in Ellis et al., 
(2008). The present reliability study therefore provided a higher, clinically relevant evidence 
for reliability of DUI than previous DUI studies.  
 
Differences of study sample could have contributed to the low reliability estimate. 
Coppieters et al (2009) reported high inter-rater reliability estimates for DUI measurement of 
median nerve LM in n=13 healthy individuals. The absence of symptoms in their study 
sample negate translation of their findings into clinical practice, and could have influenced 
their reliability estimates, because presence of pain during joint motion can limit amount of 
nerve movement produced due to activation of the nociceptive motor reflex (Coveney et al., 
1997). The implication would be less variability in nerve LM in a patient population and, 
consequently, low ICC estimates. Coppieters et al (2009) found a high variability in nerve 
movement estimates across their healthy individuals. This could explain high inter-rater 
reliability reported for their healthy individuals because ICC estimates can be affected by 
high variation across participants’ measurement (Haas 1991). de Vet et al (2006) observed 
that ICC estimates for shoulder ROM obtained by two physiotherapists in n=155 patients 
were different for the affected and non-affected sides. The authors attributed their high ICC 
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estimates to variability [heterogeneity] in ROM on the affected versus non-affected shoulder. 
Kristjansson (2004) findings corroborated claims in de Vet et al (2006) when they evaluated 
inter-rater reliability for DUI measurements of cross-sectional area of cervical multifidus 
muscle in both patient and healthy individuals. Kristjansson (2004) found good and poor 
reliability estimates for their healthy and WAD participants, respectively. Their finding of 
poor inter-rater reliability in WAD agrees with low ICC estimates in the present study. 
 
Differences in the joint motion used to produce nerve movement could have contributed to 
the low reliability estimates in the present study. Coppieters et al (2009) used a combination 
of neck and arm motion that produced more nerve movements in comparison to CNSF. 
CNSF is used as part of ULNT to further lengthen a nerve after the slack in the nerve has 
been taken up (Dilley et al., 2003, 2007). The position limits the amount of nerve movement 
that can occur beyond this point (Shacklock, 2005). However, CNSF was used in the present 
reliability study because it is the most common sensitising manoeuvre used during ULNT. 
The CNSF used in the present study could have resulted in low ICC estimates. This finding 
query usefulness of CNSF induced nerve movement when using DUI technique.   
 
B. Issues associated with DUI image analysis  
Variance in nerve image analysis skills of raters could have contributed to low reliability 
estimates. Evidence within the literature indicated that assessments made by clinicians might 
be influenced by inter-rater variation (de Vet et al., 2006), and DUI has been described as an 
operator dependent technique (Martinoli et al., 2000; Peer et al., 2002; Chiou et al., 2003; 
Beekman and Visser 2003, 2004). Ellis et al (2008) suggested sources of error within DUI 
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nerve image analysis. Systematic error during nerve image capture can affect image quality 
and, in turn, affect computed measurements of nerve movement during analysis of such 
images (Ellis et al., 2008). However, the suggested nerve image quality affect on nerve 
image analysis, and reliability merits further investigation as it has not been verified in any 
known DUI study. 
 
Ellis et al (2008) suggested that measurement error could be introduced during nerve image 
analysis as a result of incorrect and inconsistent positioning of markers used to identify 
regions of interest within the nerve. In the present study, raters’ experience of nerve image 
analysis could have introduced error that in turn affected reliability estimates. However, to 
control for plausible differences in raters’ experience of image analysis, a template was 
developed and adopted for placement of markers [boxes]. The template improved the images 
analysis [Table 3.1], but no conclusions can be drawn regarding contribution of template to 
error arising from DUI image capture component. 
 
The cross-correlation algorithm program used for nerve image analysis could have 
contributed to low reliability estimates. The image analysis program tracked DUI transducer 
movements as a fixed reference [background] to the nerve movement. The background 
movement data was then subtracted from the nerve estimates to compute actual nerve 
movement (Dilley et al., 2001; Greening et al., 2001). However, when background 
movement is large, it might have resulted in smaller residual nerve movements. The residual 
nerve movement value could represent measurement error rather than actual nerve 
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movement. However, this hypothesis has not been verified in any known DUI study and 
therefore merit further evaluation.  
 
Again, nerve movements can occur in multiple planes (Ellis et al., 2008). The cross-
correlation program was limited in that it did not capture nerve rotation movement. This 
could have impacted on nerve image quality, affected nerve movement estimates and, 
consequently, affected reliability coefficients. Kristjansson (2004) has reported a similar 
influence of multi-planar nerve movements on quality of nerve images and inter-rater 
reliability estimates. To address the issue, Ellis et al (2008) recommended using a three 
dimensional [3D] or four dimensional [4D] DUI scanner and image analysis program. 
However, as 3D or 4D ultrasound scanners are still in development, clinical practice and 
research methods continue to rely on 2D scanners for DUI measurements.  
 
3.7 Chapter conclusions 
The inter-rater reliability study found poor reliability for all TM [median and ulnar] and LM 
[ulnar]. However, inter-rater reliability for median nerve LM was fair, indicating it’s 
potential. Although these findings contrasted with previous reports indicating high reliability 
for DUI computation of nerve measurements, this study provided a higher level of evidence 
because it addressed limitations of previous DUI reliability studies. Overall, the low 
reliability findings suggested that DUI might not provide a reliable method for evaluating 
upper limb nerve movement in-vivo in CWAD II. Plausible sources of measurement error 
within DUI image capture and image analysis were proposed as contributing to poor 
reliability of the technique but these have not been verified in any DUI research to date. In 
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order to improve reliability of the technique, further evaluation potential error was 
warranted. This informed further analysis of the images obtained in this inter-rater reliability 
study to gain additional insight into potential error within the DUI technique. The further 
analysis is reported in Chapters 4 and 5 of the thesis.  
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Chapter 4 
 
A re-analysis of nerve images to investigate sources of error within DUI image capture 
and image analysis using inter-image capture and inter-image analysis methods 
 
4.1 Background  
Conflicting nerve movement estimates (Chapter 2, Tables 2.3 – 2.4), methodologically 
limited DUI reliability studies (Chapter 2, Table 2.5), and poor DUI reliability for median 
and ulnar nerve movement measurements (Chapter 3, Tables 3.3 - 3.4) suggests presence of 
potential sources of measurement error within image capture and image analysis components 
of DUI. However, the error has not been verified to date and existing knowledge of sources 
of error within DUI is speculative (Kristjansson, 2004; Ellis et al., 2008), and where 
available is focused to Doppler ultrasound (Hough et al., 2000), and muscle tendon 
(Korstanje et al., 2010). As a result, confidence in DUI estimates of nerve movement 
obtained using the Diasus equipment is limited. A significant proportion of DUI studies have 
used the Diasus equipment, and it is important to identify and address the error in order to 
improve reliability of nerve measurements. This necessitated design of a further nerve image 
analysis study, focused to sources of measurement error within DUI. It was hypothesised that 
the finding will add to existing knowledge regarding sources of error within DUI, and inform 
future DUI reliability studies. 
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4.2 Aim 
Using data from the inter-rater reliability study reported in Chapter 3, the aim of the study 
was to evaluate: 
(a) Inter-rater image capture reliability between 3 physiotherapists acquired n=18 median 
and ulnar nerve images  
(b) Inter-rater image analysis reliability between 3 physiotherapists’ analysis of n=18 median 
and ulnar nerve images  
 
4.3 Method 
4.3.1 Design 
Image re-analysis to compare reliability across computed estimates of median and ulnar 
nerve TM and LM in order to interpret the error associated with DUI image capture and 
image analysis components. Nerve movements were computed by: 
 
(a) One Physiotherapist analysed median and ulnar nerve images acquired by 3 
physiotherapists [each physiotherapists acquired (n=18) nerve images from n=18 CWAD 
II participants]. This design identified variation across the acquired nerve images that in 
turn, interpreted error arising from DUI image capture component.  
 
(b) Three physiotherapists analysed median and ulnar nerve images acquired by 1 
physiotherapist [n=18 images were acquired from n=18 CWAD II participants]. This 
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design identified variation during the image analysis that in turn, interpreted error arising 
from DUI image analysis component. 
 
4.3.2 Physiotherapists involved in the re-analysis of nerve images 
The same physiotherapists that were involved in image analysis in Chapter 3 performed the 
analysis.  The physiotherapists have previously demonstrated excellent intra-rater reliability 
during image analysis that used the developed nerve image analysis template [Table 3.1]. 
 
4.3.3 Image analysis program 
The same programs for nerve image analysis in Chapter 3 were used. 
 
4.4 Statistical Analysis 
The same statistics and statistical analysis package in Chapter 3 were used. However, the 
MDC was not computed as there is no indication for its usefulness in this chapter.  
 
4.5 Results 
Results of descriptive and inferential statistics for inter-rater image capture reliability  [nerve 
movement from each of 3 physiotherapists acquired (n=18) median and ulnar nerve images, 
to demonstrate error within DUI image capture]  and inter-rater image analysis reliability 
[nerve movement obtained by 3 physiotherapists analyses of n=18 nerve images depicting 
error during DUI image analysis] are presented as Tables 4.1 – 4.2 and Figure 4.1 – 4.2, and 
Table 4.3 – 4.4 and Figure 4.3 – 4.4 respectively. 
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4.5.1 DUI image capture  
A. Median and ulnar nerve TM 
The estimates of inter-rater image capture reliability for each of 3 physiotherapists acquired 
n=18 median and ulnar TM images are presented as Table 4.1 and Figure 4.1A-C.  
 
The inter-rater image capture reliability for median nerve TM images was poor (ICC2,1 = 
0.00) (Coppieters et al., 2009). The 95% CI of the ICC was narrow and the SEM was lower 
than the mean median nerve TM. The CV was also high except for median nerve at the 
forearm. The variation between measurements obtained from the 3 physiotherapists acquired 
median TM images is graphically illustrated in Figure 4.1A and B.  
 
The inter-rater image capture reliability for ulnar nerve TM images was fair (ICC2,1 = 0.4) 
(Coppieters et al., 2009). The 95% CI of the ICC was wide and the SEM was larger than the 
mean ulnar nerve movement. The CV was also high. The variation between measurements 
obtained from 3 physiotherapists acquired ulnar nerve TM images is graphically illustrated in 
Figure 4.1C. 
 
Table 4.1: Inter-rater image capture reliability for each of 3 physiotherapists acquired 
n=18 median and ulnar TM images  
Nerve ICC2,1 95% CI Movement 
(mm) 
SEM (mm) CV 
(%) 
Median at the wrist 0.01 0 to 0.33 0.36 0.29 20 
Median at the forearm 0.00 0 to 0.15 0.46 0.32 13 
Ulnar 0.4 0.08 to 0.65 0.67 0.98 24 
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(A) Median (wrist) 
 
(B) Median (forearm) 
 
(C) Ulnar (above elbow) 
 
Figure 4.1(A – C): Scatter plot depicting inter-rater image capture reliability for each of 
3 physiotherapists acquired n=18 median and ulnar nerve TM images 
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B. Median and ulnar nerve LM 
The estimates of inter-rater image capture reliability for each of 3 physiotherapists acquired 
n=18 median and ulnar nerve LM images are presented as Table 4.2 and Figure 4.2A-B.  
 
The inter-rater image capture reliability for median nerve LM images was fair (ICC2,1 = 0.43) 
(Coppieters et al., 2009). The 95% CI of the ICC was wide and the SEM was small in 
comparison to the mean median nerve LM. The CV for median nerve LM was smaller when 
compared to ulnar nerve LM. The variation between measurements obtained for each of 3 
physiotherapists acquired median nerve LM images is graphically illustrated in Figure 4.2A. 
 
The inter-rater image capture reliability for ulnar nerve LM images was poor (ICC2,1 = 0.29) 
(Coppieters et al., 2009). The 95% CI of the ICC was wide and the SEM was small when 
compared to mean ulnar nerve LM. The CV for ulnar nerve LM was higher than for median 
nerve LM. The variation between measurements obtained from each of 3 physiotherapists 
acquired ulnar nerve images is graphically illustrated in Figure 4.2B. 
 
Table 4.2: Inter-image capture reliability for each of 3 physiotherapists acquired n=18 
median and ulnar nerve LM images  
Nerve ICC2,1 95 % CI 
Movement 
[mm] 
SEM (mm) CV (%) 
Median 0.43 0.15 to 0.71 0.72 0.35 9 
Ulnar 0.29 0 to 0.61 0.51 0.22 14 
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4.5.2 DUI image analysis 
A. Median and ulnar nerve TM 
The estimate of inter-rater image analysis reliability for 3 physiotherapists analyses of n=18 
median and ulnar nerve TM images are presented as Table 4.3 and Figure 4.3A-B. 
(A) Median (forearm) 
 
(B) Ulnar (above elbow) 
 
Figure 4.2 (A – B): Scatter plot depicting inter-rater image capture reliability for each of 3 
physiotherapists acquired n=18  median and ulnar nerve LM images 
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The inter-rater image analysis reliability for median nerve TM was poor (ICC2,1 = 0.00) 
(Coppieters et al., 2009). The 95% CI of the ICC was narrow and the SEM was larger than 
the computed median nerve TM. The CV for median nerve TM was low when compared to 
ulnar nerve TM. The variation between measurements obtained from 3 physiotherapists 
analysis of n=18 median nerve TM images is graphically illustrated in Figure 4.3A.  
 
The inter-rater image analysis reliability for ulnar nerve TM was poor (ICC2,1 = 0.26) 
(Coppieters et al., 2009). The 95% CI of the ICC was wide and the SEM was larger than the 
computed ulnar nerve TM. The CV for ulnar nerve TM was higher when compared to 
median nerve TM. The variation between measurements obtained from 3 physiotherapists 
analysis of n=18 ulnar nerve TM images is graphically illustrated in Figure 4.3B.  
 
Table 4.3: Inter-rater image analysis reliability for 3 physiotherapists analyses of n=18 
median and ulnar nerve TM images  
Nerve ICC 95% CI Movement (mm) SEM (mm) CV %) 
Median 0.00 0 to 0.27 1.17 2.50 18 
Ulnar 0.26 0.12 to 0.56 1.11 1.52 26 
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B. Median and ulnar nerve LM 
Results of inter-rater image analysis reliability for 3 physiotherapists analysis of n=18 
median and ulnar nerve LM images are presented as Table 4.4 and Figure 4.4A-B. 
 
The inter-rater image analysis reliability was good (ICC2,1 = 0.68) for median nerve LM 
(Coppieters et al., 2009). The 95% CI of the ICC was wide and the SEM was small when 
compared to median nerve LM. The CV for median nerve LM was low when compared to 
Median(Forearm) 
 
Ulnar(above elbow) 
 
 
Figure 4.3 (A – B): Scatter plot depicting inter-rater image analysis reliability for 3 
physiotherapists analyses of n=18 median and ulnar nerve TM images  
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ulnar nerve LM. The variation between measurements obtained from 3 physiotherapists 
analysis of n=18 median nerve LM images is graphically illustrated in Figure 4.4A.  
The inter-rater image analysis reliability was poor (ICC2,1 = 0.29) for ulnar nerve LM 
(Coppieters et al., 2009). The 95% CI of the ICC was wide and the SEM was smaller than 
the ulnar nerve LM. The CV for ulnar nerve LM was high when compared to median nerve 
LM. The variation between measurements obtained from 3 physiotherapists analysis of n=18 
ulnar nerve LM images is graphically illustrated in Figure 4.4B.  
 
Table 4.4: Inter-rater image analysis reliability for 3 physiotherapists’ analyses of n=18 
median and ulnar nerve LM image 
Nerve ICC 95% CI Movement (mm)  SEM (mm) CV (%) 
Median 0.68 0.43 to 0.85 0.70 0.25 13 
Ulnar 0.29 0 to 0.61 0.41 0.22 15 
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Median  
 
Ulnar  
 
Figure 4.4 (A-B): Scatter plot depicting inter-rater image analysis reliability for 3 
physiotherapists analyses of n=18 median and ulnar nerve LM images 
 
4.6 Discussion 
This study compared inter-rater image capture reliability for each of 3 physiotherapists n=18  
median and ulnar nerve TM and LM images [DUI image capture] as well as inter-rater 
image analysis reliability for 3 physiotherapists analysis of n=18 median and ulnar nerve TM 
and LM images. This is the first analysis to identify potential sources of error within DUI 
image capture and image analysis components for median and ulnar nerve TM and LM in a 
CWAD II sample.  
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4.6.1 DUI image capture  
A.  Median and ulnar nerve TM  
Estimates of inter-rater image capture reliability for median nerve TM was poor (ICC2,1 = 
0.01) and fair for ulnar nerve TM (ICC2,1 = 0.4) [Table 4.1]. The 95% CI of the ICC was 
narrow for median (0 to 0.33) in comparison to ulnar nerve (0.08 to 0.65). The SEM was low 
for median (0.29mm) and high for ulnar nerve (0.98mm), when both are compared to their 
mean nerve movement [Table 4.1]. The nerve images demonstrated high levels of CV ≥ 20% 
(Reed et al., 2002). The ICC, SEM and CV values are interpretive of measurement error 
within DUI image capture. The findings suggest different levels of DUI image capture 
experience that could affect image quality and consequently reliability of the technique. The 
findings support previous suggestions of measurement error within DUI image capture 
(Kristjansson, 2004; Ellis et al., 2008; Chapter 3).  
 
B. Median and ulnar nerve LM 
 Median nerve 
Estimates of inter-image capture reliability for median nerve LM was fair (ICC2,1 = 0.43; 
95% CI = 0.15 to 0.71) [Table 4.2]. The SEM of 0.35mm was 48.6% of the size of the mean 
nerve movement (0.72mm) [Table 4.2]. Variability between median nerve images (CV = 
9%) was within acceptable level of 20% (Reed et al., 2002). The ICC and SEM values 
suggest presence of potential error within DUI image capture. The results corroborate the 
measurement issues of image capture suggested within the literature (Kristjansson 2004; 
Ellis et al., 2008; Chapter 3). However, the fair ICC and low CV values for median nerve 
LM suggest a potential merit for its reliability to be further investigated.   
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Ulnar nerve 
Estimates of inter-image capture reliability for ulnar nerve LM was poor (ICC2,1 = 0.29; 95% 
CI = 0.00 to 0.61) [Table 4.2]. The wide 95% CI of the ICC and a high SEM of 43% the size 
of mean nerve movement (0.51mm) [Table 4.2] suggest varying levels of DUI imaging 
capture experience, and support suggestions for presence of error during DUI image capture 
(Kristjansson 2004; Ellis et al., 2008; Chapter 3). Although variability across the ulnar nerve 
images (CV = 14%) was within acceptable level of 20% (Reed et al., 2002), the poor 
reliability weakens the merit for its reliability to be further evaluated. 
 
C. Measurement issues associated with image capture 
DUI has been described as an operator dependent technique, implying that, experience may 
affect the quality of acquired images (Martinoli et al., 2000; Peer et al., 2002; Chiou et al., 
2003; Beekman and Visser 2003, 2004). There is no evidence to date that indicates level of 
image capture experience that DUI operators e.g. physiotherapists need to achieve in order to 
provide reliable TM and LM estimates. Individual operator differences relating to visual 
interpretation of images and manual handling of DUI transducer can lead to variations in 
nerve image quality (Kristjansson 2004; de Vet et al., 2006; Ellis et al., 2008). In addition, 
differences of the anatomical characteristics of nerves e.g. its course, depth, surrounding 
tissue [nerve bed], and dynamics could equally have contributed to variability demonstrated 
across the median and ulnar nerve images (Moore and Dalley, 2005). The results require that 
future DUI study designs address potential error in order to provide reliable nerve movement 
measurements (Collinger et al., 2009). For example, single operator designs can be adopted 
to address inherent rater image capture variability (Ellis et al., 2008; Collinger et al., 2009).  
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Overall, the variation demonstrated for inter-rater image capture of median and ulnar TM 
and ulnar nerve LM limit the merit for taking this movement further, until measurement 
issues associated with the technique are addressed. However, median nerve LM 
demonstrated a potential merit for its reliability to be further investigated.  
 
4.6.2 DUI image analysis  
A. Median and ulnar nerve TM 
Estimates of inter-rater image analysis reliability was poor for median nerve TM (ICC2,1 = 
0.00; 95% CI = 0.00 to 0.27) [Table 4.3]. The narrow 95% CI and SEM (2.50mm) that was 
larger than mean median nerve TM (1.17mm) suggests presence of measurement error 
within the DUI image analysis for TM [Table 4.3]. Variability across estimates computed by 
the 3 physiotherapists (CV = 18%) was within the acceptable level of CV=20% (Reed et al., 
2002). In addition to issues related to image capture, the results demonstrate variability 
during DUI image analysis and suggest the potential for introducing error. The results 
support previous suggestion for measurement error within DUI image analysis (Ellis et al., 
2008; Chapter 3). Estimates of inter-rater image analysis reliability was poor for ulnar nerve 
TM (ICC2,1 = 0.26; 95% CI = 0.12 to 0.56)  [Table 4.3]. The narrow 95% CI and SEM 
(1.52mm) that was larger than mean median nerve TM (1.11mm) suggests presence of 
measurement error within the DUI image analysis for TM [Table 4.3], and negate further 
evaluation of TM, without first addressing the sources of error.  
 
 
  117 
B. Median and ulnar nerve LM 
Median nerve 
Estimates of inter-rater image analysis reliability for median nerve LM was good (ICC2,1 = 
0.68; 95% CI = 0.43 to 0.85)  [Table 4.4]. The 95% CI of the ICC was small and SEM was 
36% the magnitude of the nerve movement estimates [Table 4.4]. The SEM values suggest 
potential error within the DUI image analysis component. Variability across estimates 
computed by the 3 physiotherapists (CV = 13%) was within the acceptable level of CV=20% 
(Reed et al., 2002). The high ICC and low CV suggest a potential merit for reliability of 
median nerve LM to be further investigated. In addition, the results is in reliability with 
Coppieters et al., (2009) report of high inter-rater image analysis for median nerve LM 
[n=10]. However, their sample (n=10) was below proposed size (n=12) for inter-rater 
reliability using 3 raters at 80% power and 5% level of significance (Walter et al., 1998). The 
present image analysis (n=18) therefore provides a higher level of evidence compared to 
Coppieters et al., (2009).  
 
Ulnar nerve 
Estimates of inter-rater image analysis reliability for ulnar LM was poor (ICC2,1 = 0.29 and 
95% CI = 0.00 to 0.61) [Table 4.4]. The 95% CI of the ICC was wide and the SEM was 54% 
the magnitude of the mean ulnar nerve movement [Table 4.4]. Variability across nerve 
estimates (CV = 15%) was within the acceptable level of CV=20% (Reed et al., 2002). The 
findings are suggestive of differences of DUI image analysis experience, supporting previous 
reports of measurement error during DUI analysis (Hough et al., 2000; Ellis et al., 2008; 
Korstanje et al., 2010; Chapter 3). The poor level of inter-rater image analysis reliability for 
  118 
ulnar nerve LM limits merit for taking its reliability forwards, without first addressing the 
sources of measurement error. Also, there is no previous ulnar nerve DUI study to compare 
the present inter-rater image analysis results with. 
 
C. Measurement issues associated with image analysis 
Transverse and longitudinal nerve movement estimates computed from 3 physiotherapists’ 
analysis of the same n=18 nerve images returned low CVs, and poor [ulnar] and good 
[median] inter-rater image analysis reliability. The results are suggestive of differences 
across the 3 physiotherapists’ experience of nerve image analysis that compromised 
reliability coefficients across their computed nerve movement estimates (Hough et al., 
2000; Kristjansson 2004; Ellis et al., 2008). Sources of error during image analysis are 
suggested to arise from (a) inconsistent and inappropriate sizes and placement of image 
markers (due to deformations and tracking local of artefact), (b) speckle tracking moving 
out-of-plane, (c) precision of the correlation algorithm to process very small frame-to-
frame displacements (quantization error), (d) inappropriate frame intervals, and (e) 
consistency and clarity of speckle features (f) background tissue used to track transducer 
movement (Ellis et al., 2008; Korstanje et al., 2009, 2010, Chapter 3).  
 
Strategies to address some of the measurement issues (a) to (e) above have been suggested, 
including use of (a) the nerve image analysis template [Figure 3.3], (b) larger joint motion, as 
well as involving an (c) experienced DUI operator.  However, measurement issues that relate 
to stationery subcutaneous or background tissue used to track transducer movement during 
longitudinal nerve image analysis remain unaddressed. This is important because supportive 
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evidence to inform background tissue used to track movement of DUI transducer is sparse 
(Dilley et al., 2001) and is limited by its small sample (n=4). The existing evidence provides 
support for the use of superficial fascia. However, a significant proportion of DUI studies 
have used bone, without supportive scientific evidence. Different background tissue has been 
used arbitrarily within DUI studies (Dilley et al., 2001; Erel et al., 2003; Greening et al., 
2005). As a consequence, comparison of findings across studies is difficult, in addition to the 
inherent potential for computed nerve movement estimates to become inflated or 
underestimated when they are subtracted from nerve estimates. This will mislead 
conclusions drawn from DUI research and limit the usefulness of the technique. There is a 
merit for further evaluation of DUI background tissues used to track transducer motion when 
computing LM estimates.  
 
4.7 Chapter conclusions 
The aim of Chapter 4 was to evaluate measurement error during image capture and image 
analysis using methods of inter-rater image capture and inter-rater image analysis reliability 
respectively. The study was designed to investigate potential sources of measurement error 
within the DUI technique. The results of poor inter-rater image capture and inter-rater image 
analysis reliability for median and ulnar nerve TM suggest that the technique possesses 
substantial measurement error that contributes to poor reliability. The technique requires 
review and further development in order to become a useful tool for clinical and research 
purposes.  
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The poor inter-rater image capture and inter-rater image analysis reliability returned for ulnar 
nerve LM also demonstrate that the measurement technique for this movement possesses 
substantial measurement error that contributes to poor reliability. In contrast, the fair to good 
estimate of inter-image capture and inter-image analysis reliability for median nerve LM is 
indicative of its potential for providing reliable measurements. However, sources of 
measurement error within both components must first be addressed.  
 
As discussed, a potentially important source of measurement error that has not been 
addressed, relate to the choice of background tissue used to track DUI transducer movement 
during image analysis, because of its inherent potential to under or over estimate nerve 
movement. Evidence in this regard is sparse, limited and relates to superficial fascia, 
although a significant proportion of DUI studies have used bone, despite no supportive 
evidence. Responsiveness to findings for median nerve LM  in this chapter, informed further 
re-analysis of n=18 median nerve LM images, to further investigate affect of different 
subcutaneous tissue on computed nerve estimates and reliability in order to provide evidence 
for the best background tissue for nerve image analysis. The background tissue study is 
reported as Chapter 5 of the thesis.  
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Chapter 5 
 
An evaluation of inter-rater reliability and construct validity of superficial fascia and 
bone movement as representative of DUI transducer motion 
 
5.1 Background 
Evidence suggests that sources of measurement error associated with DUI components of 
image capture and image analysis can affect estimates of nerve movement and reliability of 
the technique and should therefore be addressed (Kristjansson 2004; Ellis et al., 2008; 
Korstanje et al., 2010; Chapter 4). Image capture issues are easily addressable by involving 
an experienced DUI operator (Ellis et al., 2008). However, potential error within DUI image 
analysis such as (a) inconsistent and inappropriate sizes and placement of image markers 
(due to deformations and tracking local of artefact), (b) speckle tracking moving out-of-
plane, (c) precision of the correlation algorithm to process very small frame-to-frame 
displacements (quantization error), (d) inappropriate frame intervals, and (e) consistency and 
clarity of speckle features (f) background tissue used to track transducer movement (Ellis et 
al., 2008; Korstanje et al., 2009, 2010, Chapter 3) merit attention as strategies suggested to 
address the sources of error, including use of (a) nerve image analysis template [Figure 3.3], 
(b) larger joint motion, and involving an (c) experienced DUI operator have not addressed 
error arising from stationery subcutaneous or background tissue used to track transducer 
movement during LM image analysis. This component of nerve image analysis is important 
considering its potential to inflate or underestimate LM, when subtracted from nerve 
estimates, a hypothesis that warrant investigating.  
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Background tissue tracking, is an important component of the DUI analysis algorithm is that 
is underpinned by the assumption that movement of subcutaneous tissue is reflective of DUI 
transducer motion (Dilley et al., 2001). Preliminary evidence to support the claim has been 
demonstrated using superficial fascia (Dilley et al., 2001), although the evidence is limited 
by its small sample size (n=4) and use of freehand scanning to represent a fixed transducer. 
Transducer motion was not tracked in their method, despite the potential for motion to occur 
during freehand DUI scanning (Fenster et al., 1996, 2001). Despite the limited available 
evidence, the same authors proceeded to use bone rather than superficial fascia for their 
nerve image analysis, a method that has become widely accepted and used in DUI studies 
(Dilley et al., 2001, 2003, 2007; Erel et al., 2003; Greening et al., 2005; Ellis et al., 2008; 
Coppieters et al., 2009).  
 
 The argument in favour of bone as background tissue is that because it is a rigid and fixed 
tissue, movement of bone possesses the greatest potential to represent motion of the 
transducer. To date, this argument has not been scientifically investigated. Further evaluation 
of reliability and construct validity of estimates of DUI transducer motion, computed from 
subcutaneous tissue of bone and superficial fascia is therefore required. The findings from 
this study will inform (a) choice of background tissue and (b) validate the DUI technique. 
 
5.2 Aim 
To compare for bone and superficial fascia as the background tissue: 
(i) Inter-rater reliability for median nerve LM computed from re-analysis of each of 3 
physiotherapists’ acquired n=18 images used in Chapter 3.   
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(ii) Construct validity for estimates of transducer motion using re-analysis of n=22 CWAD II 
median nerve LM images. The 22 nerve images was data collected for an intra-rater 
reliability study (Chapter 6), and was used because DUI transducer was fixed to the 
forearm, during elbow extension ROM 
 
5.3 Method 
5.3.1 Design 
(i) Frame by frame analysis of DUI images was used to compare nerve estimates computed 
from bone and superficial fascia as background tissue. One physiotherapist analysed 3 
raters acquired images of median nerve LM from 18 CWAD II participants. A sample 
size of n≥12 was required to detect a difference in ICC estimates of reliability of 0.9 and 
0.7 at 80% power and 5% level of significance level, using images from 3 raters (Walter 
et al., 1998). The images were previously obtained for a DUI inter-rater reliability study 
reported as Chapter 3.  
 
(ii) To evaluate the validity of nerve movement estimates, frame by frame analysis of DUI 
images was used to compare estimates of a fixed DUI transducer movement  [motion = 
0.0mm] computed from bone and superficial fascia. 1 physiotherapist analysed images of 
median nerve LM obtained from a fixed DUI transducer attached to the forearm of 22 
CWAD II participants. The method employed to evaluate construct validity for DUI 
nerve estimates was underpinned by the hypothesis that the background tissue that 
returned movement estimates closest to zero (mm) is reflective of the fixed DUI 
transducer and interprets a valid method for computing nerve movement in-vivo. The 
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method was informed by Dilley et al’s (2001) report of validity for DUI, while 
addressing the small sample size limitations (n=4) in Dilley et al (2001), warranted 
addressing in the present analysis.  
 
5.3.2 Physiotherapists involved in image analysis 
The same musculoskeletal physiotherapists involved in Chapter 4 nerve image analysis 
conducted the image analysis for both reliability and validity components of this study. 
 
5.3.3 Image analysis program and protocol 
The same program used to analyse LM in previous Chapters 3 and 4 was utilised for image 
analysis for both reliability and validity components of this Chapter.  
 
5.4 Statistical Analysis 
Inter-rater reliability was analysed using descriptive statistics of arithmetic mean and 
inferential statistics of ICC2,1 , 95% CI, SEM, and CV. Construct validity was analysed using 
descriptive scatter plots (Dilley et al., 2001). The statistics were computed using SPSS 
version 19.0 and Microsoft excel spreadsheet 2010.  
 
5.5 Results 
5.5.1 Inter-rater reliability of nerve estimates comparing bone and superficial facia   
The reliability across estimates of median nerve LM computed by 1 physiotherapist from 
each of 3 physiotherapists acquired n=18 nerve images, comparing bone and superficial 
fascia as background tissue, is presented in Table 5.1 and Figure 5.1. A higher reliability 
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coefficient, narrower 95% CI, larger median nerve movement and low CV for superficial 
fascia in comparison to bone, demonstrated superficial ability to provide a more reliable 
estimate of median nerve movement. Nerve movement that was computed from bone was 
under-estimated, and this suggests presence of potential error that in turn, could compromise 
DUI reliability for LM. 
 
Table 5.1: Inter-rater reliability of median nerve LM estimates computed by 1 
physiotherapist analysis of each of three physiotherapists acquired n=18 images using 
bone and superficial fascia as background  tissue 
Background 
tissue ICC 
95% CI of 
ICC 
Movement 
[mm] 
SEM 
(mm) CV [%] 
Superficial 
fascia 0.7 0.4 to 0.84 0.90 0.37 14 
Bone 0.4 0.15 to 0.71 0.72 0.35 20 
 
Superficial fascia 
 
Figure 5.1A: Description of reliability across median nerve LM computed from each of 3 
physiotherapists n=18 DUI images using superficial fascia as background tissue 
 
Bone 
 
Figure 5.1B: Description of reliability across median nerve LM estimates computed from 
each of 3 physiotherapists n=18 DUI images using bone as background tissue 
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5.5.2 Construct validity comparing estimates from bone and superficial fascia to a fixed DUI 
transducer 
A line plot of cumulative movement across 100 image frames for bone and superficial fascia 
is presented in Figure 5.2. Median nerve cumulative movement across the image frames was 
also plotted (Dilley et al., 2001).  From the results, movement was greater in the median 
nerve [2.60mm] compared to bone and superficial fascia. The result support preliminary data 
from Dilley et al (2001). Superficial fascia demonstrated a mean cumulative frame by frame 
movement of 0.00mm that was representative of the fixed transducer, and supporting 
preliminary data from (Dilley et al., 2001). In contrast, bone demonstrated a movement of 
0.3mm that translate to a 12% (0.9/0.72) underestimation of median nerve LM in comparison 
to superficial fascia. The underestimated LM has potential to mislead interpretations and 
conclusions particularly for small nerve movement, e.g. during CNSF [Chapter 3].  
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Figure 5.2: Descriptive representation of frame by frame estimate of mean cummulative 
movement of median nerve, bone and superficial fascia in 22 nerve images 
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5.6 Discussion 
The aim of this Chapter was to establish whether DUI tracking of bone and superficial fascia 
can provide reliable median nerve LM estimates as well as valid computation of transducer 
motion, to address discrepancies between DUI evidence and practice in relation to the 
background tissue of interest. 
 
5.6.1 Inter-rater reliability of nerve estimates comparing bone and superficial facia   
To evaluate inter-rater reliability for median nerve movement estimates computed using 
bone and superficial fascia as background tissue, one physiotherapist analysed each of 3 
physiotherapists  acquired n=18 images. Using superficial fascia as the background tissue 
demonstrated good reliability [ICC2,1 = 0.7; 95% CI = 0.4 to 0.84] and higher estimates of 
LM [0.9mm, SEM = 0.37mm] in contrast with fair reliability [ICC2,1 = 0.4; 95% CI = 0.15 to 
0.71] and lower estimates of LM for bone [0.72mm, SEM = 0.35mm]. This is the first study 
comparing reliability coefficients of nerve movement estimates computed from bone and 
superficial fascia as background tissue. It is also the first time superficial fascia has been 
reported as the background tissue in a DUI reliability study. A high reliability coefficient for 
median nerve LM estimates using bone as background tissue has been reported in the DUI 
literature (Coppieters et al., 2009). However, the fair reliability coefficients returned for bone 
in the present analysis questions previous findings. Methodological differences between the 
DUI analyses in the two studies could have contributed to the differences. Conclusions from 
Coppieters et al.’s (2009) study were limited by its small sample size (n=10) in comparison 
to n≥12 recommended for 3 raters to detect a difference in reliability of 0.9 and 0.7 at 80% 
power and 5% level of significance (Walter et al., 1998). Their reliability finding is also 
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limited by their focus to healthy individuals. Both of these limitations can contribute to 
compromise of reliability measurements (Haas et al., 1991; Walter et al., 1998). This study 
has addressed these limitations and therefore provided a higher quality study to enable 
confidence in conclusions.  
 
Superficial fascia demonstrated good reliability, a narrow 95% CI, larger median nerve 
movement, and a low CV in comparison to bone. The results could be due to clarity and 
consistency of speckle features within superficial fascia in comparison to bone. This is 
because both image characteristics contribute to image quality that affects reliability of nerve 
movement estimates (Hough et al., 2000; Kristjansson 2004; Ellis et al., 2008; Korstanje et 
al., 2010; Chapter 4). Based on visual analysis, all the 22 median nerve images demonstrated 
clear speckle features and distinct boundaries for superficial fascia (100%), in contrast to 
15/22 for bone (68%). The image characteristics are required for good correlation between 
consecutive DUI frames [Fenster et al., 1996, 2001; Korstanje et al., 2010]. Added to this, as 
it is a superficial tissue, its use overcomes potential problem of subcutaneous tissue [e.g. 
bone] falling out of the ultrasound field during nerve image capture (Korstanje et al., 2010). 
Both characteristics contribute to improve DUI image quality, reduce error, lead to accurate 
nerve movement estimates and overall improve reliability of measurements obtained by the 
technique (Korstanje et al., 2010). In addition, use of fascia as the background tissue will 
increase confidence in nerve movement results as well as assist interpretation and 
comparison of nerve movement data across clinicians’ measurements and DUI studies. The 
results suggest therefore that using superficial fascia as the background tissue can provide a 
more reliable nerve movement estimate than bone. However, information regarding the 
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validity of superficial fascia and bone to compute DUI transducer motion is required to 
complete the information needed to guide future clinical measurements and DUI studies.  
 
5.6.2 Construct validity comparing estimates from bone and superficial fascia to a fixed 
DUI transducer  
The frame-by-frame analysis showed that superficial fascia returned a cumulative movement 
of 0.00mm in comparison to bone (Figure 5.2). The results agree with, but provide higher 
quality supportive evidence for superficial fascia, in line with Dilley et al (2001). Dilley et al 
(2001) conclusions were limited by a small sample size (n=4) and a focus to healthy 
individuals. Both limitations were addressed in this study. Further to this, Dilley et al (2001) 
used freehand transducer scanning to investigate superficial fascia. The potential for hand 
movements suggested that the method lacked an objective reference point against which to 
compare their computed background tissue movement. This study used a fixed transducer to 
address this limitation, and image analysis used this fixed reference point to compare bone 
and superficial fascia motion. The present analysis adds to preliminary data and supports 
superficial fascia measurement of DUI transducer motion, as well as its use when computing 
nerve movement estimates. 
 
5.7 Chapter conclusions 
Measurement properties of inter-rater reliability and construct validity demonstrated for 
superficial fascia favour its use for estimating DUI transducer motion when computing 
median nerve LM in CWAD II. The results support its use for research and clinical practice, 
which challenges current practice of using bone as the background tissue. The findings from 
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this Chapter informed use of superficial fascia as background tissue in addition to other 
strategies for improving reliability of DUI (Chapters 3 and 4). As a consequence, a further 
reliability study was conducted and is reported as Chapter 6 of the thesis.  
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CHAPTER 6 
 
Intra-rater reliability of DUI method of computing median nerve longitudinal 
movement in CWAD II 
 
6.1 Background 
A range of measurement issues are suggested to affect DUI computed nerve movement 
estimates as well as reliability of the technique (Ellis et al., 2008; Chapter 3, 4, 5). They 
include rater skill and dexterity of DUI image capture and image analysis, inconsistent sizing 
and placement of boxes to track speckle motion within regions of interest, boxes falling out 
of the image plane, poor handling of small frame displacements by the analysis program, and 
effect of type of selected subcutaneous [background] tissue on computed estimate of DUI 
transducer motion (Ellis et al., 2008; Korstanje et al., 2009, 2010).  
 
Chapter 4 reported use of the method of inter image-capture and inter image-analysis 
reliability to establish the presence of measurement error within nerve image capture and 
nerve image analysis respectively. For image capture, reliability across all transverse and 
longitudinal images was poor, with the exception of median nerve longitudinal images that 
was fair [Table 4.1 - 4.2]. Within image analysis, reliability across all transverse and 
longitudinal analyses was poor, with the exception of median nerve longitudinal analysis that 
was good [Table 4.3 – 4.4]. The results demonstrate differences across images and analyses 
that are indicative of the presence of measurement error when the technique is used. 
Strategies of involving a single, skilled DUI operator, using large joint motion and utilizing a 
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nerve image analysis template have been advanced to address some of the error. However, 
they have not been investigated to establish their potential to improve reliability of DUI.  
 
An important source of error within the DUI image analysis that has potential to under or 
overestimate nerve movement relates to the choice of background tissue used to track DUI 
transducer motion. Supportive evidence to inform choice of background tissue is sparse and 
limited (Dilley et al., 2001), and relates to superficial fascia. Interestingly, the background 
tissue that is widely accepted and used in DUI practice is bone (Dilley et al., 2001, 2003, 
2007; Greening et at 2001; Erel et al., 2003; Greening et al., 2005; Ellis et al., 2008; 
Coppieters et al., 2009) and this practice contradicts existing evidence (n=4) for superficial 
fascia (Dilley et al., 2001). The contrast between DUI practice and existing evidence for 
superficial fascia warranted further investigation of inter-rater reliability and construct 
validity, comparing bone and superficial fascia (Chapter 5).  
 
Chapter 5 conducted a re-analysis of median nerve LM images (n=18) to investigate inter-
rater reliability and construct validity of using bone and superficial fascia as a fixed reference 
point to track DUI transducer motion. The analysis found fair inter-rater reliability for bone 
(ICC2,1 = 0.4; 95% CI = 0.15 to 0.71), and good inter-rater reliability for superficial fascia 
(ICC2,1 = 0.7; 95% CI = 0.4 to 0.84) (Coppieters et al., 2009). Construct validity of bone and 
superficial fascia to track a fixed DUI transducer was also assessed and the result 
demonstrated movement in superficial fascia = 0.0mm, in comparison to bone = 0.3mm. The 
findings agree with Dilley et al (2001). This evidence supports use of the superficial fascia as 
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the background reference tissue in order to reduce error and improve reliability of computed 
nerve movement estimates, although its usefulness in this regard has not been investigated. 
 
Overall, there is merit for strategies advanced to address sources of measurement error 
within DUI image capture and image analysis, to be evaluated in regards of their ability to 
improve reliability of the technique. This informed further evaluation of reliability of DUI 
estimate of median nerve LM.  
 
6.2 Aim 
To determine the intra-rater reliability of DUI estimates of median nerve LM at the mid-
forearm during elbow extension in CWAD II participants.  
 
6.3 Methodology 
6.3.1 Design 
A cross sectional intra-rater reliability design was used to compare DUI estimates of median 
nerve LM during elbow extension in CWAD II participants on one occasion by 1 
physiotherapist [rater]. Intra-rater reliability was determined to address potential influence of 
rater experience of DUI image capture and image analysis (Ellis et al., 2008; Chapters 3 and 
4). The median nerve was selected because previous analysis has showed its potential for 
achieving consistent estimates (Chapter 4). Elbow extension movement was selected to 
provide larger nerve movement that are suitable for the fixed 1 – 3 frame interval preset in 
the cross-correlation analysis program (Dilley et al., 2001; Korstanje et al., 2010). Elbow 
extension is a clinically relevant joint motion because it is used as a key component during 
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ULNT (Nee and Butler, 2006). The poor results demonstrated in Chapters 3 and 4 for 
median and ulnar nerve TM as well as ulnar nerve LM informed their exclusion from this 
study. 
 
6.3.2 Participants 
22 [19 females, 3 males] CWAD II participants, mean age (SD) = 26 (7) years who had 
experienced a previous whiplash injury were recruited into the study.  A sample size of n≥18 
was required to detect a difference in reliability of 0.9 and 0.7 at 80% power and 5% level of 
significance using 2 ratings (Walter et al., 1998).  22 participants were recruited to allow for 
potential data loss or corruption during data transfer between ultrasound scanner and 
computer system used for data analysis.  
 
6.3.3 Inclusion and exclusion criteria   
The Same inclusion and exclusion criteria for previous Chapters were used. 
 
6.3.4 Ethical Considerations 
Ethical clearance for this study was obtained from the ethics committee of the School of 
Sports and Exercise Sciences and Health and Population Sciences. 
 
6.3.5 Recruitment strategy 
The same methods for recruiting participants in previous studies were used. 
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6.3.6 Rater 
The same rater involved in previous studies, acquired and analysed nerve images.  
 
6.4 Data collection  
6.4.1 Health questionnaire and neurological examination 
The same procedure used in previous studies explored criteria for participant inclusion into 
the study. 
 
6.4.2 Participant position for nerve image capture 
The participant’s starting position for image capture was supine lying, 900 degrees shoulder 
abduction, wrist in neutral and 900 elbow flexion (Dilley et al., 2003).  Sequences of images 
of median nerve LM were captured while the elbow was moved from 900 flexion to 00 
extension (Dilley et al., 2003). Elbow extension was used to lengthen the nerve bed in order 
to produce nerve movement (Szabo et al., 1994; Shacklock 1995; Byl et al., 2002; Dilley et 
al., 2003; Coppieters et al., 2006). Median nerve movement was captured in a sequence of 
images acquired at the mid-forearm (Greening et al., 2005). This study used a fixed DUI 
transducer. The DUI transducer was placed in a holder and fixed to the mid-forearm by 
means of Velcro straps. Two sets of nerve images separated by 30 minutes (to eliminate 
learning effects) were taken by the rater for each participant. The same DUI equipment, 
nerve image size and resolution, and transducer alignment position used for median nerve 
LM in Chapter 3 was used.   
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6.4.3 Image Analysis 
The same nerve image analysis program and protocol for previous studies was employed for 
image analysis. However, movement of superficial fascia rather than bone was used to 
compute DUI transducer motion (Dilley et al., 2001; Chapter 5). 
 
6.5 Statistical Analysis 
The same statistics and statistical package of previous inter-rater reliability study (Chapter 3) 
was used. 
 
6.6 Results 
The intra-rater reliability of median nerve LM obtained at the mid-forearm by 1 rater from 
22 CWAD II participants is presented as Table 6.4 and Figure 6.1.  
 
Table 6.1: Intra-rater reliability of median nerve LM during elbow extension in n=22 
CWAD II participants 
Nerve ICC 95% CI of ICC Movement [mm] 
SEM 
(mm) 
MDC 
(mm) 
CV 
[%] 
       
Median 0.8 0.55 to 0.90 2.60 0.86 2.38 7 
 
Figure 6.1: Descriptive presentation of median nerve LM computed from 2 sets of n=22 
DUI images 
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6.7 Discussion 
The results demonstrated excellent DUI intra-rater reliability (ICC = 0.8; 95%CI = 0.6 to 
0.9) (Coppieters et al., 2009), that was associated with a small error and variability [nerve 
movement = 2.60mm; SEM = 0.86; CV = 7%] during elbow extension in a CWAD II. The 
excellent intra-rater reliability indicates that a physiotherapist can use DUI technique to 
compute reliable estimates of median nerve LM in a CWAD II during elbow extension 
motion. The excellent reliability support previous reports of high reliability of DUI 
computed for median nerve LM (Erel et al., 2003; Coppieters et al., 2009). However, the 
present study differ from previous DUI reliability studies in that it provides a higher quality 
of DUI reliability evidence that is relevant and reproducible in a clinical setting. Coppieters 
et al (2009) had evaluated inter-rater reliability for the DUI image analysis component alone, 
involving a small sample (n=10) of healthy individuals, a study method that limit their study 
conclusions, and generalisabilty of their findings to a patient sample (Haas et al., 1991). In 
contrast, the present study evaluated DUI intra-rater reliability for both image capture and 
image analysis because both components are used by physiotherapists during computation of 
estimates of nerve movement in a clinical setting. Erel et al (2003) used within-participant 
standard deviation [WSD] to report high intra-rater reliability for DUI estimate of median 
nerve LM in a small sample of CTS patients (n=4). Adding to error associated with 
interpreting findings generated from small sample data (Haas, 1991), the potential of the 
WSD statistic to be affected by increases in mean nerve movement can mislead 
interpretation of reliability and therefore limit its usefulness (Bland and Altman, 1996). This 
issue informed the recruitment of n=22 CWAD II participants and the use of the 
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recommended ICC statistic in the present study (Bland and Altman 1996; Eliasziw et al., 
1998; de Vet et al., 2006).    
 
This DUI intra-rater reliability study is the first to be conducted in CWAD. The results and 
method adopted provide evidence to support its use in a clinical setting, because intra-rater 
reliability coefficients achieved in the study meets the ICC = 0.8 cut-off recommended for 
clinical measurements (Haas et al., 1991). Heterogeneity or differences between participants’ 
nerve data can lead to high ICC estimates (Haas 1991). However, the low SEM and CV 
obtained in the present study showed that the achieved reliability coefficients cannot be 
attributed to participant heterogeneity (Keating and Matyas 1998; Bruton et al., 2000; 
Domholdt 2005; de Vet et al., 2006; Tighe et al., 2010). The size of the SEM has been 
suggested to affect the estimate of reliability (Tighe et al., 2010). However, the low SEM 
demonstrated in this study increases confidence in the returned intra-rater reliability estimate.  
 
6.8 Chapter conclusions 
The aim of this study was to determine intra-rater reliability of DUI technique of computing 
median nerve LM at the mid-forearm during elbow extension in CWAD II. The results 
support DUI as a reliable method for computing median nerve LM in CWAD II participants, 
using large joint motion [elbow extension].  
 
The results provide supportive evidence to inform use of DUI to evaluate nerve movement as 
one of the theorised components underpinning the ULNT 1 [median nerve bias] (Greening et 
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al., 2005). These conclusions informed using the DUI technique to compute median nerve 
movement for a ULNT validity study that is reported as Chapter 7 of the thesis.  
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CHAPTER 7 
 
Construct validity of ULNT 1 using median nerve longitudinal movement, elbow 
extension ROM, pain response, and Brachialis muscle activity in CWAD II 
 
7.1 Background  
The evidence for the validity of the ULNT 1 test to assess hypersensitivity of peripheral 
nerves in chronic pain conditions such as CWAD is incomplete (Chapter 2, Section 2.6.IVb). 
Theorised constructs that underpin the test indicate that restriction of nerve movement 
contribute to increased nerve tension, increased pain response, decreased elbow extension 
ROM and increased flexor muscle activity during the test (Nee and Butler, 2006). However, 
in clinical practice, physiotherapists interpret the ULNT 1 test through constructs of 
increased pain response, decreased elbow extension ROM and increased flexor muscle 
activity (Nee and Butler, 2006). 
 
Nerve movement can now be measured in-vivo with the emergence of the DUI technique, 
although evaluation of in-vivo nerve tension measurements remains a challenge for existing 
biomedical equipment. It is recognised that nerve movement and tension have been 
measured in cadaveric studies that are widely relied upon to inform validity of the ULNT 
(Kleinrensink et al., 1995, 2000; Shaclock 1996; Wright et al., 1996; Lewis et al., 1998; 
Coppieters et al., 2001; Coppieters and Butler 2008). However, a limitation of these studies 
is that they lack the detail of the pain response and flexor muscle activity required to 
complete the evaluation of the validity of the test. In addition, nerves in cadavers possess 
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characteristics that are different from those of living tissue; with embalming procedures 
further compromising tissue characteristics (Coppieters et al., 2009). As a result, existing 
cadaver studies provide limited evidence to evaluate the validity of the ULNT through the 
theorised constructs.  
 
Studies in humans have also been conducted to provide supportive evidence for constructs 
underpinning the ULNT, although they are sparse [n=3] and incomplete as they lack nerve 
movement and nerve tension (in-vivo) data, due to the unavailability of appropriate medical 
equipment at the time of conducting the studies. In addition, the majority of the studies were 
focused to healthy individuals, and this limits their translation to a patient population. 
Overall therefore, evidence for validity of ULNT in CWAD is lacking. In addition, present 
understanding of physiological mechanisms that contribute to responses during the ULNT is 
limited. This understanding could underpin conflicting arguments regarding clinical 
relevance and usefulness of the test for a patient population such as CWAD. While some 
authors favour the test because it can assist interpretation of neural hypersensitivity, (Nee 
and Butler 2006), others advocate against its use because of its potential to further provoke 
hypersensitivity of nerves that are already sensitised (Dilley et al., 2008). The conflicting 
arguments corroborate limitations of existing information regarding validity of the ULNT 
and highlight a need for further evaluation of ULNT, particularly, with the emergence and 
evidence for the DUI technique to provide in-vivo nerve movement estimates (Chapter 6). 
Supportive reliability and validity evidence for DUI estimates of median nerve LM in 
CWAD II have been established in Chapters 5 and 6. Potential clinical benefits such as 
clarity of reasoning to justify clinicians use of the test for patients, and supportive evidence 
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for constructs used to interpret the test, amongst others, will emerge as the validity evidence 
for ULNT, particularly within a patient population e.g. CWAD,  is updated. This informed 
the design of a study to further evaluate construct validity of ULNT 1 in CWAD II. The 
specificity and sensitivity of the median nerve ULNT 1 has been reported (Kleinrensink et 
al., 2000). Intra- and inter-rater reliability of ULNT 1 measurements has also been 
established within the literature (Selvaratnam et al., 1994; Grant et al., 1995; Byng, 1997; 
Kelly and Jull, 1998; Coppieters et al., 2001, 2002; Wainner et al., 2003; Heide et al., 2006; 
Oliver and Rushton, 2011).  
 
7.2 Aim of study 
To evaluate construct validity of the ULNT 1 [median nerve] using correlation of test 
constructs of median nerve LM, brachialis muscle activity, pain response, and elbow 
extension ROM in CWAD II. 
 
7.3 Methodology 
7.3.1 Design 
A construct validity design to establish correlation between estimates of median nerve LM, 
pain, brachialis muscle activity and range of elbow extension in a CWAD II population. 
 
7.3.2 Participants 
A sample of 22 CWAD II participants [19 females, 3 males], mean age (SD) = 26 (7) years, 
who had experienced a previous whiplash injury participated in the study. Coppieters et al 
(2009) reported validity for different types of median nerve neurodynamic exercises [sliders 
  143 
and tensioners], from a calculated sample size n=13, used to detect a significant difference of 
nerve movement at a power of 90% and 10% level of significance. A sample size n≥13 was 
adopted to account for potential loss or corruption of data.  
 
7.3.3 Inclusion and exclusion criteria   
The same inclusion and exclusion criteria for previous studies were used. 
 
7.3.4 Ethical Considerations 
Ethical clearance was obtained from the ethics committee of the School of Sports and 
Exercise Sciences and Health and Population Sciences. 
 
7.3.5 Recruitment strategy 
The same methods for previous studies were used.  
 
7.3.6 Rater 
Electromyography [EMG] recordings were captured and acquired by the same 
physiotherapist who captured and analysed the DUI images in previous studies (Chapters 5 
and 6), who was trained in EMG data capture and data analysis. A second researcher was 
involved in taking measurements of elbow range of movement and routinely uses 
goniometry during patient assessment in clinical practice. Both researchers are 
musculoskeletal physiotherapists with ≥ 2 years post qualification clinical experience and 
were studying at the postgraduate level during the time of data collection.  
7.3.7 Testing Protocol 
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G.  Health questionnaire and neurological examination 
The same procedure for previous studies was used.  
  
7.3.8 Data collection   
The participants starting position was supine lying, shoulder fixed to prevent elevation, 900 
shoulder abduction, shoulder lateral rotation, forearm supination, wrist and finger extension, 
and 900 elbow flexion (Shacklock, 2005) [Figure 7.1C]. Pain level prior to performing the 
ULNT was marked by the participant on a VAS marked 0 [no pain] to 10 [worst pain]. The 
Visual Analogue Scale [VAS] score is widely recognised, and used in research and clinical 
settings, to measure pain response, and has been used in CWAD (Sterling, 2004). Resting 
electromyography recordings of brachialis muscle was also captured at this point. The EMG 
is the gold standard for evaluating muscle activity, and has been used in previous ULNT 
studies (Jaberzadeh et al., 2001). The upper limb neurodynamic test was performed by 
moving the elbow joint from 900 flexion into extension.  Elbow extension ROM, an 
important component of ULNT, was taken to participant’s limit of pain [P2] or available 
range [R2] in other to lengthen the nerve bed and produce nerve movement (Szabo et al., 
1994; Shacklock 1995; Byl et al., 2002; Dilley et al., 2003; Coppieters et al., 2006; Nee and 
Butler 2006). Median nerve LM (Dilley et al., 2003) and Brachialis muscle activity 
(Jaberzadeh et al., 2001) were captured simultaneously during the ULNT. Elbow extension 
[ROM] to P2 or R2 was measured for both arms (Jaberzadeh et al., 2001) and side differences 
were computed. Pain level post ULNT was marked by the participant on the visual analogue 
scale [VAS] and compared with pre ULNT levels. 
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Images of median nerve LM were captured using same DUI equipment and protocol used for 
previous studies (Chapters 3, 4, 5 and 6) [Figure 7.1A]. Bipolar surface EMG electrodes 
were attached over the brachialis muscle in the distal third of the arm (Moore and Dalley, 
2006) [Figure 7.1C]. The electrodes were Velcro-secured to the participant’s arm to 
minimise movement artefacts (Jaberzadeh et al., 2001). Detection electrode surface was 
made of pure silver (>99.5%) in the form of 2 parallel bars 10 mm long and 1 mm wide with 
an inter-detection surface spacing of 1.0 cm [Figure 7.1B]. The small electrode size and 
inter-detection surface spacing minimised cross-talk susceptibility from adjacent muscles 
(DeLuca 1997). A bandwidth between 20 and 450 Hz was used to capture the full frequency 
spectrum of brachialis EMG signal and to suppress noise at higher frequencies (DeLuca, 
1997, 2002). Control measures such as clear instruction at the start and end point of data 
capture were adopted to ensure that EMG data for the duration of the ULNT was captured. 
The test protocol was described clearly to the participants in other to eliminate plausible 
apprehension or fear avoidance that could lead to subtle arm movement as well as signal 
artefacts within the muscle, both of which can contribute to affect EMG data quality. This 
method was adopted as evidence indicates that psychological factors of pain catastrophising 
within a fear-avoidance model of musculoskeletal pain are suggested to predict clinical pain 
response in healthy individuals [n=62; p<0.01] (Beneciuka et al., 2010). The authors 
recommended consideration of the effect of psychological factors on evoked pain responses 
when performing the neurodynamic test. Elbow extension ROM was measured using a 
universal goniometer positioned along the longitudinal axis of the tested arm and forearm as 
described in the goniometry literature to ensure accuracy of obtained measurements 
(Jaberzadeh et al., 2001). 
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7.4 Data analysis  
The same method for conducting DUI image analysis in previous study (Chapter 6) was 
used. For Brachialis muscle activity, acquired EMG data was first amplified 3000 times by a 
low-noise EMG amplifier with a high common mode rejection ratio [120 db] (Basmajian et 
al., 1985). The signals were then filtered with a band-pass filter with corner frequencies of 10 
– 500 Hz. A band-reject filter centred on 50 Hz removed the power line hum. The filtered 
EMG signals were band-limited using a second order Butterworth filter and digitised using a 
sampling rate of 1000 Hz (Jaberzadeh et al., 2001). Change in pain score was obtained by 
computing difference between participant’s pre and post test pain levels. The difference 
between both arm’s elbow extension ROM was also recorded to assist comparison. 
 
 
 
 
Fig 7.1A: DUI scanner and transducer  Fig 7.1B: EMG equipment set up 
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Fig 7.1C: ULNT 1 arm starting position 
with transducer and EMG electrode at 
the mid-forearm and distal third of arm 
respectively 
Fig 7.1D: ULNT 1 arm ending position 
with transducer, EMG electrode and 
goniometry measurements 
 
7.5 Statistical Analysis 
The Pearson product moment correlation coefficient [denoted by r] was used to measure 
correlation between the ULNT 1 test constructs measured in this study. The statistic is 
widely used as a measure of strength of linear dependence between two variables (Sim and 
Wright, 2000), and has also been used in previous human ULNT validity studies (Jaberzadeh 
et al., 2001, 2005). Pearson’s r can have a value between +1 and −1 (Sim and Wright 2000). 
SPSS [version 19.0] was used to compute Pearson’s r. A value r = 0.5 has been 
recommended as a cut-off point to interpret clinically important and strong association 
between outcome variables (Cohen, 1988).   
 
7.6 Results  
The study sought to evaluate construct validity of ULNT 1 using association between 
estimates of median nerve LM; pain response; activity of Brachialis muscle; and elbow 
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extension ROM in CWAD II participants. The results demonstrated a statistically significant, 
strong positive association between elbow extension ROM and median nerve LM (r=0.6) as 
well as pain response and median nerve LM (r=0.7) [Table 7.1]. There was however a 
statistically non-significant, weak but positive association between brachialis muscle activity 
and pain response (r=0.1), median nerve LM (r=0.2), and elbow extension ROM (r=0.1) 
[Table 7.1]. The correlation coefficient returned for 3 (nerve movement, pain and elbow 
ROM) out of 4 theorised constructs underpinning the ULNT support the validity of the test 
in addition to previous cadaver (Kleinrensink et al., 1995, 2000; Shaclock 1996; Wright et 
al., 1996; Lewis et al., 1998; Coppieters et al., 2001; Coppieters and Butler, 2008) and 
human (Jaberzadeh et al., 2001, 2005) ULNT studies. The results obtained for a 4th construct, 
flexor muscle activity, and contrast reports with previous report suggesting association 
between flexor muscle activity and pain response (Jaberzadeh et al., 2001, 2005). 
  
Table 7.1: Mean, standard deviation and Pearson r for the ULNT 1 test components 
studied  
ULNT   
Component 
Pearson’s r 
Mean  Standard Deviation Nerve 
movement  
Elbow  
ROM 
Pain  
Change 
Brachialis 
Activity 
Nerve movement 1 0.5* 0.7** 0.2 1.5mm 0.85mm 
Elbow ROM 0.5* 1 0.4 0.1 780 5.00 
Pain Change 0.7** 0.4 1 0.1 43mm 29.32mm 
Brachialis Activity 0.2 0.1 0.1 1 1.5mV 1.46mv 
* Correlation is significant at the 0.05 level (2-tailed)  
** Correlation is significant at the 0.01 level (2-tailed) 
 
 
 
7.7 Discussion 
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The construct validity study of the ULNT 1 test in CWAD II population has provided further 
evidence to support use of the test for assessing chronic musculoskeletal pain conditions. In 
addition, the study results justify current clinical practice of using pain response and elbow 
extension ROM when interpreting the ULNT 1 test (Shacklock, 2005). The result also 
supports nerve movement data being used as an additional construct for interpreting the 
ULNT 1 test. This information was previously unknown in the ULNT literature and merits 
dissemination and translation to clinical practice. The results will also inform future ULNT 
validity studies that are focused to in-vivo nerve tension that the present construct validity 
evidence has been unable to address, because of previous limitations of medical equipment. 
Despite these merits, the results of poor correlation between flexor muscle activity and pain, 
as well as for nerve movement and elbow ROM constructs warrant further consideration, 
particularly as they challenge current practice that uses a physiotherapist’s subjective 
perception of a patient’s muscle resistance to interpret the test (Nee and Butler, 2006). This is 
an important issue as quantification of a physiotherapist’s perception of a patient’s resistance 
is difficult and could bias comparison and interpretation of results (Nee and Butler, 2006). 
Pain response during the test is equally difficult and depends on the patient’s cognitive 
feedback (Nee and Butler, 2006), although the adoption of the VAS minimises the bias. 
Further evaluation of the usefulness and clinical relevance of this construct is warranted, 
particularly as it shows a potential to mislead clinicians assessment of ULNT findings. 
 
The construct validity evidence for ULNT in CWAD showed a statistically significantly 
strong but positive association between constructs of elbow extension ROM, median nerve 
LM and pain score [VAS]. The study therefore substantiated most of the theorised constructs 
  150 
underpinning the ULNT 1. The ULNT is theorised to challenge the physical and mechanical 
capabilities of peripheral nerves using multi-joint movements of limbs and/or trunk that 
produces increase in nerve tension in and nerve movement (Elvey 1997; Hall and Elvey 
1999; Millesi et al., 1990; Butler, 1991, 2000; Shacklock 1995; Beith et al., 1996; Coppieters 
et al., 2001; Nee and Butler 2006). The test reflects an interdependent link between 
physiological response (sensory) and mechanics of neural tissue (movement) that determine 
the extent of joint motion (Shacklock, 1995). This theorised concept is also supported by the 
present construct validity results.  Also, a pathological [positive] response during the ULNT 
is determined by reproduction of pain symptoms that coincide with a decrease in range of 
movement [elbow extension] (Shacklock, 2005; Nee and Butler 2006). The construct 
validity findings of a statistically significant and strong positive correlation for elbow 
extension ROM and median nerve LM (r=0.6) as well as for pain score [VAS] and median 
nerve LM (r=0.7) support this construct for interpreting a positive ULNT test. The study 
findings also support findings from cadaver-based ULNT validity studies (Kleinrensink et 
al., 1994, 1995, 2000; Shacklock, 1995; Wright et al., 1996; Lewis et al., 1998; Coppieters et 
al., 2001; Coppieters and Butler 2008), although its merit over these studies has already been 
highlighted.  
 
The present study did not show a statistically significant correlation between brachialis 
muscle and pain (r=0.1), median nerve movement (r=0.2) and elbow extension (r=0.1). The 
result contrasts with findings of previous ULNT validity studies (Jaberzadeh et al., 2001, 
2005). However, differences of study sample and methods might account for the present 
study results. For example, Jaberzadeh et al (2001) investigated correlation between passive 
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elbow resistive torque and EMG activity of shoulder and arm muscles during elbow 
extension at periods of pain onset and limit of pain in healthy participants [n=10]. Their 
result showed that pain and elbow resistive torque were positively correlated with EMG 
activity of shoulder and arm muscles. The same authors (Jaberzadeh et al., 2005) evaluated 
correlation between elbow ROM, elbow flexor resistive torque and EMG activity of 10 
shoulder and arm muscles at movement onset, pain onset and pain limit during ULNT 1 in 
healthy individuals [n=26]. They found elbow extension range to be positively associated 
with an increase in resistive torque and the EMG measurements of muscles evaluated. Nine 
out of the 10 muscles evaluated demonstrated increased muscle activity pre pain onset that 
became further increased post pain onset. Their results suggest a relationship between 
elevated perception of pain and motor responses that the present study failed to replicate. 
The healthy individuals investigated in their study differ from the patient sample in the 
present construct validity study. In addition, study methods were different. For example, the 
present validity study did not measure EMG activity of brachialis muscles at time points of 
movement onset, pain onset, and pain limit as was reported in Jaberzadeh et al (2001, 2005). 
The inability of available DUI (image analysis focused to frame by frame correlation) to 
synchronize nerve movement data at these time points prevented replication of their method. 
This might have influenced the correlation results between DU and EMG data. The same 
reason can be advanced for poor correlation between brachialis muscle activity and elbow 
extension ROM.  
 
 
7.8 Chapter conclusions 
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The evidence for the construct validity of the ULNT 1 test support use of median nerve LM, 
pain, and elbow extension ROM when assessing chronic pain conditions like CWAD II in a 
clinical setting. However, findings of a weak correlation between Brachialis muscle activity 
and constructs of pain, median nerve LM and elbow extension ROM does not support use of 
muscle activity when interpreting ULNT responses. However, considering limitations of 
DUI technique to synchronise with EMG data at times points reported in previous ULNT 
studies, further evaluation of muscle activity is warranted in a patient sample. This will in 
turn provide the opportunity to add to the present study results in order to further explore the 
validity of theorised constructs for ULNT 1 test. Until then, clinicians and researchers can 
continue to rely on the present evidence when performing and interpreting ULNT. This 
includes its consideration as a reliable and valid sensory test, in addition to QST when 
assessing CWAD II. 
 
Chapter 2 [literature review] of the thesis has showed merit for ULNT inclusion amongst the 
range of sensory tests to discriminate CWAD II. However, evidence regarding its validity 
was limited and incomplete, therefore warranting further evaluation. This study has provided 
evidence in support of the validity of the ULNT. As a result, its inclusion in a sensory 
discrimination study [Chapter 8] based on the criteria of its measurement validity is 
supported by the results from this study.  
 
 
 
Chapter 8 
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Sensory Hyperalgesia, Hypersensitivity and Hypoaesthesia Discriminate between 
CWAD II and Healthy individuals 
 
8.1 Background 
Impairments of sensory hypersensitivity and hypoaesthesia are suggested as discriminative 
of CWAD from INP and healthy individuals (Scott et al., 2005; Elliott et al., 2008; Chien 
and Sterling 2010). Evidence in support of this claim is however limited, incomplete and 
inconclusive. A detailed critique of the sensory discriminative evidence has been discussed 
in the literature review (Chapter 2). However, the key limitations within the existing 
evidence are highlighted in this Chapter to justify further evaluation of sensory impairments 
to discriminate CWAD II.  
 
Scott et al (2005) investigated sensory changes in CWAD [n=29] and INP [n=20] 
participants using PPT and TPT and von Frey hair sensibility over sites local and remote to 
the injury. They found that PPT discriminated both groups over local (P < 0.05) and remote 
sites (P < 0.001). In addition, a decreased HPT as well as increased CPT at all sites 
discriminated both groups (P < 0.03). The increased CPT contrasted with findings from both 
Elliot et al (2008) and Chien and Sterling et al (2010) in support of a decreased CPT 
discrimination between CWAD and INP. The PPT discrimination of CWAD however was 
not replicated in future studies (Elliot et al., 2008; Chien and Sterling, 2010).  
Elliot et al (2008) investigated characteristics of fatty infiltrate in the cervical extensor 
musculature as well as QST measures of PPT and TPT to determine those that discriminated 
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CWAD [n = 79 women, mean age(SD) = 29.7(7.8) years] from INP [n=23 women; mean 
age (SD)= 29.2 (6.9) years]. Although their study reported that the QST [CPT (p < 0.001) 
and HPT (p = 0.001)] discriminated both groups, their bias to the female gender [Elliot et al., 
2008] limited generalisation of their conclusions, particularly, as gender differences to QST 
have been reported (Edwards et al., 2004; Sullivan et al., 2005; Rolke et al., 2006). Further, 
PPT in their study failed to discriminate both groups. This contrasts with results reported by 
Scott et al (2005) and Chien and Sterling et al (2010) to support PPT discrimination between 
CWAD and INP populations.   
 
Chien and Sterling (2010) investigated sensory hypersensitivity and hypoaesthesia using a 
range of QST detection and pain thresholds [thermal, pressure, electrical] applied over local 
and remote site to the injury in CWAD [n= 50] and INP [n=28] participants. They found that 
remote lowered PPT discriminated both groups (p = 0.02), in contrast to Scott et al (2005) 
findings that both local (P < 0.05) and remote lowered PPT (P < 0.001) discriminated the 
groups. Chien and Sterling (2101) reported that elevated VDT (p < 0.04), HDT (p < 0.02) 
and EDT (p < 0.04) over local and remote sites (indicative of peripheral and central 
hypoaesthesia) discriminated between CWAD and INP participants. However, confidence in 
their conclusion is limited because their INP group did not demonstrate features of sensory 
hypoaesthesia (p > 0.12). Surprisingly, sensory hypoaesthesia has been reported in similar 
musculoskeletal pain conditions such as diffuse upper limb pain, hip osteoarthritis and 
patellofemoral pain (Jensen et al., 2007b; Tucker et al., 2007). It was therefore interesting 
that their INP participants did not demonstrate these sensory impairments. The authors 
therefore recommended further replication of their findings.   
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Another limitation of the discrimination studies is their exclusion of a routinely used ULNT 
sensory test.  ULNT is a simple and costless sensory test, widely used to interpret changes to 
peripheral and central neural functioning (Elvey 1997; Nee and Buttler 2006). The exclusion 
negates recent cost saving initiatives in the NHS for simple and affordable clinical 
assessment tests. This omission in combination with the limitations within the existing 
evidence reflects an incomplete, limited, and inconclusive evidence for sensory 
discrimination of CWAD, and necessitated a further sensory discrimination study of CWAD 
II. However, because other impairments and mechanisms exists in CWAD, and are useful for 
gaining further understanding of the condition, outcome measures that capture pain and 
disability as well as psychological factors were explored and used to describe the study 
CWAD II participants. 
 
8.1.1 Psychological impairments in CWAD 
Certain features of psychological impairment and elevated levels of pain and disability are 
reported to co-exist with and contribute to modulate sensory manifestations in CWAD 
(Rhudy and Meagher, 2000). The features are not considered to be discriminative of CWAD 
(Sterling, 2010). Reports to indicate moderate association between sensory impairments 
[pressure and cold hypersensitivity at some upper and lower limb sites] and psychological 
factors [PTSD, psychological factors and pain catastrophisation] in CWAD participants 
exists and potentially suggests psychological factors may also contribute to a hyperexcitable 
neural system. Importantly, PTSD, measured by the impact of event scale [IES] provides 
prognosis for WAD patient at risk of poor recovery (Williamson 2007). This finding further 
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indicates importance of psychological factors to better understand CWAD. PTSD does not 
possess discriminative ability in CWAD, although this was not investigated in previous 
sensory studies (Sterling, 2010). This implies that psychological factors are not predominant 
triggers for spinal cord hyperexcitability demonstrated in CWAD (Sterling et al., 2008; 
Sterling, 2010). However, measures of psychological impairments are important to reflect 
other mechanisms in the complex clinical presentation of WAD, and are used in the sensory 
discrimination study to describe the participants, as in previous discriminative studies (Scott 
et al., 2005; Elliot et al., 2008; Chien and Sterling 2010). 
 
A. Impact of Event Scale [IES] 
The Impact of Event Scale [IES] is a widely used patient-reported questionnaire comprising 
15 items used to measure current subjective stress related to specific life event or post-
traumatic stress reactions (Horowitz et al., 1979). The IES has been used in previous work by 
Sterling et al (2005) to describe such relationships. Seven statements address intrusive 
symptoms and 8 statements address avoidance symptoms. IES is reported to demonstrate 
measurement properties of reliability and sensitivity (Horowitz et al., 1979). Its construct 
validity has been reported (Karlehagen et al., 1993; Sundin and Horowitz, 2002; Joseph, 
2000). The use of IES in clinic and research has also been justified (Joseph, 2000). The IES 
comprises a total score 0 to 80, that can be described in four categories: sub-clinical [0–8], 
mild [9–25], moderate [26–43] and severe stress reactions [44–75] (Kongstd et al., 2007).  
 
8.1.2 Pain and disability association with sensory impairments in CWAD 
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CWAD precipitates a number of clinical symptoms such as pain and disability (Kamper et 
al., 2008). The disability occurs because patients limit and restrict their level of personal 
functioning in other to cope with symptoms of pain (Dysvik et al., 2005; Krohne and 
Ihlebaek 2010). Such maladaptive coping strategies are used to prepare for potential pain-
triggering situations or events (Krohne and Ihlebaek 2010). The resulting restriction of 
activity leads to disability that further impacts on levels of pain and activity [Figure 8.1]. 
Pain and disability co-exist with sensory impairments of local hypersensitivity to cold and 
pressure in CWAD (Sterling and Kenardy, 2006; Sterling et al., 2008; Bossman et al., 2011). 
This suggests that the same mechanisms that promote sensory impairments in CWAD may 
be responsible for pain persistence in the condition. However, pain has not been shown to be 
discriminative of CWAD participants, stressing the point that it is not the trigger for 
symptoms in CWAD. Pain and disability however helps to understand and interpret sensory 
impairments post whiplash injury, and Kamper et al (2008) have used same measures to 
describe their CWAD participants such as the Neck Disability Index [NDI].  
 
Figure 8.1: Diagram illustrating relationship of pain, psychological impairment and disability 
 
A. Neck Disability Index [NDI] 
Maladaptive 
coping 
Disability 
[Impaired 
Pain 
Limitation of 
personal 
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NDI comprises of 10 items describing functional activities as well as pain intensity, 
concentration and headache (Sterling et al., 2006). A higher score indicates greater pain and 
disability (Vernon & Mior 1991). The NDI was originally designed for chronic neck pain 
disorders but has been used in WAD (Sterling et al., 2006). It is the most validated pain-
disability outcome measure in the literature (Vernon & Mior 1991; Pietrobon et al., 2002). 
WAD groups have been previously classified using the NDI as recovered (<8 NDI), mild 
pain and disability (10 – 28 NDI) and moderate/severe pain and disability (≥30 NDI) 
(Vernon, 1996; Sterling et al., 2003). A cut-off score of ≥30/100 is accepted as predictive of 
poor recovery post whiplash, as well as a reference for identifying moderate/severe levels of 
pain and disability by clinicians (Nederhand et al., 2004; Sterling et al., 2005).  
 
B.  Whiplash Disability Questionnaire [WDQ]  
The WDQ was designed to assess the impact of whiplash injury on patient symptoms and 
lifestyle. It uses 13 items that measure disability post whiplash injury (Pinfold et al., 2004). 
WDQ covers current levels of pain, personal care, role performance (work/study/home 
duties), mobility (driving / public transport), sleep disturbances, tiredness, social and leisure 
(sporting and non-sporting) activity, emotional (sadness/depression, anger, anxiety) and 
concentration impairments. The WDQ was developed following observed limitations of the 
NDI and Northwick Park Neck Pain Questionnaire relating to social and emotional issues 
reported in WAD (Leak et al., 1994; Hoving et al., 2003). The WDQ total score is 130, with 
higher scores indicating a higher level of disability. A minimum detectable change in score 
of 15 is regarded as clinically important (Willis et al., 2004). The WDQ has excellent content 
and construct validity (Niere, 2006), demonstrated short term [24 hour] reliability ICC = 
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0.96 and medium term [one month] reliability ICC = 0.93 in 63 WAD patients (Willis et al., 
2004). It also demonstrated excellent internal consistency (Cronbach’s alpha = 0.96); sound 
factor structure; no substantial floor or ceiling effects, and excellent response rates in 101 
whiplash patients (Pinfold et al., 2004).  
 
C. Self-report version of Leeds Assessment of Neuropathic Symptoms and Signs pain scale 
[S-LANSS]  
The LANSS pain scale is a 7-item (5 symptom items - patient reported; and 2 clinical 
examinations – clinician reported) bedside tool that was developed and validated to 
discriminate pain underpinned by neurogenic and nociceptive mechanisms (Bennett, 2001). 
Screening tools such as LANNS assist separating patients into categories of diagnostic 
certainty (Rasmussen et al., 2004a). The original LANSS was developed from a sample of 
60 patients presenting with chronic nociceptive or neuropathic pain and further validated in a 
sample of 40 patients presenting with the same pain features. Comparing results obtained 
from the LANNS and clinical assessment, the LANSS correctly identified 82% of patients, 
demonstrating 85% sensitivity and 80% specificity (Bennett, 2001). LANNS Cut-off score > 
12 points yielded a positive predictive value of 81% and a negative predictive value of 84% 
[16/19] (Bennett, 2001). However, a limitation of the original LANNS was its need for 
clinical examination component, including the use of pin prick, both of which are 
impracticable in a non-clinical setting (Backonja 2002; Bennett et al., 2005). A self-report 
version [S-LANNS] of the LANNS was subsequently developed to achieve the aim of the 
LANSS without the need for clinical examination (Bennett, 2005). A comparison of 200 
chronic pain patients self-completed SLANNS against a researcher administered S-LANSS 
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[using interview format] found that the SLANNs identified 75% and 80% of pain types when 
compared to a clinical diagnosis (Bennett et al., 2005). Sensitivity for the S-LANSS was 
74% to 78%. The LANSS and S-LANNS have been tested in fibromyalgia (Martínez-Lavin 
et al., 2003); low back pain (Kaki et al., 2005); and WAD (Sterling, 2008).  
 
8.2 Aim 
The aim of this study was to evaluate the capacity of sensory tests that evaluate hyperalgesia, 
hypersensitivity and hypoaesthesia to discriminate CWAD II from healthy individuals using 
ULNT and QST. 
 
8.3 Methodology 
8.3.1 Design 
A cross-sectional design was used to discriminate between two groups of participants 
(CWAD II and healthy) using QST pain [cold and pressure] and detection [vibration] 
thresholds, and ULNT induced responses [pain change, nerve movement and elbow 
extension ROM]. A total of 11 sensory tests were investigated. 
 
8.3.2 Participants 
Ninety nine individuals showed interest but 54 actually participated in the study. A total of 
45 (n=4 illness, n=10 work commitment, n=31 no reason given) did not join the study, 
coinciding with the treacherous weather condition experienced in UK at the time of data 
collection and 9 were excluded at the screening stage for not satisfying the eligibility criteria.  
There were 22 CWAD II participants (19 female; mean (SD) age 26(7) years) and 32 healthy 
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participants (24 females, mean (SD) age 24(9) years). A sample size calculation of n=110 
was planned, as 10 participants per outcome variable (sensory test) have been recommended 
for logistic regression analysis (Tabachnick and Fidell, 2001).  
 
8.3.3 Inclusion and exclusion criteria  
8.3.4 Ethical approval 
8.3.5 Recruitment strategy 
The procedures developed for previous studies, reported in Chapters 3, 6 and 7 were 
followed for Section 8.3.3 – 8.3.5 
 
8.3.6 Researchers involved in data collection  
Data were collected by two musculoskeletal physiotherapists (designated as researchers 1 
and 2), with ≥ 10 years post-qualification clinical experience and studying at postgraduate 
level at the time of data collection. Both physiotherapists were trained on use of the QST and 
ULNT measures. A third physiotherapist, researcher 3, conducted pre-test screening to 
ensure that participants fulfilled eligibility criteria for the study, and identified the most 
symptomatic side for testing in CWAD II  participants.  
 
8.3.7 Testing protocol 
 A. Health questionnaire and neurological examination 
The same procedures as previous studies were used. In addition, patient reported 
questionnaires (NDI, WDQ, IES, SLANNS) were completed by CWAD II participants.  
B. Participants position, testing sites and equipments  
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The participant’s position during sensory testing was supine lying for the hand and leg and 
prone lying for the neck. Neck measurements were taken over the articular pillars of C5/6. 
This position corresponds to the nerve root for the median nerve and was relevant to the 
ULNT variant adopted for the study. Hand measurements taken over the thenar eminence 
corresponded to the median nerve distribution, supporting the study focus to ULNT 1. The 
three test sites have been used in previous CWAD sensory studies (Sterling et al., 2003; 
2004, 2009). Testing over the Tibialis Anterior muscle was to demonstrate presence of 
sensory impairments not directly due to the original injury but potentially indicating altered 
central pain processing mechanisms (Sterling et al., 2003; 2004, 2009; Gerdle et al., 2008). 
The three sites were tested in a randomised order across participants, based on the six 
possible permutations of testing three sites. The most symptomatic side was tested for 
CWAD II participants (Greening et al., 2005), and the dominant side for those presenting 
with a bilateral distribution of symptoms. The dominant side was tested for healthy 
participants because no inter-side differences to QST have been found by Rolke et al. (2006). 
A clear explanation of testing procedures and sites were given to each participant by 
researcher 3 before testing began. Testing was carried out within a quiet room, void of 
distractions. Researchers 1 and 2 were blind to participants’ group allocation and followed 
standardised protocols and scripts of instructions for each participant. Triplicate recordings 
were taken for each sensory measure over the test areas (Chien et al., 2008). A pictorial view 
of QST and ULNT 1 testing is presented as Figure 8.2 – 8.6. 
 
Researcher 1 conducted ultrasound scanning and the ULNT 1 test, while researcher 2 
performed all the QST testing. The participants’ starting position for the ULNT 1test was 
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supine lying, shoulder fixed to prevent elevation, 900 degrees shoulder abduction, shoulder 
lateral rotation, forearm supination, wrist and finger extension, and 900 elbow flexion 
(Shacklock, 2005). During the ULNT 1 test, the elbow joint was moved from 900 flexion into 
extension (Szabo et al., 1994; Shacklock, 1995; Byl et al., 2002; Dilley et al., 2003; 
Coppieters et al., 2006; Nee and Butler, 2006). As the elbow was moved, median nerve LM 
data through the DUI and Brachialis muscle activity through the EMG were obtained 
simultaneously. The elbow movement during the ULNT 1 test was stopped either at the 
participant’s limit of pain [P2] or end of available ROM [R2] (Shacklock 2005; Nee and 
Butler, 2006). Elbow ROM was measured to P2 or R2 by universal goniometer (Jaberzadeh et 
al., 2001) and pain levels pre- and post- test were recorded by the participants on a VAS 
scale [0 to 100]. At the end of testing, the SLANSS, WDQ, NDI and IES questionnaires 
were completed by CWAD II participants. The QST and DUI equipments and their 
measurement properties were discussed in Chapter 2 of the thesis. A pictorial view of QST 
and ULNT 1 testing is presented as Figure 8.2 – 8.6. 
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(A) Equipment  
 
(B) Thermotest 
 
(C) Pressure Algometer 
 
(D) Vibratimer and tuning fork 
 
 
 
 
 
Figure 8.2: Equipment Setup for Sensory Discrimination Study 
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(A) CPT testing over the neck 
 
(B) CPT testing over the 
thenar 
 
(C) CPT testing over the 
Tibialis anterior muscle 
 
Figure 8.3: CPT testing using the thermotest’s thermode over 3 sites 
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(A) PPT testing over the neck 
 
(B) PPT testing over the thenar 
 
(C) PPT testing over the Tibialis 
anterior muscle 
 
Figure 8.4: PPT testing using the algometer over 3 sites 
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(A) Vibratimer and Tuning fork 
 
(B) VDT testing over the neck 
 
(C) VDT testing over the thenar 
eminence 
 
(D) VDT testing over the 
Tibialis anterior muscle 
 
Figure 8.5: VDT testing using the tuning fork over 3 sites 
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(A) ULNT 1 arm starting position 
 
ULNT 1 test with simultaneous DUI 
median nerve LM image capture and 
EMG Brachialis muscle activity 
recording 
 
(B) ULNT 1 arm ending position to 
P1 or P2 
 
 
 
(C) Measurement of elbow extension 
ROM at the end of ULNT 1 test 
using a universal goniometer 
 
Figure 8.6: ULNT 1 testing 
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Data analysis 
8.4.1 Descriptive statistics  
All analyses were conducted using Excel (version 2010) and SPSS (versions 19). Participant 
characteristics were summarised using counts and percentages, means and standard 
deviations, medians, or minimum and maximum values, as appropriate. Symptom profiles of 
participants in the CWAD II group were summarised using reported cut-offs on NDI 
(Vernon 1996; Sterling et al., 2003), WDQ (Pinfold et al., 2004), IES (Kongstd et al., 2007) 
and SLANSS (Bennett, 2001).   
 
8.4.2 Factor analysis 
The literature review (Chapter 2) suggests associations between several of the sensory 
outcome measures. Exploratory factor analysis [EFA] was used to pull together sensory 
outcome measures that correlate highly to form a new relatively independent variable called 
a ‘factor’ (Field, 2000). EFA involved a series of steps: (1) estimate or extract the factors (2) 
decide how many factors to retain (3) rotate factors to an interpretable orientation and (4) 
obtain individual factor scores (Lorenzo-seva and Ferrando, 2006). Factors were first 
extracted using principal component analysis (Osborne and Costello, 2009). This method is 
predominantly reported in behavioural sciences research and is comparable to other methods 
for factor extraction (Velicer, 1988; Velicer and Jackson, 1990). Identified factors that were 
associated with eigen values ≥1.0 were considered important using Kaiser’s rule (Kaiser 
1960). This value is widely accepted to represent a substantial amount of variation explained 
by extracted factors (Osborne and Costello, 2009). A scree plot or graph of the eigen values, 
show a natural bend or break point in the curve (Eigen = 1), used to make decisions about 
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factors that are retained (Osborne and Costello, 2009). Factors above the bend were retained 
and then rotated using varimax (method to align factors), so that loadings [correlation of the 
original measure with a factor] of sensory outcome measures are maximised to the factors to 
which they relate most (Osborne and Costello, 2009). Reliability and interpretation of factors 
is hypothesised to depend largely on the weightings of the loadings as well as the sample size 
(Field, 2000). However, clear cut-offs for loadings in relation to sample size are arbitrary and 
inconclusive (Osborne and Costello, 2009). Stevens (1992) recommended that only factor 
loadings with an absolute value ≥ 0.4 [explaining 16% of the variance] should be interpreted. 
Guadagnoli and Velicer (1988) however suggested that factors with four or more loadings 
greater than 0.6 are reliable, regardless of the sample size. Field (2000) recommended 
loading cut-off ≥ 0.5 for a sample size (n=54) was adopted to retain and interpret generated 
factors in the analysis. Retained factors yielded scores for each participant [factor scores] 
that was entered into the logistic regression analysis to assess sensory discrimination of 
CWAD II from a healthy group. 
 
8.4.3 Logistic Regression 
A logistic regression was conducted to predict “participant group” using factors scores that 
were generated from the factor analysis (Rietveld & Van Hout 1993; Portney and Watkins 
2000). Logistic regression was developed to allow prediction of dichotomous category 
membership [dependent variables of presence or absence of CWAD] from continuous 
independent variables [sensory outcome measures]. This method has been used in studies 
that have investigated sensory impairment discrimination of CWAD II from healthy 
participants (Scott et al., 2005; Elliot et al., 2008; Chien and Sterling 2010). Peduzzi et al 
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(1996) and Steyerberg et al (2001) recommended a sample size of at least ten events per 
variable. A criterion probability cut-off value of 0.5 was set, above which a participant factor 
score was assigned to the CWAD II group (Kinnear and Gray 2004). Factor scores were first 
entered into the regression using forward stepwise (likelihood ratio) and then backward 
stepwise (LR) methods and the results were compared for plausible differences in variance 
accounted for by the model (Kinnear and Gray 2004). To assist interpretation of the logistic 
regression analysis, statistics of (a) Barletts test of sphericity and Kaisers measure of 
sampling adequacy  [indicative of reliability of correlations] (b) β, Wald and p-value wer 
used to assess statistical significance of each factor at a significance level of 5% (Tabachnick 
and Fidell 2001).  
  
8.5 Results 
8.5.1 Description of physical characteristics of CWAD II and healthy individuals 
Data was analysed for all 22 CWAD II participants; summary statistics are presented in 
Table 8.1. The mean (SD) age was 25.5 (7.4) years. The majority of whiplash injuries 
occurred from road traffic accidents (n=21), with duration of injury ranging from 9 months 
to 14 years.  Fourteen participants had sought treatment comprising examination by a 
General Practitioner or Accident and Emergency medical officer, 9 had attended 
physiotherapy, and 6 have never sought treatment since their injury. Reported distribution of 
pain in the CWAD II group included localised pain being described over the neck [n=14], 
neck and shoulders [n=6], or neck and hands [n=2]. None described symptoms over remote 
areas, such as the legs. There were n=32 healthy individuals, 20 females aged (SD) = 20 (62) 
years. 
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Table 8.1: Characteristics of study participants (n=54), by Group 
 
CWAD II  group 
(n =22) 
Healthy group 
(n = 32) 
Demographics   
Gender [Female]: n (%) 19 (86) 20 (62) 
Age [years]: mean (SD) 25.5 (7.4) 21.4 (6.0) 
Clinical    
Duration of Injury [years]: (Minm to Maxm)                      0.75 to 14 
- 
Distribution of symptoms: n (%)                    
 - 
Neck 12 (54) 
 
Neck and shoulder 6 (27) 
- 
Hands 2 ( 9) 
- 
Leg 0 (0) 
- 
Accessed Treatment before post injury: n (%)   - 
GP / A&E 14 (64)  
Physiotherapy 9 (41) - 
Chiropractor 2 (9) - 
Physiotherapy and Chiropractor 2 (9) - 
Cervical Collar 1 (5) - 
None 6 (27) - 
Symptoms on dominant side: n (%) 15 (68) - 
Social   
Compensation / claims: n (%) 9 (41) - 
Off work / Studying: n (%) 0 (0) - 
Footnote: A&E = Accident and Emergency; GP = General Practitioner; Maxm = Maximum; Minm = 
Minimum; SD = Standard deviation  
 
 
8.5.2 Pain, disability and psychological characteristics of CWAD II participants 
The CWAD II participants had scores ranging from 0 to 46 (median = 21) on NDI; 0 to 83 
(median = 16) on WDQ; 0 to 14 (median = 3) on SLANSS; 0 to 60 (median = 8) on IES.  
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Using cut-offs described in Section 8.1 – 8.2, six (27%) of participants had moderate or 
severe pain or disability (NDI or WDQ); two (9%) reported moderate or severe stress 
reactions (IES) and one (5%) showed signs of neurogenic pain (SLANSS) [Table 8.2]. This 
data indicated that a significant proportion of the CWAD II participants reported mild levels 
of pain, disability and psychological characteristics. This was consistent with none in the 
CWAD II group accessing treatment at the time of data collection. 
 
Table 8.2: Symptom profile of CWAD II participants (n=22) 
Symptom Profile 
CWAD II 
group 
n (%) 
Supporting Reference 
Features of pain and disability   
NDI  ≥ 30 / 100 [Moderate/Severe] 6 (27) (Vernon 1996; Sterling et al., 2003) 
WDQ  ≥  30 / 130  [Moderate/Severe] 6 (27) (Pinfold et al., 2004) 
Features of post-traumatic stress    
IES ≥ 26 /80 [Moderate/Severe stress reactions]  2 (9) (Kongstd et al., 2007) 
Features of Neurogenic Pain   
SLANNS ≥ 12 / 52 
[Presence of neurogenic type pain] 1 (5) 
(Bennett 2001) 
 
8.5.3 Factor analysis and logistic regression result 
Mean values for CPT were marginally higher for participants in the CWAD II group, at all 
three sites (Table 8.3). Mean values for PPT were higher at each site for healthy participants, 
as were the standard deviations (Table 8.3). Small inter-group differences were observed in 
mean VDT across the three sites between the groups of participants, for mean nerve 
movement during ULNT and for mean change in pain during ULNT (Table 8.3).   
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Table 8.3: Sensory outcome variables, by Group 
Sensory Outcome Variable CWAD II group 
Mean (SD) 
(n=22) 
Healthy group 
Mean (SD) 
(n=32) 
CPT  
  
Neck (0C) 17.37 (8.88) 14.05 (8.90) 
Thenar (0C) 17.58 (6.87) 14.33 (7.74) 
Tib. Anterior (0C) 14.75 (8.58) 11.92 (8.98) 
PPT   
Neck (N) 19.84 (8.59) 24.11 (11.07) 
Thenar (N) 35.25 (16.87) 45.50 (21.83) 
Tib. Anterior (N) 51.42 (24.23) 63.29 (33.36) 
VDT   
Neck (s) 11.09 (3.95) 12.06 (5.40) 
Thenar (s) 22.74 (8.78) 22.80 (7.29) 
Tib. Anterior (s) 12.83 (7.04) 10.55 (3.82) 
Nerve movement during ULNT (mm) 1.44 (0.76) 1.72 (0.71) 
Change in Pain during ULNT (VAS) 37.71 (36.76) 36.33 (21.97) 
Footnote: SD = standard deviation; Tib. = Tibialis; ULNT = Upper limb neurodynamic test; VAS = 
Visual analogue scale 
 
The factor analysis resulted in three factors associated with eigen values greater than 1.0 
(Figure 8.3), that jointly accounted for 64% of the variation associated with the data from the 
original 11 sensory outcome measures (Table 8.4). Using the highest loadings, from each of 
the 11 outcome measures, against each factor (Table 8.5) led to labelling the three 
components as Hyperalgesia (accounting for 35% of variation), Hypoesthesia (accounting 
for 16% of variation) and Hypersensitivity (accounting for 13 of the variation) (Table 8.5) 
based on previous reports in the CWAD literature (Scott et al., 2005; Elliot et al 2008; Chien 
and Sterling, 2010).  
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None of the three sensory components were statistically significant in the logistic regression 
(all p-values > .05 [Table 8.6]). On the basis of these data, group membership (CWAD II and 
Healthy participants) could not be predicted from these components.  Overall, 60% (12 out 
of 20) CWAD II participants were correctly identified and 81.5% (22 out of 27) healthy 
participants (Table 8.7) using the best fit logistic regression model. The 3 generated factors 
supported a sample of n=30 (10 events per variable) was adequate for the logistic regression 
analysis (Tabachnick and Fidell 2004).   
 
Figure 8.7\: Scree plot of Eigen values for factors generated from the factor analysis on 11 
sensory outcome measures  
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Table 8.4: Factor Analysis on 11 Sensory Outcome Measures (n= 47): Un-rotated and 
Rotated loadings [Data corruption of some sensory measures affected n=7]. 
 Un-rotated loadings  Rotated loadings 
Component Eigen 
value 
% 
Variance 
Cumulative % 
Variance 
 Eigen 
value 
%  
Variance 
Cumulative  
% Variance 
1 4.2 38 38  3.8 35 35 
2 1.6 14 52  1.7 16 52 
3 1.3 12 64  1.4 13 64 
4 0.95 9 73     
5 0.7 7 79     
6 0.7 6 86     
7 0.6 5 91     
8 0.4 4 94     
9 0.3 2 96     
10 0.2 2 99     
11 0.2 1 100     
 
 
Table 8.5: Interpreting the three main components; loadings against each sensory outcome in 
the rotated 3-factor model (n=47) 
Sensory Outcome variable 
Components from the factor 
analysis Clinical Features 
1 2 3 
Cold Pain Threshold    
Hyperalgesia 
Neck 
-0.71   
Thenar 
-0.80   
Tib. Anterior 
-0.82   
Pressure Pain Threshold    
Neck 0.77   
Thenar 0.85   
Tib. Anterior 0.77   
Vibration Detection Threshold    
 
Neck 
 0.69  
Hypoesthesia Thenar  0.72  
Tib. Anterior 
 0.53  
Nerve movement during 
ULNT    
-0.69 
Hypersensitivity 
Change in Pain during ULNT 
  
0.65 
Footnote: Tib. = Tibialis; ULNT = Upper limb neurodynamic test 
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Table 8.6: Results from the logistic regression of Group (CWAD II, Healthy) on the three 
sensory factors (hyperalgesia, hypoesthesia and hypersensitivity) 
 B S.E Wald df 
p-
value 
Exp (B) 
95% CI (Exp B) 
Lower Upper 
Hyperalgesia -0.54 0.34 2.48 1 0.12 0.59 0.30 1.14 
Hypoesthesia -0.03 0.32 0.01 1 0.94 0.98 0.52 1.83 
Hypersensitivity 0.55 0.36 2.32 1 0.13 1.7 0.86 3.51 
Constant -0.32 0.31 1.05 1 0.31 0.73   
Footnote: B= regression constant; CI = 95% Confidence interval; df = degree of freedom; p-value = 
level of statistical significance; SE: Standard Error ; WALD Statistics; Exp(B): Exponential of B 
 
 
Table 8.7: Classification of cases (CWAD II and Healthy participants) using the best fit 
logistic regression model 
 
 Predicted classification/Group  
Step 1  CWAD II    Healthy Percentage Correct 
Observed 
classification/ 
Group 
CWAD II  12 8 60.0  
Healthy 5 22 81.5 
Overall Percentage   72.3 
*Best fit model was achieved at step 1 using factors of Hyperalgesia, Hypoesthesia and 
Hypersensitivity   
 
8.6 Discussion 
The results demonstrated that sensory features of hyperalgesia, hypoesthesia and 
hypersensitivity were present in CWAD II participants [Figure 8.3], emphasising that 
different pain mechanisms exists in WAD. The presence of these features in CWAD was 
consistent with previous studies (Curatolo et al., 2001; Ide et al., 2001; Sterling et al., 2002a, 
2003a; Banic et al., 2004; Kasch et al., 2005; Greening et al., 2005). The features are 
hypothesised to reflect a sensitised nervous system from prolonged peripheral nociceptive 
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[peripheral sensitisation] input, as well as, a disordered central nervous system pain-
processing mechanism [central sensitisation] (Curatolo et al., 2001; Sterling et al., 2003a, 
2008, 2009; Banic et al., 2004; Kasch et al., 2005; Chien et al., 2009). Sensory 
hypersensitivity, hypoaesthesia and hypersensitivity were observed at two sites for the 
CWAD II participants in the neck (nerve root of C5/6) and hand (peripheral of C5/6) the 
remote site of the Tibialis anterior muscle. 
 
Some results however contrast with findings from previous WAD sensory discriminatory 
studies (Scott et al., 2005; Elliot et al., 2008; Chien and Sterling 2010). Differences in the 
symptom severity level of the study sample could have contributed to the contrasting 
finding. Scott et al (2005) did not collect data relating to their study participants self report of 
pain and disability or psychological impairment and therefore limits comparison of their 
findings to the present study. On the other hand, Elliot et al (2008) and Chien and Sterling 
(2010) recruited participants with pain and disability score NDI > 30 (moderate / severe] 
(Vernon 1996; Sterling et al., 2003). This is in contrast to the significant proportion of the 
present study participants [80%] (Figure 8.4) who reported NDI scores < 30 reflecting 
recovered / low disability levels (Vernon 1996; Sterling et al., 2003). The previous studies 
(Scott et al., 2005; Elliot et al., 2008; and Chien and Sterling, 2010) all recruited participants 
from a Primary Care Trust, in contrast to the convenience sample recruited from within a 
university community. These differences could have accounted for the low severity of the 
CWAD II participants in this study, and in turn the non-discrimination between the study 
groups. Similar findings of non-significant group differences, based on independent t-test 
statistical analysis, between their CWAD presenting as recovered / low disability and healthy 
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individuals Sterling et al (2003, 2004). However, this present study did not investigate group 
differences. It was unanticipated at the outset of the study that the majority of the recruited 
participants will present as low severity subgroup. 
 
This study additionally obtained data for pain and disability using the WDQ, a whiplash 
specific self-reported questionnaire (WDQ), IES that is reflective of PTSD and the S-
LANNS that interpreted neuropathic type pain. These questionnaires assisted interpretation 
of the symptom severity of the CWAD II participants beyond using only pain and disability 
or psychological characteristics (Scott et al., 2005; Elliot et al., 2008; Chien and Sterling 
2010). For example, the present study participants reported subclinical / mild levels of PTSD 
as well as absence of signs reflective of neuropathic pain that is associated with low NDI and 
WDQ scores and suggestive of low disability.  
 
These findings could also explain the non-significant discrimination of measurements 
between the two study groups. Sensory hyperalgesia, hypoaesthesia and hypersensitivity 
discrimination of CWAD II is largely moderated by severity levels of pain, disability as well 
as psychological impairments (Sterling, 2010), supported by previous reports that these 
impairments co-exist with and contribute to modulate sensory manifestations in CWAD 
(Rhudy and Meagher 2000; Sterling and Kenardy 2005; Sterling et al., 2008; Bossman et al., 
2011). The implication is that different mechanisms exists and interact in CWAD II and their 
consideration during assessment and management of the condition in a clinical setting is 
warranted.  
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Previous CWAD discriminative studies (Scott et al., 2005; Elliot et al., 2008; Chien and 
Sterling 2010) did not include ULNT 1amongst their sensory tests. The present study 
included the ULNT 1 but did not show benefit of the test for CWAD II participants reporting 
low pain, disability, as well as mild psychological impairment. No conclusion can be drawn 
regarding the use of ULNT 1 test for CWAD II patients presenting with moderate to severe 
levels of pain, disability and psychological factors, and this needs to be investigated through 
future sensory studies. 
 
8.7 Chapter conclusions 
The results demonstrated that although sensory features of hyperalgesia, hypoesthesia and 
hypersensitivity are present in CWAD II, these sensory impairments lack the capacity to 
discriminate between low severity CWAD II participants and healthy individuals. It also 
demonstrated that sensory tests used in the study lack the capacity to discriminate a low 
severity CWAD II subgroup. Further evaluation of CWAD II patients presenting with higher 
levels of pain and disability as well psychological factors is warranted using both QST and 
ULNT. In addition, further evaluation of discriminative capacity of additional sensory tests 
for the low severity group is warranted, as they emerge in the evolving body of knowledge of 
CWAD II. Furthermore, a range of other impairments, pain, disability and psychological 
factors exists in a low severity CWAD II subgroup that merit consideration during 
assessment of patients, and this approach fits well with the widely advocated 
biopsychosocial model. 
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Chapter 9 
Discussion 
 
9.1 Background to the study (Chapters 1 and 2 of thesis) 
CWAD is an example of a chronic pain condition that can affect an individual’s quality of 
life and earning (Breivik et al., 2006, 2008).The cost of managing the condition can be 
considerable, with  lost hours due to work absences being significant (Spitzer et al., 1995; 
Provinciali et al., 1999). The incidence and impact of WAD is increasing (Provinciali et al., 
1996; Borchgrevink et al., 1998; Rosenfeld et al., 2000, 2003), largely due to poor 
understanding of the mechanisms responsible for chronicity of the condition (Panjabi et al., 
1998; Jull et al., 2007). Consequently, current management methods provide only marginal 
benefit for reducing the incidence of CWAD (Jull et al., 2007; Stewart et al., 2007). Research 
over the last decade has focused on impairments in CWAD to assist understanding of the 
predominant mechanisms in the condition to guide assessment and management decisions 
(Sterling et al., 2011).   
 
WAD has been described as a complex and heterogeneous condition, because of the range of 
impairments presenting in the condition (Sterling 2009). Impairments include motor 
[movement loss, altered muscle recruitment patterns] (Heikkila & Wenngren 1998; 
Dall’Alba et al., 2001; Nederhand et al., 2002; Sterling et al., 2002, 2004; Jull et al., 2004), 
sensory hypersensitivity and hypoaesthesia (Curatolo et al., 2001; Moog et al., 2001; Sterling 
et al., 2003a, 2004, 2006, 2007, 2008; Raak & Wallin 2006, 2008; Chien et al., 2009) and 
psychological factors (Williamson et al., 2008). Motor dysfunction of loss of cervical 
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movement, is not present in CWAD (Kasch et al., 2001), neither does it provide predictive 
capacity of poor recovery post whiplash injury (Sterling et al., 2005). This is supported by 
treatment targeting motor dysfunction yielding marginal effects on patients’ self reported 
pain and disability levels (Jull et al., 2007; Stewart et al., 2007). Evidence suggests that 
psychological factors are associated with reported levels of pain and disability (Rhudy and 
Meagher 2000), although data from Wenzel et al (2002) only found the association in 
participants reporting persistent pain and disability, and not in those who recovered. This 
suggests that symptom persistence could be the overriding trigger for psychological factors 
(Sterling 2010). Evidence therefore suggests that other mechanisms are responsible for the 
persistence of symptoms in WAD.  
 
Recent evidence suggests that some of the sensory impairments indicate an underlying 
augmented or disinhibited nervous system (Sterling 2009), a finding that is gaining support 
as a plausible trigger for symptom persistence in CWAD (Sterling, 2010). Sensory 
impairments are not, however, peculiar to CWAD, as they have also been identified in 
chronic diffuse upper limb pain (Jensen et al., 2007b), patellofemoral pain (Tucker et al., 
2007), fibromyalgia, tension-type headache and migraine (Yunus, 2007). An important 
finding across recent WAD studies (Scott et al., 2005; Elliott et al., 2008; Chien and Sterling 
2010) is that sensory hypersensitivity and hypoaesthesia can discriminate CWAD from INP. 
The findings are however inconclusive, due to conflicting results across the sensory 
discriminative studies (Chapters 2 and 8). In addition, all the sensory discriminative studies 
omitted the ULNT, a sensory test commonly used in clinical practice. Also, supportive 
evidence for using ULNT to assess CWAD is implied from other samples but its ability to 
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discriminate between CWAD and other musculoskeletal neck pain conditions has not been 
verified. This finding plausibly underpins divergent opinions regarding clinical usefulness of 
ULNT in chronic pain conditions as CWAD (Greening et al., 2008). Evaluation of sensory 
impairments to discriminate CWAD using both QST and ULNT was warranted.  
 
However, evidence in regards of validity of ULNT is incomplete due to lack of nerve 
movement data; an important theorized construct for the test (Coppieters et al., 2009). 
Further evaluation of the validity of ULNT in CWAD was therefore required. With recent 
advance in medical imaging, in-vivo nerve movement data can be obtained using DUI in 
order to validate the constructs underlying the test. However, confidence in DUI estimate of 
nerve is weak due to conflicting estimates of nerve movement within the same [NSAP] and 
symptom-related [WAD / NSAP] patient samples (Greening et al., 2001; Greening et al., 
2005; Erel et al., 2003; Hough et al., 2007; Greening et al., 2005; Dilley et al., 2007) 
necessitating a consideration of the evidence for reliability and validity of DUI.  
 
Reliability studies for DUI are also sparse (Hough et al., 2000; Greening et al., 2001; Dilley 
et al., 2001; Erel et al., 2003; Ellis et al., 2008; Coppieters et al., 2009), particularly in a 
patient  sample (Greening et al., 2001; Erel et al., 2003). Findings from published studies are 
largely inconclusive due to small study sizes and the use of inappropriate statistics. 
Evaluation of inter-rater reliability of DUI in a CWAD II sample was therefore required first 
as an important component of the thesis. Inter-rater reliability design provided a higher level 
of evidence in comparison to intra-rater design (Haas 1991). 
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9.2 Inter-rater reliability of DUI for median and ulnar nerve movement in a CWAD II 
population (Chapter 3) 
This Chapter investigated inter-rater reliability of DUI measurements of median and ulnar 
nerve transverse and LM in CWAD II using 3 raters. Fair inter-rater reliability [ICC=0.4] 
(Coppieters et al., 2009) was returned for median nerve movement, indicating its potential 
for further improvement. All TM of median as well as TM and LM for the ulnar nerve 
returned poor [ICC<0.4] inter-rater reliability estimates (Coppieters et al., 2009). The results 
were in contrast to high reliability reported for DUI (Hough et al., 2000; Dilley et al., 2001; 
Greening et al., 2001; Erel et al., 2003; Ellis et al., 2008; Coppieters et al., 2009). Notably, 
reliability estimates by Greening et al (2001) [median nerve TM in NSAP] and Erel et al 
(2003) [median nerve LM in carpal tunnel syndrome] were directly comparable with the 
results as both studies involved patient samples presenting with symptoms as CWAD 
(Greening et al., 2005). However both studies were limited by their low sample size [n=4] 
and use of within-participant standard deviation, rather than the ICC, the recommended 
statistic for interpreting reliability (Bland and Altman 1996; Eliasziw et al., 1998). The 
CWAD II inter-rater reliability had addressed methodological limitations of previous 
reliability studies in other to improve internal validity and provide a higher quality of 
evidence for DUI reliability. It also involved physiotherapists as raters, in order to 
demonstrate external validity and clinical applicability of its findings.  
 
Despite the rigour of the study methods (Chapter 3), results of low reliability for DUI 
indicate that the technique is associated with potential sources of measurement error that 
were not reported in the literature at the time of conducting the study. However, in recent 
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DUI publications, it is now acknowledged that such error does exist (Ellis et al., 2008; and 
Korstanje et al., 2010). Measurement issues relating to DUI image capture e.g. slight 
angulations and excessive pressure and movement of the DUI transducer have been 
advanced as affecting quality of DUI images, and the quality issues compromise nerve 
movement estimates as well as reliability of the technique (Kristjansson 2004; Ellis et al., 
2008). Although advanced, these issues have not been investigated in any DUI study to date. 
Findings from the inter-rater reliability study corroborate such measurement issues during 
DUI image capture. Although training was provided to the raters prior to DUI image capture, 
it can be hypothesised from the results that rater experience influenced their dexterity in 
providing high quality DUI images, and supports DUI being described as an operator –
dependent technique (Martinoli, 2000).  
 
Apart from error arising from DUI image capture, Ellis et al (2008) also proposed that erro 
can be introduced during DUI image analysis. Supportive evidence for this claim has been 
provided for Doppler Ultrasound by Hough et al (2000) finding of a 2-5% over estimation of 
nerve movement using the Doppler image analysis technique. The error was attributed to 
inconsistent placement of image markers due to poor visual discrimination of nerve borders 
(Ellis et al., 2008), though this is not supported by evidence. The effect of the error on nerve 
estimates and reliability has not been verified. Other aspects of nerve image analysis such as 
method used to track DUI transducer motion during image capture as well as size of the 
frame interval have been hypothesised as contributing to poor reliability of DUI (Korstanje 
et al., 2011). A further evaluation of the DUI image capture and image analysis component 
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was therefore warranted to investigate potential sources of error in the technique. This 
informed re-analysis of DUI nerve images in Chapter 4 and 5. 
 
9.3 Further analysis of nerve images focused to measurement error within DUI image 
capture and image analysis (Chapter 4) 
Limited evidence investigating measurement error within DUI image capture and image 
analysis necessitated further re-analysis of DUI images. The methods adopted were: (a) 1 
researcher analysed each of 3 physiotherapists acquired n=18 median nerve LM images to 
investigate error arising from DUI image capture and (b) 3 researchers’ analysed n=18 
median nerve LM images to investigate error arising from DUI image analysis. The re-
analysis method assisted interpretation of issues contributing to the poor reliability (Chapter 
3). The analysis returned poor reliability for inter-image capture and inter-image analysis for 
all transverse and ulnar nerve LM [ICC<0.4] (Coppieters et al., 2009), indicating that error 
were associated with both DUI image capture and image analysis. In contrast, reliability for 
inter-image capture and inter-image analysis for median nerve LM was fair [ICC=0.4] and 
good [ICC = 0.7] respectively (Coppieters et al., 2009), indicating a potential for further 
evaluation of its reliability. The analysis established presence of measurement error within 
DUI technique of image capture and image analysis that more recent DUI studies 
corroborate (Korstanje et al., 2010). The image capture issues are easily addressable through 
involving an experienced DUI operator (Ellis et al., 2008). However, potential error within 
DUI image analysis such as (a) inconsistent and inappropriate sizes and placement of image 
markers (due to deformations and tracking local of artefact), (b) speckle tracking moving 
out-of-plane, (c) precision of the correlation algorithm to process very small frame-to-frame 
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displacements (quantization error), (d) inappropriate frame intervals, and (e) consistency and 
clarity of speckle features (f) background tissue used to track transducer movement (Ellis et 
al., 2008; Korstanje et al., 2009, 2010, Chapter 3) merit attention as strategies suggested to 
address the sources of error, including use of (a) nerve image analysis template [Figure 3.3], 
(b) larger joint motion, and involving an (c) experienced DUI operator have not addressed 
error arising from stationery subcutaneous or background tissue used to track transducer 
movement during LM image analysis. This component of nerve image analysis is important 
considering its potential to inflate or underestimate LM, when subtracted from nerve 
estimates, a hypothesis that warrant investigating. 
 
Interestingly, bone is accepted and used, despite absence of evidence to support the practice. 
The use of superficial fascia is supported within the DUI literature, although the evidence is 
limited by its small sample size [n=4] (Dilley et al., 2001). Conflicting nerve results, existing 
limited evidence for superficial fascia, and no evidence for bone tissue warranted a further 
re-analysis of nerve images to assess background tissue [bone and superficial fascia] that 
provide reliable estimates of nerve movement (Sim and Wright 2000) as well as construct 
validity of using both tissue to track a fixed DUI transducer (Dilley et al., 2001).  
 
9.4 Further nerve image analysis focused to bone and superficial fascia as DUI 
background tissue (Chapter 5) 
Chapter 5 investigated the effects of different background tissue [bone and superficial facia 
used as fixed reference to track DUI transducer motion] on reliability of estimates of median 
nerve movement as well as construct validity of using both tissues to track a fixed DUI 
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transducer. The reliability component was evaluated using inter-image capture reliability 
where 1 researcher analysed each of 3 physiotherapists acquired n=18 median nerve LM, 
comparing bone and superficial fascia as background tissue. The construct validity 
component was assessed by frame by frame analysis of median nerve images to compare 
computed motion of DUI motion from bone and superficial fascia against a fixed DUI 
transducer [motion = 0.0mm], where 1 physiotherapist analysed 22 median nerve LM 
images. Results for the inter-image capture reliability component showed that superficial 
fascia demonstrated good reliability [ICC2,1 = 0.7; 95% CI = 0.4 to 0.84] and higher nerve 
movement estimates [0.9mm, SEM = 0.37mm] in contrast with fair reliability [ICC2,1 = 0.4; 
95% CI = 0.15 to 0.71] and lower nerve movement estimate for bone [0.72mm, SEM = 
0.35mm]. Unlike Dilley et al (2001) that investigated superficial fascia, the present study if 
the first to compare reliability of estimates of nerve movement using bone and superficial 
fascia as background tissue. It is also the first time superficial fascia is reported as 
background tissue in a DUI reliability study. For the construct validity component, frame-by-
frame analysis showed that superficial fascia returned zero cumulative movement in 
comparison to bone (Figure 5.2). The finding agrees with, but provides higher quality 
supportive evidence for superficial fascia than Dilley et al (2001).  
 
Summary of further analysis of data (Chapter 4 and 5) 
Chapters 4 and 5 evaluated sources of error within DUI image capture and image analysis 
components to inform strategies to address the identified error, so as to improve reliability of 
DUI technique, particularly for median nerve LM in CWAD II. Strategies such as single 
operator design (Ellis et al., 2008), use of large joint motion (Dilley et al., 2001; Korstanje et 
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al., 2010), use of image analysis template (Chapter 3), as well as using superficial fascia as 
comparative background tissue have been hypothesised to improve reliability of the 
technique. However, the effect of the strategies to improve reliability estimates of DUI has 
not been investigated. This informed design of an intra-rater reliability study to reflect the 
strategies (Chapter 6).  
 
9.5 Intra-rater reliability of dynamic ultrasound imaging method of computing median 
nerve movement in CWAD II (Chapter 6) 
 
Chapter 6 evaluated intra-rater reliability of DUI estimates of median nerve LM obtained at 
the mid-forearm during elbow extension in CWAD II. The results showed excellent intra-
rater reliability [ICC=0.8; 95% CI = 0.6 to 0.9] (Coppieters et al., 2009). The ICC was 
associated with low error and variability [nerve movement = 2.60mm; SEM = 0.86; CV = 
7%] (Reed et al., 2002; Tighe et al., 2010). This is the first study to report DUI reliability in 
CWAD II and the results provide a higher quality of DUI evidence that relate to both 
components of image capture and image analysis. This in contrast to Coppieters et al (2009) 
report of high inter-image capture reliability for median nerve [n=10]. Their small sample 
size fell below that recommended [n=13] by Eliasziw et al (1998). This study’s intra-rater 
reliability sample size [n=22] and focus to physiotherapists and CWAD participants 
increases it’s internal and external validity and therefore increases confidence in the study’s 
conclusions. The evidence supported the use of DUI to estimate median nerve LM during 
elbow extension in CWAD II, and provided LM data to validate the ULNT. This informed 
the use of DUI to validate constructs underpinning the ULNT 1 test.   
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9.6 Construct validity of upper limb neurodynamic test 1 in CWAD II (Chapter 7) 
The evidence to support theorised constructs that underpin the ULNT is sparse in humans 
and limited because in-vivo nerve movement data, an important construct underpinning the 
test has not been investigated (Greening et al., 2005; Shacklock 2005; Nee and Butler 2006). 
Chapter 7 investigated validity of theorised constructs underpinning ULNT 1 by evaluating 
association between nerve movement, elbow extension ROM, Brachialis muscle activity and 
pain response during the test. The results showed a statistically significant, strong positive 
association between elbow extension ROM and nerve movement (r=0.6) (Cohen 1998), and 
for pain score and nerve movement (r=0.7) (Cohen 1998). This is consistent with previous 
ULNT 1 cross sectional studies in CWAD that found elevated levels of pain perception to be 
associated with decreased elbow ROM (Sterling et al., 2002); and reduced median nerve LM 
(Greening et al., 2005). The findings are also consistent with previous cadaver and human 
ULNT validity studies (Kleinrensink et al., 1994, 1995, 2000; Shacklock 1996; Wright et al., 
1996; Lewis et al., 1998; Daborn et al., 2000; Coppieters et al., 2001; Jaberzadeh et al., 2001; 
Byl et al., 2002; Coppieters and Butler 2008), although this validity study investigated nerve 
movement alongside other constructs that was not investigated in previous studies. The 
results support clinician’s use of measures of pain perception and elbow ROM to interpret 
the test (Shacklock 2005). The results also showed, for the first time, that DUI nerve 
movement data can add to constructs used to interpret ULNT 1 test.  
 
The mechanism underpinning response of pain and decreased elbow extension ROM during 
the application of ULNT 1 is suggested to occur following altered nerve mobility and 
mechanical irritation due to compressive, tensile, friction or vibration forces acting near 
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anatomically narrow tissue spaces through which the nerve passes (Takahashi et al., 2003; 
Murata et al., 2005; Shacklock, 2005). It is proposed that the forces compromise intraneural 
circulation and axoplasmic flow, leading to inflammatory response and sensitivity in dorsal 
root ganglion and nerve trunks to mechanical stimuli (Hall and Elvey 1997; Kobayashi et al., 
2000; Parke and Whalen 2002; Watkins and Maier 2004). The injured nerve segment and 
DRG may develop into abnormal impulse generating sites producing symptoms of increased 
pain and signs of mechanosensitivity when stress is applied to it (Devor and Seltzer 1999). 
This could explain association between pain, median nerve movement and elbow extension 
ROM in the ULNT construct validity study.  
 
There was a non-significant weak, positive association between brachialis muscle activity 
and measures of pain (r=0.1), median nerve LM (r=0.2), and elbow extension ROM (r=0.1) 
(Cohen 1998). This contrast previous studies that have showed association between 
increased motor response and elevated levels of pain (Jaberzadeh et al., 2001, 2005), and 
decreased elbow ROM (Wright et al., 1994; Hall and Quintner 1996; Balster and Jull 1997; 
Elvey 1997; Hall and Elvey 1997; Jaberzadeh et al., 2001, 2005). The evidence regarding 
flexor muscle activity during ULNT is inconclusive. Whereas Jaberzadeh et al (2001, 2005) 
and Van der Heide et al (2001) have showed association between pain, elbow ROM and 
muscle activity during ULNT in healthy participants, work by Balster and Jull (1997) for 
ULNT and Boyd et al (2009) using the straight leg raise testing, both in healthy participants, 
have found no association between the constructs of muscle activity and elevated levels of 
pain.  
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Jaberzadeh et al (2001) found a positive association between pain and passive elbow 
resistive torque of shoulder and arm muscles at periods of pain onset and pain limit in 10 
healthy. The authors also found in 26 healthy, positive association between elbow ROM and 
elbow flexor resistive torque of 10 shoulder and arm muscles at movement onset, pain onset 
and pain limit (Jaberzadeh et al., 2005). Van der Heide et al (2001) reported similar 
association between onset of pain and muscle activity for ULNT in healthy participants. 
 
Differences of study sample and methods could be responsible for the conflicting findings. 
Whereas Jaberzadeh et al (2001) involved healthy participants, the present construct validity 
study involved a patient sample in other to reflect patient sample that the test is used for 
(Shacklock 2005). The method also ensures direct application of findings to clinical practice. 
Additionally, muscle activation in Jaberzadeh et al (2005) was captured at 3 time points 
(movement onset, pain onset, and pain limit), whereas the present study captured brachialis 
muscle activity through the range of elbow extension. As discussed in Chapter 7, this method 
was not adopted due to limitations of DUI image analysis to synchronise with these points. 
Brachialis muscle activity was therefore analysed from movement onset through to pain or 
movement limit [P2 or R2], consistent with the nerve movement data analysis. The ULNT 
construct validity findings of no association between muscle activity and pain level at pain 
onset and pain limit agree with previous ULNT study (Balster and Jull 1997). This study 
conclusion agree with findings from the present.  
 
Overall, this study supports previous work regarding validity of ULNT. However, nerve 
movement data included in the present study, particularly in a symptomatic population, 
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CWAD II has added to existing ULNT validity evidence. In addition, this is the first ULNT 
validity study to be conducted in CWAD, using physiotherapists. This increases external 
validity of the study, and increases confidence in translating the findings into a clinical 
setting. Overall, this study has demonstrated that 3 [pain perception, elbow ROM, nerve 
movement] out of the 4 [flexor muscle activity] constructs that underpin ULNT demonstrate 
construct validity. The merits for including the ULNT amongst sensory test to be used for 
sensory discrimination of CWAD II participants have been argued (Chapter 2). As construct 
validity of ULNT has now been established in CWAD II (Chapter 7), its inclusion based on 
criteria of measurement properties is justified. This informed design of a study to evaluate 
sensory discrimination of CWAD II using QST and ULNT (Chapter 8). 
 
9.7 Sensory hyperalgesia, hypersensitivity and hypoaesthesia discrimination of CWAD 
II from healthy individuals (Chapter 8) 
The evidence for sensory impairments that discriminate CWAD using QST is inconsistent 
and weak due to a focus to the female gender and use of a limited range of sensory tests that 
excludes the ULNT. This sensory discrimination study evaluated capacity of sensory 
impairments of hyperalgesia, hypersensitivity and hypoaesthesia to discriminate CWAD II 
participants from healthy individuals using ULNT 1 and QST. The results showed that 
sensory features of hyperalgesia, hypoesthesia and hypersensitivity were present in CWAD 
II, emphasising that different mechanism operate in WAD; and supports previous 
descriptions of WAD as a heterogeneous condition. The presence of these features in CWAD 
II is consistent with previous studies (Curatolo et al., 2001; Ide et al., 2001; Sterling et al., 
2002, 2003a; Banic et al., 2004; Kasch et al., 2005; Greening et al., 2005). These features are 
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suggested to be indicative of a disordered and sensitised nervous system as a result of 
prolonged peripheral nociceptive [peripheral sensitisation] input as well as altered central 
nervous system pain-processing mechanism [central sensitisation] (Curatolo et al., 2001; 
Sterling et al., 2003a, 2008, 2009; Banic et al., 2004; Kasch et al., 2005; Chien et al., 2009). 
In this study, sensory hypersensitivity, hypoaesthesia and hypersensitivity were found over 
local areas of the neck (nerve root of C5/6), hand (peripheral input of C5/6) and leg (remote 
area) reflecting involvement of peripheral and central mechanisms (Coderre et al., 1993; Li 
et al., 1999; Kidd and Urban 2001; Graven-Nielsen and Arendt-Nielsen 2002; Staud and 
Smitherman 2002; Carpenter and Dickenson 2005).  
 
The study findings of non-discrimination of CWAD II, however contrast with previous 
reports indicating that sensory impairments discriminate CWAD from other neck pain and 
healthy individuals (Scott et al., 2005; Elliot et al., 2008; Chien and Sterling 2010). 
Differences in levels of symptom severity between the present study and previous 
discrimination studies might have contributed to the contrasting findings. Scott et al (2005) 
for example, did not collect data relating to their study participants pain and disability or 
psychological factors levels, unlike the present study. The lack of data in this regard for their 
study sample limits comparison of participants’ symptom profile as well as findings across 
the 2 studies. Data from Elliot et al (2008) and Chien and Sterling (2010) showed that their 
participants reported pain and disability scores of NDI > 30 reflecting moderate / severe 
levels of disability (Vernon 1996; Sterling et al., 2003). In comparison, 90% participants in 
this study reported NDI scores < 30 reflecting recovered / low disability levels (Vernon 
1996; Sterling et al., 2003). Additionally, study participants reported in (Scott et al., 2005; 
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Elliot et al., 2008; Chien and Sterling, 2010) was recruited from a Primary Care Trust, unlike 
the present study that recruited a convenience sample within a university community. This 
method of recruitment could have accounted for the low severity symptom profile reported 
in the present study. The existing sensory discrimination evidence (Scott et al., 2005; Elliot 
et al., 2008; Chien and Sterling 2009) showed that local and generalised hypersensitivity and 
hypoaesthesia to mechanical stimuli, and hyperalgesia to mechanical and cold stimuli 
discriminated CWAD presenting with persistent moderate/severe symptoms [NDI ≥30/100]. 
Sensory discrimination of CWAD patients presenting with mild to moderate symptoms [NDI 
= 10 to 28/100] has not been investigated or previously reported. Findings in the present 
study have demonstrated that sensory impairments of hyperalgesia, hypersensitivity, 
hypoaesthesia, although present in this low severity subgroup, lack the capacity to 
discriminate CWAD II from healthy individuals.  Similar findings in a recently published, 
secondary data re-analysis (Verhagen et al., 2011) found that pain, functional limitation and 
recovery were not discriminative of CWAD presenting with mild to moderate symptoms 
[n=133] and other neck pain conditions [n=671]. Their conclusions query consideration of 
the low severity CWAD subgroup as a distinct clinical cluster when accessing or managing 
patients.    
 
It is important to note that unlike previous studies (Scott et al., 2005; Elliot et al., 2008; 
Chien and Sterling 2010), this study captured additional data of pain and disability [WDQ], 
PTSD that is reflective of post traumatic stress [IES] and the S-LANNS that interprets 
neuropathic type pain. These questionnaires provided the additional advantage of assisting 
interpretation of the results by providing further information on the biopsychosocial 
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components of the CWAD II participants, illustrating the importance of these impairments 
for understanding CWAD and the significance of the biopsychosocial model adopted by the 
WHO ICF (Bossman et al., 2011). The model recognises whiplash injury can cause minor 
tissue damage that can lead to impairments of physical and psychological functioning as well 
as disability and participation problems in work and other activities (Scholten-Peeters et al., 
2002). The biopsychosocial model has been suggested as important to understand the 
development of CWAD (Malt and Sundet 2002; Richter et al., 2004). The study participants 
reported subclinical / mild levels of PTSD as well as absence of signs reflective of 
neuropathic pain. Their reported levels for both characteristics corroborates with their NDI 
and WDQ scores, indicative of low levels of disability.  
 
Previous WAD discriminative studies (Scott et al., 2005; Elliot et al., 2008; Chien and 
Sterling 2010) did not include ULNT, an important sensory test, widely used by 
physiotherapist for assessing WAD.  An aim of the present study was to evaluate the 
discriminative capacity of ULNT in CWAD so that the use of the test could be evaluated. 
The study did not demonstrate discriminative capacity of ULNT for the CWAD II 
participants, plausibly due to the reasons advanced above regarding severity of the 
population.   
 
9.8 Limitation of study 
The key limitation of the study relates to the low severity CWAD II participants it accessed, 
although this was not anticipated at the onset. The profile of the CWAD II participants 
impacted on preliminary work on inter-rater reliability of DUI as well as the overall sensory 
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discrimination study. However, areas to progress different components (studies) of the thesis 
have already been identified in the individual Chapters, but key ones have been summarised 
as recommendations.   
 
9.9 Recommendations for future studies 
I. Further evaluation of CWAD II patients presenting with higher levels of pain, disability 
and psychological impairments using both QST and ULNT.  
II. Further evaluation of the discriminative capacity of additional sensory tests for the low 
severity CWAD II population is also warranted. 
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Chapter 10 
Conclusion 
 
The preliminary studies undertaken found good inter-rater reliability and construct validity 
for superficial facia used to track transducer during DUI image analysis, good intra-rater 
reliability of DUI measurement of median nerve LM, supportive evidence for construct 
validity of the ULNT 1. The use of both QST and ULNT to assess CWAD II was evidenced 
from the literature review of the thesis. The sensory features of hyperalgesia, hypoesthesia 
and hypersensitivity, although existing in CWAD II, did not discriminate low severity 
CWAD II participants from healthy individuals. The present study found that although 
sensory features of hyperalgesia, hypoesthesia and hypersensitivity exists in low severity 
CWAD II participants, the presence of other mechanisms such as psychological factors, pain 
and disability, moderate their capacity to discriminate the condition from healthy individuals. 
The implication is that whereas sensory impairments are widely accepted as reflective of 
predominant central mechanisms operative in CWAD II, they do not dictate the symptom 
profile in the condition alone, as other mechanisms also contribute. This is supported by the 
biopsychosocial approach adopted by WHO ICF framework, used to evaluate impact of 
disease on health and functioning. The thesis therefore emphasised the importance of 
different mechanisms in CWAD II that should be considered when addressing a low severity 
CWAD II population. The findings in the present study have important implications for 
clinical assessment of a low severity CWAD II population, and for future research.  
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THE UNIVERSITY OF BIRMINGHAM 
SCHOOL OF SPORT AND EXERCISE SCIENCES 
M E M O R A N D U M 
 
 
 
FROM:  Members of the Ethics Sub Committee  
TO:       Dr. Alison Rushton 
   Chris Wright 
   Dr. Martin Lakie 
   Edeni Kennedy 
          
     
DATE: 12.8.08 
 
LE 08/20 An evaluation of the physical characteristics in subjects who have 
previously experienced a whiplash injury 
 
  
The Ethics Sub-Committee is happy to approve this proposal.   
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School of Sport and Exercise Sciences 
 
MEMORANDUM 
 
 
To: Dr. Alison Rushton, Dr. Martin Lakie, Chris Wright, Edeni Kennedy 
From: Professor Douglas Carroll 
Tel: 47240 
Date: 10.10.08 
 
Amendment to 08/20 – An evaluation of the physical characteristics in subjects who 
have previously experience a whiplash injury 
 
I am happy to take chairs action and approve the amendment/extension to the above protocol. 
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THE UNIVERSITY OF BIRMINGHAM 
SCHOOL OF SPORT AND EXERCISE SCIENCES 
M E M O R A N D U M 
 
 
 
FROM  Professor D Carroll   
TO:  Dr. Alison Rushton 
  Dr. Martin Lakie 
  Edeni Kennedy 
 
 
  
   
DATE: 11.8.09  
 
 
LE 08/20 An evaluation of sensory and physical characteristics in subjects who have 
previously experienced a whiplash injury 
 
I am happy to take chairs action and approve the further extension/modifications to the above 
proposal. 
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APPENDIX A: HEALTH SCREENING QUESTIONNAIRE 
IDENTIFICATION NUMBER: ____________________________ 
SURNAME: ____________________________________________ 
FIRST NAME: __________________________________________ 
AGE: ___YEARS  GENDER: MALE / FEMALE (PLEASE CIRCLE) 
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APPENDIX 1: HEALTH SCREENING 
QUESTIONNAIRE 
 
The following information is required before you are able to partake in this study. If you 
answer positive to any of the following questions, it is important that you make this known 
to the researcher. Please take your time to read all questions and answer honestly. If you do 
not understand a question or need further clarification with a particular question please ask. 
 
Thank you for agreeing to be a participant in this study. You are vital to our research project 
and we appreciate you giving up your time to participate. An appointment has been made for 
you to register for the study at the Health Sciences Labs. A map of the campus is included in 
this pack. If you are unable to attend for any reason please let us know by contacting us as 
soon as possible. You will have the chance to ask any further questions before you are 
registered into the study. Please complete the questions below prior to attending for 
registration. All answers will be kept strictly confidential. If there are any sections you are 
not sure how to answer, leave that question blank and inform the person who registers you at 
your appointment. 
 
Section 1: Your Details 
 
Identification number: ________________________________________ 
Please answer the following questions relating to your health (please circle). 
1. Have you been diagnosed with: 
Diabetes Y / N 
  
Renal Failure Y / N  
 
Rheumatoid Arthritis Y / N  
 
Epilepsy Y / N  
 
HIV / AIDS Y / N  
 
Tuberculosis (TB) Y / N  
 
Cancer Y / N 
 
Hypertension Y / N 
 
Infection Y / N 
 
2. Are you currently pregnant?       Y / N  
3. Have you ever had pain or other symptoms in your neck, shoulders or arms? Y / N 
4. Have you ever had an operation on your neck, shoulders or arms?  Y / N 
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5. Have you ever had a fracture in your neck, shoulders or arms?  Y / N  
6. How many units of alcohol do you consume in a typical week?  ____ 
 
If you have answered yes to any of there questions you may not be eligible to take part 
in the study. If you are not sure please contact us to discuss this. 
 
If you have answered ‘no’ to questions 1 to 5 above please continue. 
 
Section 2: All participants 
 
Are you right handed? Y / N 
 
Have you ever experienced dizziness while turning you head or looking up and down? Y / N      
If yes, when? …………………………. and how frequent? 
…………………………………………………                                                                                                          
If so, what actions did you take (e.g. visit to a GP, inner ear disorder, etc)? 
……………………………………….....and what was the problem…………………….          
Have you ever experienced unsteadiness with a feeling of almost falling or bumping into 
things? Y / N 
If yes, when? ………………………….and how frequent? ………………………………… 
  
   
 If so, what actions did you take (e.g. visit to a GP, inner ear disorder, etc)? 
……………………………………….....and what was the problem…………………………. 
 
 
If you have not been involved in a road traffic accident in the past, please do not 
complete any of the remaining sections. Thank you for completing the above questions. 
 
Section 3: Participants who have been involved in a road traffic accident 
 
If you have suffered a road traffic accident in the past please answer the following 
questions (please circle one answer only): 
 
1. How long ago was the accident? __________Years_________months.  (If you 
cannot remember exactly, please estimate). 
 
2. Which part of your vehicle was involved?   Front / Side / Rear  
   
3. Did you suffer concussion, loss of consciousness or a direct head injury as a result of 
the accident?         Y/N 
 
4. Have you made a compensation claim as a result of the accident? Y/N 
If so, is the claim process now completed?  Y/N 
 
5. Have you had any treatment for your whiplash injury?   Y/N 
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 If so: what treatment did you receive:  
Physiotherapy treatment 
Chiropractic treatment 
Acupuncture 
Other (please state): _____________________ 
 
How many treatments did you have? 1-5 / 6-10 / 10+ 
 
 
Section 4: Your symptoms 
 
 
1. Are you currently experiencing any pain? Y / N  
If yes, please put an X on the line below to indicate your current level of pain (when 
resting).  
 
2. Please indicate any pain medication you are currently taking  
................................................................................................................................................. 
................................................................................................................................................. 
 
3. Please use the scale below to indicate how cold your pain feels. Words often used to 
describe cold pain feelings include “like ice” and “freezing”. 
 
1. Are you more or less sensitive to cold in the area of your pain?  
      (E.g. sitting by an open window) More / Less / Neither 
 
2. Is your pain provoked or increased by contact with something cold on the painful area? 
 Y / N 
 
3. Do you find hot weather increases your symptoms?      Y / N 
 
4. Do you find pressure increases your symptoms?       Y / N 
 
5. Do you find touch increases your symptoms?        Y / N 
 
 
 
Thank you for completing the above questions. 
No “freezing” 
pain  
 
Worst 
“freezing” pain 
imaginable
No pain  
 
Worst pain 
imaginable 
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  The University of Birmingham 
 
Nursing and Physiotherapy and School of Sport and Exercise Sciences 
 
 
 
 
 
 
Study title  
 
An evaluation of the physical characteristics in subjects who have previously experienced a 
whiplash injury 
 
 
Invitation  
 
You are being invited to take part in a research study. Before you decide, it is important for 
you to understand why the research is being done and what it will involve.  Please take time 
to read the following information carefully and discuss it with others if you wish.  Please ask 
if there is anything that is not clear or if you would like more information.  Take time to 
decide whether or not you wish to take part. This work is being undertaking as part of an 
educational qualification. 
 
 
What is the purpose of the study?  
 
The purpose of this research is to compare the physical characteristics (ultrasound evaluation 
of nerve characteristics and the upper limb tension test) in subjects who have previously 
experienced a whiplash injury compared with those who have not previously had an injury.  
 
Why have I been chosen?  
 
You have been asked to participate because you are a member of staff or a student at the 
university and you either: 
1. have previously experienced a whiplash injury 
2. have no previous whiplash, head or neck injury. 
 
 
Do I have to take part?  
 
It is up to you to decide whether or not to take part.  If you do decide to take part you will 
be given this information sheet to keep, and be asked to sign a consent form. If you decide 
to take part, you are still free to withdraw at any time and without giving a reason. A 
decision to withdraw at any time, or a decision not to take part, will not affect you in any 
way. 
Participant Information Sheet 
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What will happen to me if I take part?  
 
We will phone you to organise a time when you can attend for the study during the week of 
the testing. Before you arrive at the study we will send you a health questionnaire. On the 
day of the study, a maximum of one hour of your time will be required.  
 
 
What do I have to do? 
 
You will need to attend one session that will last approximately one hour. During this 
session, the researchers will answer any questions you may have and if you are willing to 
take part. A researcher will then discuss your completed questionnaire with you to ensure 
you meet all the inclusion criteria for the study and that you consent to your participation in 
the study. The physical measurements can then be completed on that same day.  
 
The researcher will explain the procedure in full to you and show you the equipment that we 
need to use in testing. Ultrasound imaging of your arm nerves will then be taken. The 
measurements will be taken in the School of Sports Sciences.  
 
In the laboratory a researcher will ask you to complete three questionnaires that will take 
approximately 10 minutes. If you have any difficulty completing the questionnaires the 
researcher will be able to assist you. The questionnaires will provide us with some 
background information for the study. In the Sports Science laboratory you will have 
measurements taken of the movement of the nerves in your arms. One test will ask you about 
any symptoms you experience as your arm is moved by a researcher to tension the nerves, 
and this may cause some temporary discomfort. The researcher will ask you to rate any 
discomfort that you feel on a scale. The other tests will measure the movement of the nerves 
using an ultrasound machine similar to the machine used to look at babies during pregnancy. 
You will not feel any discomfort during the ultrasound testing. These tests will take 
approximately 45 minutes and 3 researchers will take the ultrasound measurement. The 
research team will be working together to ensure that the measurements are taken efficiently 
and that you are comfortable throughout the tests. 
 
To take the required measurements, the researcher needs access to your neck and arms, so it 
is preferred that you wear a short sleeved upper garment such as a vest or t-shirt, and shorts.  
If you wear a long sleeved shirt/top, you will be asked to remove this and you will be 
provided with an open backed gown. 
 
What happens after the session?  
You will not be required to return for further testing. 
 
  
What are the possible benefits of taking part?  
 
This is an opportunity to take part in an exciting research project that may help us further 
understand how nerves are affected, both physically and in their function following some 
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whiplash injuries. Knowing this information may help healthcare professionals to decide 
how best to assess nerve function. The results could also assist in the development of future 
management strategies following whiplash. 
 
 
Am I eligible for this study?  
 
If you are between 18-55 years of age and you are a staff member or student of the 
University of Birmingham then you are eligible to be included in the study. If you have 
also had a previous ‘whiplash’ injury as a result of a road traffic accident over 6 months, 
and you still have restricted neck movements and/or tenderness in the neck and/or arm – 
you are also eligible to be included in the study. 
 
To take part in the study you must not: 
• Have had any surgery or fracture to the upper limb or neck in the past. 
• Have diabetes, epilepsy, HIV, renal failure, tuberculosis, rheumatoid arthritis, or 
cancer.  
• Be pregnant. 
• Have an ongoing infection. 
• Have experienced neck or arm pain prior to any road traffic accident that required 
healthcare treatment. 
• Currently be receiving treatment for whiplash injury. 
 
What are the possible disadvantages and risks of taking part?  
 
The use of ultrasound is considered a safe procedure and widely used by health. The study 
will be utilizing low frequency and levels of power which meet the American Federal Drug 
Administration (FDA) levels of exposure. There have been no documented side effects in 
the use of ultrasound using these powers. The use of the other sensory testing procedures is 
considered safe and is widely used by health care professionals. Some of the measures will 
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cause you to feel pressure / temperature / vibratory sensations which are only present when 
measurements are made. 
Will my taking part in this study be kept confidential? 
 
All information that is collected about you during the course of the research will be kept 
strictly confidential. Information about you will be removed so that you cannot be recognised 
from it.  
 
What will happen to the results of the research study? 
 
They will be presented as part of educational qualifications. They may be presented within 
the university, and used for conference presentations or publications in academic journals.  
 
Can I claim expenses?  
 
We regret that we are unable to offer any expenses payment. 
 
Who is organising and funding the research?  
 
Dr Alison Rushton* is the lead researcher and this study is being conducted in collaboration 
with Chris Wright*, Dr. Martin Lakie**, Edeni Kennedy (Research student)*. There is no 
funding for this research. 
 
* Nursing and Physiotherapy 
** Sport and Exercise Sciences. 
 
Who has reviewed the study?  
Sport and Exercise Sciences Research Sub-Committee 
Thank you for taking the time to read this leaflet.  
 
If you have any questions or complaints, please do not hesitate to contact: 
 
Alison Rushton (Supervisor)  
0121 415 8597  
Email: a.b.rushton@bham.ac.uk 
 
Christine Wright (Supervisor)  
0121 415 8597  
Email: c.c.wright@bham.ac.uk 
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APPENDIX 3: CONSENT FORM 
 
The University of Birmingham 
 
School of Health Sciences and School of Sport and Exercise Sciences 
  
Participant Identification number: ..........................................................  
 
 
CONSENT FORM 
 
Title of Project 
An evaluation of the physical characteristics in subjects who have previously experienced a 
whiplash injury  
 
Name of Researchers: Kennedy Edeni 
 
This research is not a diagnostic tool, nor a means for providing treatment. 
 
          
Please tick appropriate box 
 
1. I confirm that I have read and understand the information sheet and have had the 
opportunity to ask any questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
  without giving any reason. 
 
 
3. I agree to take part in the above study.  
  
________________________ ____________________________ 
Name of Participant Date Signature 
 
 
________________________ ___________________________ 
Name of person taking consent  
 (If different from researcher) Date Signature 
 
________________________ ____________________________ 
Name of Researcher Date Signature 
 
(Copies of consent for: participant and researcher) 
 
All information collected will be stored in accordance with the Data Protection Act 1998.
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APPENDIX 4 
Hazard and Risk Assessment Summary 
School/Dept Nursing and Physiotherapy  Location of 
Activity  
Ultrasound Lab, Sport and 
Exercise Sciences 
 Date of 
Assessment 
October, 2008 
        
Assessor Lead Researcher – Dr. Alison Rushton 
Edeni Kennedy 
 Activity 
Assessed 
An evaluation of the physical characteristics in subjects who have
previously experienced a whiplash injury 
   (Attach 
protocols) 
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Key PERSONS AT RISK  PERSONAL  LIKELIHOOD  Risk Significance Date for Review  
 Ug Undergraduate  F Fatality  Y Yes/ Very 
High 
  Y Pr P
o 
R      
 Pg Postgraduate  Mj Major Injury  Pr Probable  F      / = Significant risk   
 S Staff  Mn Minor Injury  Po Possible  M          
Assessment of Hazard and Risk Control Measures Required 
HAZARD 
(List only hazards from which there is a 
significant risk of serious harm under 
foreseeable conditions) 
PERSONS 
AT RISK  
(See key,  
PERSONA
L HARM? 
LIKELIHOOD  
Of HARM? 
 
 Indicate 
number) 
F Mj Mn Y Pr Po R  
          
1/ Obstacles in room leading to trips and 
falls 
 
 
2/ Possibility of plinth failure – brakes, 
mechanism 
 
 
3/ Possibility of neck soreness from 
performing contralateral neck lateral 
flexion movement as part of the testing 
procedure  
 
 
4/ Use of US. 
Ug, Pg, S 
 
 
Ug, Pg, S 
 
 
Ug, Pg, S 
 
 
 
 
Ug, Pg,S 
 
 
  X 
 
 
X 
 
 
X 
 
 
 
 
X 
   
 
 
 
 
 
 
 
R 
 
 
R 
 
 
R 
 
 
 
 
R 
 
 
Ensure environment is clear of obstacles and risks prior to performing
study. 
 
 
Check plinth prior to testing and between testing sessions. 
 
 
Ensure Subjects are aware that movement performed would not be
uncomfortable and that they are aware that they are free to withdraw from
the study at any stage without giving a reason. 
 
 
Investigators trained in the use of US.  Ensure equipment meets safety
standards. 
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 C Contractor     R Remote  M   X X  X = Insignificant risk   
 V Visitor                  
 Pa Patient   Major Injury: Loss of or broken limb   
 Pu General Public    Loss of or damaged eye   
 Yp Young Person    Loss of consciousness   
 Nm New/Expectant 
Mother 
   Acute illness needing medical treatment   
      Permanent ill health or disability   
  
Appendix B: DUI Image capture protocol  
 
Ultrasound imaging of the median and ulnar nerve in the transverse and longitudinal plane 
was assessed using the Diasus Ultrasound system (Dynamic Imaging, Livingston, Scotland, 
UK); 8-16 MHz 26mm linear array transducer. Sequences of images were obtained at 10 
frames per second and the images were converted to digital format and analysed offline 
using software developed in Matlab®. The image resolution was 0.093 mm/pixels with an 
image size of 590 X 790. The offline analysis employed a cross-correlation algorithm to 
determine relative movement between adjacent frames in sequences of the ultrasound images 
(Dilley et al., 2001).  
 
Subject’s identification details were entered into the ultrasound system. Two test positions 
was utilised in capturing nerve movements in the upper limb during the study. One test 
position was used for median nerve imaging and the other for the ulnar nerve. In both test 
positions, contralateral neck side flexion (CNSF) to the limit of pain tolerance (P1) or the 
available ROM (R2) for each subject was carried out. The CNSF has been used in previous 
DUI study (Dilley et al., 2003) and is also used in clinical practice as a component of the 
ULNT to sensitize or desensitize a peripheral nerve when it is loaded. 
 
Five practice repetitions were carried out passively to eliminate serial effect (Shuba, 
unpublished dissertation, 2008). The CNSF was maintained during all measurements for 
each subject. Three measurements were taken by each rater for each subject in each test 
position and the order of rating was balanced to eliminate order effect. There were no rest in 
between measurements as there is no evidence within literature supporting adverse reaction 
following such manoeuvre. 
 
Median Nerve 
Limb position  
In the laboratory, measurements of the movement of the median nerve in the upper limb 
were taken at the wrist and forearm. Subjects were required to expose the arms and a full 
explanation of the procedure was given. The participant lay down in supine position on a 
  
couch. The arm was placed in a splint that allowed for 30 degrees shoulder abduction, elbow 
extension and wrist in neutral position. Movement is induced in the median nerve when the 
shoulder is abducted and the elbow and wrist are extended (Wright et al, 1996; Dilley et al., 
2003). Velcro strapping was used to prevent the arm from moving off this position. 
Subsequently, the CNSF was applied and images of nerve movement were captured. Passive 
CNSF stopped if the subject experienced pain or reported P2; otherwise movement was 
carried to the end of available ROM. 
 
Transverse Section 
Imaging in transverse section of the median nerve was taken at both the wrist crease and mid 
forearm. In this test position, the median nerve lay superficially and this enhanced image 
clarity. These test positions have been reported in the literature to demonstrate transverse 
movement (Greening et al, 2005; Dilley et al, 2007).  
 
Probe position 
(a) Wrist crease: this was the skin crease just proximal to the two prominences in the palmer 
surface of the hand. 
(b) Mid forearm: this position was defined as the midpoint between the wrist crease and 
elbow joint line. In both test positions, the surface of the skin was marked using thin strips of 
tape (2mm).  
 
The testing protocol involved: 
• Ultrasound Gel was placed on the arm position where the measurement was taken. 
• Two strips were positioned apart along the longitudinal axis of the forearm to serve as 
skin markers so that nerve movement was measured relative to these markers.  
• Passive CNSF was performed. 
• Nerve images pre and post CNSF in the transverse plane of the nerve was captured into 
the PC hard drive. 
• Captured images were transferred into a memory stick and stored. 
 
  
Longitudinal Section 
Probe position 
• Mid forearm: This position has been used in previous studies (Dilley et al., 2003; 
Greening et al., 2005). 
The testing protocol involved: 
• Ultrasound Gel was placed on the mid forearm 
• Passive CNSF movement was performed  
• Cine loop measurements of the corresponding nerve movement were captured into the 
PC temporal memory.  
• The image was played and then saved into the PC hard drive. 
• Saved images were transferred into memory stick and stored. 
 
Ulnar Nerve 
Limb position 
Measurements of ulnar nerve movement in the upper limb were taken 4 inches proximal to 
the medial epicondyle of the humerus. The ulnar nerve lay superficially in this position, and 
this enhanced image clarity. The ultrasound probe was freed from any bony interference 
(Humeral medial epicondyle) as it moved from the transverse to the longitudinal plane 
(Greening et al., 2005)  
 
Subjects were required to expose their arm and a full explanation of the procedure was given. 
The participant lay down in supine position on a couch. The arm was positioned in full 
available shoulder abduction, elbow flexion and wrist extension. Dilley et al (2007) reported 
that the ulnar nerve begins to stretch when the wrist is extended with the shoulder abducted 
to 90o and the elbow flexed to 90o, simulating the ULTT 2a used in clinical setting to 
mechanically provoke the ulnar nerve. Velcro strapping was used to prevent the arm from 
moving off this position. Subsequently, the CNSF was applied and images of nerve 
movement were captured. Passive CNSF stopped if the subject experienced pain or reported 
P2; otherwise movement was carried to the end of available ROM. 
 
  
Transverse plane 
Probe position 
(a) 4 inches proximal to the medial epicondyle of the humerus 
The testing protocol involved: 
• Ultrasound Gel was placed on the arm position where the measurement was taken. 
• The surface of the skin was marked using thin strips of tape (2mm).  
• Two strips were positioned apart along the longitudinal axis of the arm to serve as skin 
markers so that nerve movement can be measured relative to these markers.  
• Passive CNSF was performed. 
• Nerve images pre and post CNSF in the transverse plane of the nerve was captured into 
the PC hard drive. 
 
Longitudinal Section 
Probe position 
(a) 4 inches proximal to the medial epicondyle of the humerus 
The testing protocol involved: 
• Ultrasound Gel was placed over this position. 
• Passive CNSF movement was performed  
• Cine loop measurements of the corresponding nerve movement were captured into the 
PC temporal memory.  
• The image was played and then saved into the PC hard drive. 
• Saved image was transferred into memory stick and stored. 
 
 
 
 
 
  
APPENDIX C: DUI image analysis protocol 
STEPS  
 
• Horizontal Nerve Movement 
A. Run Analysis program  
a) Double click ® on the Analysis program icon “shortcut to motion06.exe” on the 
desktop  
b) Click ok. 
c) Double click on Ultrasound, and then click ok. 
d) Use the browser to find the image files to be analysed on the desktop. 
e) Highlight any ‘bmp’ file from the sequence to be analysed, and press open (you 
should see JUST ONE file in the browser) and then press continue.  
f) Use the initial two symbols in the browser (single point/double point) to return to 
previous/higher directories). 
g) Select frame number sequence: If the sequence is numbered 1, 2, 3….10 etc, 
select No. However, if the sequence is numbered 01, 02 03….10, i.e. there is a 
zero in front of frames 1-9, then select Yes.  
h) Preview movie. 
i) Enter the length of the loop at the prompt. This is useful to determine the 
approximate frame during the sequence that the movement starts.  
 
B. Cross-Correlation Image Analysis panel 
a) Start Frame                    Enter the start frame number.  
b) End frame                 Enter the end frame of sequence.  
c) Start horizontal pixel shift     Maximum extent in pixels that the compared    
(Left) frame will be offset along the horizontal image  
 plane to the left (denoted by negative value). 
d)  End horizontal pixel shift      As above but maximum shift to the right (positive 
(right)                     value) 
 
  
e) Save As                   Filenames of the excel results files. Change              
‘_Nerve’ to the name of the tissue of interest. 
 
f) Directory    Directory in which the files will be saved (the default      is the 
original ‘bmp’ directory). 
 
g) Vertical tracking of ROI  Switches off vertical tracking (only required if the     
  tissue of interest has a steep gradient).    
 
h) Start vertical pixel shift (up)  Maximum vertical offset (up screen). Each      
 Horizontal cross correlation is performed with the  compared frame offset along 
the vertical image plane (default= -2 to +2 pixels) so a value for  vertical 
movement can also be obtained.     
 
i) End vertical pixel shift (down) Maximum vertical offset (down screen). 
 
j) Background (0)/Tissue of interest (1)           Select (1) for tracking nerve 
etc. Select (0) for  tracking background (e.g. bone etc). The  background can 
then be subtracted from the  tissue of interest. 
 
k) Pixels/mm   Selects the number of pixels per mm 
 
I. Determine the probe length used to capture the images 
 
II. Determine the resolution and pixel size of stored image 
 
III. Calculate the conversion scale for the cross-correlation offline program. The 
scale is a ratio of the image length in pixels divided by the transducer length 
in mm and it enables the offline analysis program to convert any nerve 
movement measured in pixels in the image to length in mm. 
 
  
Dilley & Greening et al (2001) 
 280 Pixels (Image length) = 10.8 pixels/mm 
26mm (Probe length) 
 
Present Study  
                      596 Pixels (Image length) = 22.9 pixels/mm 
26mm (Probe length) 
 
l) The last two boxes enable the pixel shift threshold and the ‘a’ value threshold to 
be altered. These values should not be altered. 
 
C. Select Region of Interest 
 
a) Press and hold left mouse button at the top left corner of the region of interest. 
Drag mouse (holding button) to bottom right corner of region. The coordinates 
are displayed at the top left of screen (x, y, x offset, y offset). Multiple regions 
can be selected. Press ‘No’ (on ‘another region?’) to run cross correlation. 
 
b) The larger the area, the more reliable the result (because there are more pixels to 
cross correlate). Previous studies that utilised this method for nerve movement 
analysis have found that three areas over the nerve is sufficient. However, the 
present study carried out a pilot analysis which showed that 4 areas will reduce 
error due to variability in box positioning within the nerve. 
 
c) Selected region of interest should not cross areas between different tissues. 
 
a. Divide the nerve into 4 regions or segments and place a box in each using a 
transparent template 
 
b. Place a box in areas of grey contrast within each region of the nerve and 
avoid areas with little or no grey contrast 
  
 
c. Place 2 boxes in areas of grey contrast on the bone interface and avoid areas 
with little or no grey contrast. The boxes should cover the same area of nerve 
analysed above. 
 
d. Gold standard for accepting the values from data analysed will be a 
straight or near–straight square wave graph of the horizontal movement 
after subtraction from the hypotenuse (Dilley et al., 2001). 
 
e. The estimated time of the analysis is displayed at the bottom right. 
 
f. To maintain consistency with the placement and size of boxes used in the 
region of interest during image analysis, a transparent template containing 4 
and 2 equidistant boxes for the nerve and background respectively will be 
placed on the screen over the image to be analysed.  
 
g. To further improve the quality of the result, the boxes within the nerve will be 
in a way that keeps them inside the region of interest throughout the 
movement. 
 
d) Background subtraction (Hypotenuse): The horizontal result for the background 
has been subtracted from the tissue of interest hypotenuse result.  
 
e) Background subtraction (Horizontal): The horizontal result for the background 
has been subtracted from the tissue of interest horizontal result. 
 
f) A movie can be previewed of the results. The blue rectangles represent the 
regions of interest. The small yellow squares represent the result for each area. 
The white squares are the result for the total/combined area. The white squares 
move the same in each area of interest. 
 
  
g) With the background analysed, the following option will be displayed: ‘Do you 
wish to view the subtracted background from the total area results?’ This option 
will produce graphs of the results for the background (total/combined area result) 
subtracted from the tissue of interest (total/combined area result). 
 
h) Pressing ‘Yes’ will produce the following option: ‘Subtract from the hypotenuse 
(select no to subtract from the horizontal’). This allows you to either subtract the 
background (horizontal result) from either the hypotenuse or the horizontal 
total/combined area results for the tissue of interest.  
 
i) The graphs are arranged in 3 columns:  
 
I. Velocity profile and cumulative hypotenuse result for the total/combined area 
of the tissue of interest. 
 
II. Velocity profile and cumulative hypotenuse result for the total/combined area 
of the background. 
 
III. Velocity profile and cumulative hypotenuse result for the subtraction. 
 
IV. These graphs can be printed. 
 
V. Each image is analysed 3 times and the average of the 3 values calculated. 
 
D. Result 
 
a) The results for the total (combined areas) and each individual area are displayed 
in each column. The first column is the total/combined area result. The total 
combined column (1st column) is generally the most reliable result. This is similar 
to an average of the individual regions. 
 
  
b) A poor result may be because the individual areas of interest were too small or 
the image quality is not good enough. It may be necessary to reanalyse but 
without the bad areas. 
 
c) Most movements should be smooth. The velocity profile graph should look like a 
square wave.  
 
d) Each of the above is displayed in mm and a summary of these results can be 
printed off. 
 
• Transverse Nerve Movement 
 
A. Image Optimization 
 
a) Open the transverse image in Microsoft Office picture manager. 
 
b) Press ‘’autocorrect’’ to enhance visibility of the nerve margin and adjacent 
markers. 
 
B. Run Analysis program  
 
a) Double click on the Analysis program folder “tpsDig2” on the desktop. 
 
b) Double click on the ‘’tpsDig2.exe’’ to run the program. 
 
c) Select the first image (pre-movement) to be analysed from the image folder. 
 
d) Image is displayed in the main window.  
 
e) Digitize the landmarks or the outlines of the nerve and adjacent markers. 
 
  
I. Digitize the landmarks of the Nerve by clicking on the top centre, bottom 
centre, right edge and left edge of the nerve. 
II. Digitize the landmarks of the markers by clicking on the top midpoint of each 
marker. 
 
f) Click on ‘’Save data as TPS file’’ through the file drop down menu.  
 
g) Input a file name and clink on ‘’Save’’ 
 
h) Select the second image (post-movement) to be analysed from the image folder. 
 
i) Image is displayed in the main window. 
 
j) Digitize the landmarks or outlines of the nerve and adjacent markers. 
 
I. Digitize the landmarks of the Nerve by clicking on the top centre, bottom 
centre, right edge and left edge of the nerve. 
 
II. Digitize the landmarks of the markers by clicking on the top midpoint of each 
marker. 
 
k) Click on ‘’Save data as TPS file’’ through the file drop down menu. 
 
l) Input the same file name used above and clink on ‘’Save’’. 
 
m) Click on ‘’Append’’ in the resulting dialogue box. 
 
n) Exit the TpsDig2 program. 
 
o) Double click on the ‘’WhipTrans2cons.xls’’ inside the TpsDig folder. An excel 
spreadsheet opens. 
  
 
p) Calculate the conversion scale for the WhipTrans offline program. The scale is a 
ratio of the image length in pixels divided by the transducer length in mm and it 
enables the offline analysis program to convert any nerve movement measured in 
pixels in the image to length in mm. 
 
Greening et al (2005) 
  
280 Pixels (Image length) = 10.8 pixels/mm 
26mm (Probe length) 
 
Present Study 
 
596 Pixels (Image length) = 22.9 pixels/mm 
26mm (Probe length) 
 
q) Input the conversion scale into the ‘’Calibration’’ row in the WhipTrans 
spreadsheet. 
 
r) Open the saved TPS data file in a new page in Excel using the file drop down 
menu. 
 
s) Click on ‘Next’ in the ‘’text import wizard’’ and check the ‘’space’’ box  
 
t) Click on the Next and Finish button thereafter. 
 
u) The spreadsheet shows 2 sets of figures in two columns 
 
v) Copy and paste each set into the WhipTrans program. The upper set of figures is 
pasted into “row 15’’ and the lower set of figures into “row 23” of the 
spreadsheet. 
  
 
w) The nerve movement in the AP and horizontal plane is calculated in pixels and 
mm. 
 
x) Each image is analysed 3 times and the average of the 3 values calculated. 
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